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Enteric viruses pose a significant health risk to the public through exposure to contaminated 
environmental waters, costing society billions of dollars to treat millions of excess illnesses 
annually. Current available methods to monitor human fecal pollution in impacted waters either 
do not correlate with viral pathogen presence and risk, cross-react with other animal sources, or 
are not abundant enough in environmental waters to be reliably detected. This dissertation 
investigates a novel target for a human-specific indicator of fecal pollution, the bacteriophage 
“crAssphage”. First, a metagenomic evaluation was conducted as an initial step to evaluate the 
potential of the crAssphage genome for assay development. Results indicated that crAssphage is 
enriched in sewage and more abundant than other viruses and bacteriophages in sewage, 
suggesting its high potential as a target for human-specific marker development. Next, end-point 
PCR primers were designed along the length of the crAssphage genome and screened against 
human sewage samples and non-human animal fecal samples to assess which genomic regions 
may be the most useful as source tracking markers. The two best performing primer pairs were 
adapted to TaqMan qPCR assays. These assays were evaluated head-to-head against two 
bacterial qPCR human source tracking markers to evaluate their performance. The assays were 
widespread in geographically diverse human sources and as abundant or more abundant in 
  v 
sewage and impaired environmental water than the bacterial-based assays. Moreover, the assays 
displayed high human-association. Finally, an initial environmental evaluation was conducted to 
correlate the crAssphage-based assays to pollution events, culturable bacterial and phage 
indicators, and molecular bacterial and viral indicators. This study demonstrated the usefulness 
of the crAssphage assays in a real-world system, validating their high abundance and correlation 
with pollution events and other indicators of fecal pollution. Ultimately, the research in this 
dissertation contributes two novel viral-based technologies for detection of human fecal pollution 
that will enhance management of environmental waters and protect public health through the 
development of an abundant viral fecal source-tracking marker.  
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1.0  INTRODUCTION 
This dissertation details the development and initial evaluation of novel human-specific, viral-
based source tracking technologies. The methods developed in this dissertation research were 
designed based on a newly discovered bacteriophage, crAssphage, to be used for water 
management applications. 
1.1 MOTIVATION 
Evidence exists that enteric viruses are the leading causes of recreational waterborne illnesses, 
representing a significant portion of the environmental water disease burden [1, 2]. Norovirus is 
recognized as the single leading cause of outbreaks with total norovirus gastroenteritis incidence 
amounting to $4.2 billion in direct health systems costs and $60.3 billion in societal costs 
annually worldwide, with approximately 20 million cases occurring annually in the United States 
[3-6]. It has been shown that about 16% of all norovirus gastroenteritis illness is caused by 
environmental sources, such as consuming contaminated water and shellfish [7]. Considering the 
number of environmentally relevant viruses, total cost and incidence estimates are expected to be 
much higher; however, the economic and disease burden of enteric viruses is not well 
characterized. Currently, no environmental water quality regulations exist to measure norovirus 
or other enteric viruses in environmentally polluted waters [8]. Regulations have been difficult to 
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implement based on unreliable detection methods for low environmental concentrations of 
viruses.  
 Regulations for monitoring environmental waters are currently only available for 
bacteria. Environmental waters are monitored for fecal pollution by detection of general fecal 
indicator bacteria (FIB) by culture-based methods. While these methods can give valuable 
insight into general pollution conditions of bodies of water, many shortcomings remain with 
these methods. First, these bacteria are general indicators, meaning they are shed by many warm-
blooded animals. The animal source of the pollution cannot be ascertained, confounding 
management efforts. Second, FIB can survive and persist in environmental waters; therefore, 
their detection is not necessarily indicative of a recent pollution event. Third, detection methods 
for FIB remain culture-based; however, culture-independent methods are desirable to provide 
more rapid data acquisition and more immediate regulatory action [9]. Lastly, FIB have been 
shown to not correlate well with viral health risk. As stated above, viruses represent a significant 
health burden in environmental waters, with the incidence of viral environmental outbreaks 
rising and viral outbreaks even occurring when bacterial indicators were undetected or below 
regulated levels [1, 2]. Current research efforts seek to address these shortcomings using novel 
technology development. 
 Microbial source tracking has emerged as a research field in the past ~25 years to 
determine the sources of fecal pollution to environmental waters. Improving on the lack of 
specificity of FIB, many assays have been developed to detect fecal material specific to various 
species of animals including cows, pigs, chickens, dogs, ducks, geese, and gulls [10-14]. In 
addition, numerous assays have been developed to specifically detect human fecal material [15-
17]. Human-specific assays are particularly desirable as human waste has been shown to pose a 
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greater health risk to humans than waste from other animals [2, 18, 19]. In addition, pollution 
from human sources is more readily controlled than waste from other animals, such as wildlife. 
 Several assays for detection of human fecal waste have been developed based on viruses, 
both pathogenic and non-pathogenic [20-24]. These assays have been devised for use as a direct 
measure of viral health risk of an impacted water body. Despite their direct correlation with 
health risk, enteric viruses have proven difficult to track due to lack of culture methods and 
dilute concentrations in environmental waters [8, 25-28]. Since they are specific to human 
sources, their detection results in high confidence that human fecal pollution is present. 
Conversely, as they are not reliably detected at low concentrations, their absence in 
environmental waters does not instill the same confidence that human fecal pollution is absent. 
Consequently, there is a critical need for a surrogate indicator of enteric viruses in the 
environment to accurately assess health risk and guide remediation efforts.  
Bacteriophages have long been considered as surrogates for modeling viruses in 
environmental systems and studies [29, 30]. Bacteriophages are useful due to their similar size 
and morphology as pathogenic viruses, in addition to their high abundance in sewage [31]. 
Further, they pose no health risk to human researchers. Recently, a novel bacteriophage, 
crAssphage, was discovered by metagenomic data mining [32]. The genome sequence for 
crAssphage was assembled from an individual human gut metagenome and likely represents a 
crAssphage metapopulation. CrAssphage was found to be more abundant than all other known 
human gut phages combined and was mostly associated with human gut metagenomes [32]. 
CrAssphage has the potential to be utilized as a highly sensitive and specific marker of human 
fecal pollution that could be used as a surrogate of viral-risk in environmental waters. In 
addition, the initial evidence of high abundance and high human-specificity that crAssphage 
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exhibits could improve upon shortcomings witnessed with general FIB and other developed MST 
assays, making crAssphage an ideal target for human-specific marker development.  
 The research presented in this dissertation investigates the utility of crAssphage as a 
template for human-specific source tracking technology development. CrAssphage was first 
evaluated as a candidate for assay development based on bioinformatics data. Next, PCR 
technologies were developed and evaluated across the crAssphage genome to explore the 
variable performance across the genome and select the best performing regions. Subsequently, 
PCR assays were adapted to a qPCR platform and evaluated for performance metrics. Finally, an 
initial environmental evaluation of the developed crAssphage qPCR assays was performed.  
1.2 RESEARCH OBJECTIVES 
The research objections of this dissertation have been addressed through the following research 
projects and represent three manuscripts for publication (represented by chapters 3, 4, and 5). 
The dissertation is laid out in the following way to present the findings of the research. 
 Chapter 2: A review of human source tracking technologies: state of the science and 
research needs 
 This chapter provides an extensive review of genetic markers that have been proposed 
and evaluated for detection of human fecal pollution in environmental waters. Discussion is 
particularly focused on how these technologies have improved on general indicator technologies 
and shortcomings of the specific assays. This information is synthesized to provide context for 
how crAssphage markers for source tracking contribute to the tools currently available for 
managing environmental waters.  
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Chapter 3: Metagenomic evaluation of the highly abundant human gut bacteriophage 
crAssphage for source tracking of human fecal pollution  
This work has been published as: 
Stachler, E. and Bibby, K. Metagenomic evaluation of the highly abundant human gut 
bacteriophage crAssphage for source tracking of human fecal pollution. Environ. Sci. Technol. 
Lett. 2014, 1 (10), 405-409. 
This chapter evaluates the potential of crAssphage for development of human-specific 
source tracking technologies. An initial metagenomic evaluation is valuable as a first step to 
determine if more extensive and more expensive lab evaluation is warranted in evaluating 
potential source tracking microbial targets. In this study, 86 publically available metagenomes 
were surveyed for crAssphage presence. Metagenomes were taken from various environments, 
including human sewage, non-human animal fecal matter, and environmental waters. 
Metagenomic DNA reads were mapped against the crAssphage genome as a proxy for 
crAssphage abundance in that environment. In addition, metagenome reads from human sewage 
samples were mapped against other viruses found in the human gut or suggested for source 
tracking technologies. Results suggested that crAssphage was highly specific to human sewage 
and more abundant than other viruses typically monitored in sewage, making it an ideal 
candidate for human source tracking technology development.  
Chapter 4: Quantitative crAssphage PCR assays for human fecal pollution measurement 
This work has been published as: 
Stachler, E.; Kelty, C.; Sivaganesan, M.; Bibby, K.; Shanks, O. Quantitative CrAssphage pcr 
assays for human fecal pollution measurement. Environ. Sci. Technol. 2017, 51(16), 9146-9154. 
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This work is also the subject of a patent application: 
Stachler, E.; Bibby, K.; and Shanks, O. Cross-Assembly Phage DNA Sequences, Primers and 
Probes for PCR-based Identification of Human Fecal Pollution Sources. Application Number: 
62/386,532 
This chapter outlines the development of human specific qPCR assays based on 
crAssphage. These assays were designed and rigorously tested through three main tasks. The 
first task was to design primer pairs in silico across the length of the crAssphage genome. The 
second task was to evaluate the primer pairs designed in the first task by PCR in the laboratory 
against fecal reference composite material. The objective of the third task was to adapt the best 
performing primer pairs based on the results of the second task to a qPCR platform. Two qPCR 
assays were developed based on crAssphage and were tested head to head with two bacterial 
qPCR assays for performance criteria including specificity, geographic stability, and an 
environmental proof-of-concept. This effort resulted in two viral-based qPCR assays that were 
highly human-specific and abundant in reference materials, having significant potential in water 
management applications.  
Chapter 5: Evaluation of crAssphage-based qPCR markers in an impacted urban 
watershed 
This work is currently in review for publication: 
Stachler, E.; Akyon, B.; Aquino, N.; Ference, C.; Bibby, K. Evaluation of crAssphage-based 
qPCR markers in an impacted urban watershed. In Review. 
This chapter provides an initial environmental evaluation of the qPCR assays developed 
in the research discussed in the above chapter. It is necessary to test the assays in a real-world 
system to verify assay performance. Stream water was collected daily for 30 days from Nine 
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Mile Run in Pittsburgh, PA and evaluated for chemical and biological water quality parameters. 
Biological parameters included culturable bacterial and viral assays as well as bacterial and viral 
molecular assays. CrAssphage assay occurrence and abundance was correlated with chemical 
and biological parameters as well as with pollution events. The crAssphage assays were found to 
correlate with pollution events and other indicators of fecal pollution, both culturable and 
molecular.  
Chapter 6: Summary and conclusions 
This chapter summarizes the major findings of the dissertation research, discusses the 
implications of the research, and suggests areas of future research.  
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2.0  A REVIEW OF HUMAN SOURCE TRACKING TECHNOLOGIES: STATE OF 
THE SCIENCE AND RESEARCH NEEDS 
2.1 MICROBIAL SOURCE TRACKING INTRODUCTION 
2.1.1 Shortcomings of the Current Approach 
Environmental waters polluted with fecal matter have been shown to pose a definite health risk 
to humans [18, 33, 34]. Traditionally, environmental waters have been monitored for fecal 
pollution with general fecal indicator bacteria (FIB), such as E. coli or enterococci. These 
bacteria were chosen based on their abundance in feces and assumed co-occurrence with 
pathogens, although these bacteria are not pathogenic themselves. The use of FIB is justified by 
a correlation with adverse health outcomes at a limited number of epidemiological test sites [35].  
Despite this, FIB possess many shortcomings when it comes to environmental water quality 
monitoring. One limitation of FIB is their potential to persist and grow in environmental 
reservoirs [36-38]. For instance, FIB have been shown to colonize and grow in river sediments 
[39]. This suggests their detection may not be indicative of a recent pollution event and 
inherently limits their utility as an indicator of fecal pollution and subsequent health risk. In 
addition, FIB are shed by numerous warm-blooded animals, confounding discrimination of the 
animal source of the pollution [40, 41]. Correct source attribution is crucial to focus monitoring 
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and remediation efforts where they are most needed. Additionally, although FIB occurrence 
generally correlates with bacterial pathogen presence in environmental waters, FIB do not 
always correlate with viral pathogen presence [42-45]. One explanation for this is differential 
decay rates exhibited by FIB, viruses, and molecular markers in environmental waters [46, 47]. 
This can lead to FIB not being detected in a system although viruses are still present, giving a 
false indication of low health risk. Indeed, enteric viral outbreaks in environmental waters have 
been documented when levels of FIB are below detection limits or regulatory limits [48-51]. 
Despite obvious shortcomings of FIB for microbial water quality monitoring, this approach 
persists due to regulatory inertia and lack of viable alternatives, especially for viruses. 
2.1.2 Origins of MST 
Microbial source tracking (MST) is a recently developed field that seeks to solve one major 
shortcoming of FIB monitoring by distinguishing the source of fecal pollution in environmental 
waters. Elucidating the source of fecal pollution is advantageous to inform monitoring and 
remediation efforts, in addition to inferring health risk. Early MST technology focused on 
library-dependent methods that compared environmental samples to databases built to 
characterize the pollution present. Current MST technology uses a library-independent approach 
that screens for one specific microbe or gene expected to be present in a pollution source. These 
MST methods operate on the principle that certain strains of microorganisms are host-specific; 
therefore, their detection informs the animal species contributing to the impairment of the 
system. Many MST assays have been developed for various animal hosts including wildlife, 
domestic animals, and farm animals [10-13]. Significant effort has been expended to develop 
human-specific MST technologies as human waste poses a greater human health risk than waste 
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from other animals [2, 18, 19, 34, 52]. In addition, human sources of pollution are more readily 
controlled and managed, such as investing in infrastructure improvements. The field of MST has 
also focused significant effort on developing culture-independent detection methods, such as 
qPCR. This allows for technology development that is not limited by culturability of target 
microorganisms and enables rapid processing of water samples [53]. For the above reasons, this 
review focuses on molecular MST technologies targeting human fecal pollution.  
2.1.3 Terms and definitions 
Most technologies discussed in this review are end-point PCR or qPCR assays. End-point PCR is 
designed to amplify a specific DNA sequence, enabling detection of that sequence in a 
presence/absence test. Similarly, qPCR is designed to amplify a specific DNA sequence; 
however, it is capable of quantifying the amount of target DNA present in the sample. A 
“marker” is defined as the specific DNA sequence that is being detected to indicate the presence 
of human fecal material. An “assay” is defined as the specific qPCR or end-point PCR 
experiment that is used to detect the “marker”.  
 MST assays are often evaluated for several criteria to assess the performance of the 
assays. Most of these criteria are determined by screening assays against target (e.g. sewage) and 
non-target (e.g. animal feces) DNA. Sensitivity is defined as the percentage of samples expected 
to be positive (e.g. sewage) that are accurately determined to be positive [54]. Specificity is 
defined as the percentage of negative samples (samples containing non-target animal fecal DNA) 
that are accurately determined to be negative [54]. In general, an assay is considered to perform 
well if both its sensitivity and specificity are 80% or above [55]; however, this limit has been 
arbitrarily defined and no standard exists for the defined number of samples an assay should be 
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tested against to determine their sensitivity or specificity. The limit of detection (LOD) describes 
the smallest amount of marker that may be detected, while the limit of quantification (LOQ) 
describes the smallest amount of marker that can be accurately quantified [9]. Lastly, markers are 
often evaluated for geographic stability, in which they are tested against human and non-human 
fecal DNA distributed across a wide geographic range as certain markers have been shown to 
vary geographically. 
2.2 BACTERIAL MST ASSAYS 
The majority of human MST assays have been developed on bacterial targets, specifically the 
16S rRNA gene of Bacteroides species. Bacteroides is one of the predominant genera in the 
human gut microflora, making it a potential target for development of human-specific markers 
[56, 57].  
2.2.1 Bacteroides 16S rRNA Assays 
The most common target for human MST assay development to date has been the 16S rRNA 
gene of Bacteroides species. Many of the DNA sequences targeted by the assays discussed in 
this section overlap in the same genomic region of the 16S rRNA gene of B. dorei [9]. Designed 
assays exhibit differences in performance, which may reflect varied optimization of PCR 
reaction conditions, specific location of primers, or fecal libraries the assays have been screened 
against. 
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2.2.1.1 HF183 
HF183, one of the first human source tracking PCR assays designed, has consistently been 
shown to be among the top-performing MST technologies available. The HF183 assay was first 
designed as an end-point PCR assay and demonstrated 84% sensitivity when tested against 
human fecal samples (n=13) but 100% sensitivity when tested against sewage (n=3) [58]. The 
assay exhibited 100% specificity against an animal fecal library (n=46) and an LOD of 0.01 ng 
DNA which corresponded to a high 105 gene copies [58]. The assay was later adapted to a qPCR 
assay utilizing SYBR Green chemistry which exhibited 86% sensitivity against human fecal 
samples (n=7), 100% sensitivity against sewage samples (n=4), and 95% specificity (n=19; 
cross-reacting with a single chicken sample) [59]. The LOQ of the assay was 5.67 log10 copies/L 
in freshwater [59].  The HF183 assay was further adapted to TaqMan qPCR chemistry which 
exhibited 100% sensitivity based on a human fecal composite (n=1) and sewage samples (n=14); 
however, the assay exhibited 60% specificity, cross-reacting at lower concentrations with 
chicken and dog composite samples [60]. The HF183 TaqMan assay was shown to form 
nonspecific amplification products and was therefore modified by replacing the reverse primer 
with a more specific reverse primer (BacR287) [17]. The two assays were then tested head-to-
head and exhibited the same sensitivity and specificity and similar concentrations in all reference 
samples; however, the HF183/BacR287 assay eliminated the nonspecific amplification products 
experienced with the former assay which improved the limit of detection of the assay slightly 
[17]. Both the original TaqMan assay and the new HF183/BacR287 assay demonstrated 67% 
sensitivity with human fecal samples (n=6), 100% sensitivity in sewage (n=58), and 93% 
specificity (n=123, cross-reacting with chicken and turkey samples) [17]. Again, both assays 
exhibited an LOD of 1 pg DNA per reaction when human fecal DNA was used, but the 
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HF183/BacR287 assay showed a slight improvement with an LOD of 5 pg DNA per reaction 
versus 50 pg DNA per reaction for the former assay when sewage DNA was used for input [17].  
 The HF183 assays have been included in several comparison studies between other 
developed assays and have consistently demonstrated the best performance or among the best 
performances [60-64]. A multi-lab study that investigated 23 human-specific assays found that 
the only two assays to exhibit both a sensitivity and specificity of 80% or above were the HF183 
endpoint and HF183 SYBR assays [55].  Due to their consistently high performance, the HF183 
assays are widely considered to be top performing technology in human MST methods. 
However, the assays have also shown cross-reactivity with non-target animal fecal DNA, namely 
from cat, dog, and chicken samples [17, 59, 61, 65]. 
2.2.1.2 BacH 
In addition to HF183, multiple other MST assays have been designed from the 16S rRNA gene 
of Bacteroides species. BacH is a TaqMan qPCR assay that upon initial development exhibited a 
95% sensitivity in human fecal samples (n=21) and 100% sensitivity in sewage (n=20) [66]. The 
assay exhibited 99% specificity (n=302), cross-reacting with a single cat fecal sample, and was 
detected down to 6 copies per reaction [66]. The assay performed well when compared head-to-
head with other MST assays in a single lab study, displaying 100% sensitivity and 94% 
specificity, cross-reacting with sheep, goat, and dog samples [63]. A multi-lab comparison study 
found the assay to exhibit a lower specificity at ~75% [55]. The assay was also evaluated for 
international stability against samples from 16 countries across 6 continents. This study 
demonstrated the importance of local validation of assays, as the global sensitivity of BacH was 
77% based on human fecal samples (n=61) and specificity was low at 53% (n=219) [67].   
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2.2.1.3 HuBac 
Another qPCR TaqMan assay developed on the 16S rRNA Bacteroides gene is HuBac. This 
assay was found to have 100% sensitivity based on human fecal samples (n=3); however, it had a 
specificity of 68% (n=18), cross-reacting with pig samples [68]. The low specificity of this assay 
has been consistently verified since its initial development, exhibiting specificities from 22.7-
63% in studies that evaluated HuBac head-to-head with other assays, despite 100% sensitivities 
in all studies [61, 63, 65].  
2.2.1.4 BacHum 
BacHum, another TaqMan qPCR assay based on the 16S rRNA gene of Bacteroides, 
demonstrated high initial performance, exhibiting a 67% sensitivity in human fecal samples 
(n=18), a 100% sensitivity in sewage (n=14), and a 98% specificity (n=41, cross-reacting with 
one dog sample) [65]. It also exhibited a low LOD of 3.5 gene copies per reaction and an LOQ 
of 30 gene copies per reaction [65]. The high performance was verified in a follow-up study, 
displaying 100% sensitivity (n=50); however, the assay did cross-react with pig, sheep, horse, 
and dog samples, although the overall specificity was 96% [63]. As is the case with many MST 
markers, initial evaluations are favorable but performance decreases as additional studies are 
conducted. Another study confirmed the assay’s high sensitivity at 100% in sewage samples 
(n=12) but found a much lower specificity of 71%, cross-reacting with cow, horse, and dog 
samples [69]. A multi-lab comparison study demonstrated very high sensitivities (>90%) but 
showed the specificity to vary widely between labs (0-60%) [55]. Similarly, in a global study, the 
assay exhibited 87% sensitivity in human fecal samples (n=61) and 68% specificity (n=219) 
[67]. In addition, studies can have seemingly contradictory results based on the fecal libraries 
screened. One study found the BacHum assay to be 100% specific (n=25); however, the assay 
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was detected in 25% of human fecal samples (n=12) and 0% of sewage samples (n=5) [62]. The 
assay was only detected in human samples, which led to the high reported specificity but was not 
found in all or even most of the human-derived samples. The lack of detection in human samples 
likely contributed to the reported high specificity value, as human-specific assays are typically 
found at concentrations orders of magnitude lower in non-target animal samples and therefore 
were most likely below the limit of detection in the animal samples in this study.    
2.2.1.5 HumanBac1 
Another 16S rRNA Bacteroides marker, HumanBac1, was found to exhibit 100% sensitivity 
(nfecal=4) but low specificity at 10% (n=10), cross-reacting with cow and pig samples at similar 
concentrations to human samples [70]. The assay did exhibit a low LOD and LOQ, both at 4.3 
copies per reaction [70]. Further evaluation of the assay demonstrated continued problems with 
low specificity. Comparison studies including the assay demonstrated specificities of 57% 
(n=30) and 79% (n=136), cross-reacting with cow, sheep, horse, dog, and kangaroo samples [63, 
71].  
2.2.1.6 BacHuman 
The BacHuman qPCR assay again targets the 16S rRNA gene of Bacteroides. Initial evaluation 
found the assay to be 100% sensitive in sewage samples (n=16) and 81% specific (n=54), cross-
reacting with pig, dog, and cat samples [72]. The assay exhibited a low LOD at 6.5 gene copies 
per reaction; however, demonstrated poor correlation with FIB in river water samples [72].  
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2.2.2 Other Bacteroides Assays 
Bacteroides 16S rRNA genes have been targeted for assay development due to their high 
abundance, which facilitates detection. However, since the gene is highly conserved it often 
cross-reacts with non-target samples. This has led to efforts to target other genes in Bacteroides 
species that may be more specific to humans. Potential human-specific sequences were found 
using genome fragment enrichment and used to design PCR assays based on a region of a 
hypothetical protein and on a putative RNA polymerase sigma factor [15]. The assays were 
found to be 100% sensitive based on sewage samples (n=16) and 100% specific (n=90) [15]. 
Based on these results, the assays were adapted to qPCR assays as HumM2 and HumM3. Both 
assays exhibited 100% sensitivity (nfecal=16; nsewage=20) while HumM2 exhibited a slightly 
higher specificity (n=265) at 99.2% compared to 97.2% for HumM3 [16]. A study comparing 
multiple MST assays found the assays to have some of the highest specificities at 90.9% and 
95.5% (n=158), cross-reacting with sheep, elk, and chicken samples [61]. A multi-lab study 
found that HumM2 was >80% sensitive but was <80% specific [55]. In addition, the HumM2 
assay was found to be significantly less reproducible than other qPCR assays such as HF183 and 
BacHum, due to lower concentrations in test samples [64].    
Another assay targeted the gyrB gene of B. fragiles, a gene involved in super-coiling of 
DNA. The assay was found to be 100% sensitive based on human fecal samples (n=10) and 97% 
specific (n=30) [71]. Despite the high performance demonstrated in the initial study, an 
additional comparison study showed the assay to have exhibit lower performance at ~70% 
sensitivity and ~90% specificity [55].     
Another qPCR assay was designed on the α-1-6, mannanase of B. thetaiotomicron, a 
dominant species in the human gut microbiome [73]. The assay exhibited high initial 
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performance criteria with 100% sensitivity (nfecal=10; nsewage=20) and 100% specificity (n=160) 
[74]. The assay exhibited 100% sensitivity in another comparison study, but only ~50% 
specificity [55]. 
2.2.3 Other Bacterial Targets 
Other bacterial targets for MST technology development have been investigated. The 16S rRNA 
gene of Bifidobacterium adolescentis has been targeted as a marker for MST method 
development. The sensitivities of the assays ranged from 90-100% while the specificities ranged 
from 89-100% [75-77]. However, when tested head-to-head the HF183 assay was shown to 
perform better than the Bifidobacterium assay [75].  Additionally, the enterococcal surface 
protein (esp) of E. faecium has been targeted for MST method development. The sensitivities of 
the developed assays have been reported from 67-100%, while the specificities have been 
reported from 95-100% [78-80]. However, these uncommon methods are often left out of 
comparison studies and must be further verified to accurately assess performance metrics. 
2.2.4 Challenges and Limitations 
Many human MST assays have been developed based on bacterial targets, specifically the 16S 
rRNA gene of Bacteroides species. Performance varies widely between the assays discussed, and 
assay performance often varies widely between studies and fecal libraries. However, when 
looked at as a whole several trends appear. Overall, bacterial MST assays exhibit generally high 
sensitivities, indicating their high concentrations in human fecal material and sewage and 
facilitating their detection in diluted environmental waters. While the assays often exhibit high 
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specificities, no assay has yet been found to be 100% specific towards humans in all fecal 
libraries. The assays often cross-react with a wide range of non-target animal sources, and 
therefore may be less useful in areas where these animal species are frequently found. Between 
several comparison studies, the marker that consistently performs the best is HF183, and 
therefore this assay has been developed the furthest. Some studies have even been conducted to 
relate HF183 marker presence to predicted health risk of impaired waters [34, 81]. One study 
found that a gastrointestinal illness rate of 30 per 1000 swimmers occurred at HF183 
concentrations of 4200 copies/100 mL of recreational water [81]. This number changes, 
however, if other sources of pollution are present. It was estimated that for risk attributed to gull 
sources at California beaches, HF183 would have to be present at 12-630 copies per 100 mL to 
not exceed the same level of risk [34]. However, these studies were based on models and not 
epidemiological data. In addition, research has been conducted to correlate bacterial MST 
markers with general indicator and viral pathogen presence and decay in environmental waters; 
however, the results vary widely, finding no correlation with pathogen presence in some studies 
while finding positive correlation with pathogen presence in other studies [44, 47, 75, 82-85]. 
Additional studies are necessary to elucidate true trends between bacterial MST markers and 
health risk, especially health risk from viral pathogens.  
2.3 VIRAL MST ASSAYS 
Enteric viruses are a significant source of health risk from environmental waters polluted by 
human fecal waste [1, 2]. They can be transmitted directly to the environment through combined 
sewer overflow events, leaky septic systems, or illegally connected downspouts. In addition, 
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viruses can be released from wastewater treatment plant effluent, where viruses pass through at 
higher rates than FIB [86, 87]. As discussed above, current methods of monitoring using FIB or 
bacterial qPCR assays do not necessarily correlate with viral pathogen presence in environmental 
waters. It is estimated that exposure to coastal waters results in millions of excess GI illnesses in 
the U.S. and hundreds of millions of excess GI and respiratory illnesses globally every year [88, 
89]. However, the actual human health risk due to virus exposure in environmental waters and 
associated costs have not been characterized even though the percentage of outbreaks attributed 
to viruses have been rising in recent years [1]. Due to this, MST technologies have been 
developed based on both pathogenic and non-pathogenic viruses in order to better capture viral 
risk in environmental waters.  
2.3.1 Enteric Pathogen Viral Assays 
Many qPCR assays have been developed based on pathogenic enteric viruses. These assays have 
typically been developed as diagnostic tools and not necessarily for source tracking applications. 
These viruses have also been explored in a source tracking context as improved human-specific 
markers and to directly measure the health risk of exposure to an impacted water body. Advances 
in metagenomics may make it possible to screen for all pathogens of concern in the future [90]; 
however, screening for every virus is a currently laborious practice and therefore the most 
relevant viruses are often evaluated.  
2.3.1.1 Norovirus 
Norovirus is recognized as the leading cause of viral health risk in environmental waters. 
Norovirus is the cause of more than 50% of all outbreak-associated gastroenteritis and more than 
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90% of non-bacterial outbreaks [5]. In addition, norovirus has been shown to be the cause of 
45% of all viral caused outbreaks in recreational waters [1]. Due to the significance of norovirus, 
PCR assays have been developed for its detection [22, 91-93]. PCR assays have successfully 
detected norovirus in 99% of human fecal samples that were shown to be positive for norovirus 
by microscopy [93]. One study developed norovirus assays for specific use in source tracking 
applications. The assays for norovirus GI and GII exhibited sensitivities of 40 and 67% in human 
fecal samples (n=15), respectively, and each exhibited 82% sensitivity in sewage (n=11) [91]. 
The assays also demonstrated 100% specificity (n=56) [91]. A multi-lab study comparing 
different viral assays demonstrated that norovirus-based assays exhibited 0% sensitivity but 
100% specificity [94]. However, it is generally accepted that norovirus assays are themselves not 
ideal MST technologies due to the well-documented seasonal variation in norovirus abundance 
throughout the year based on active human infection rates, with peak concentrations occurring in 
winter months [92, 95, 96]. This contributes to the lack of data on norovirus for source tracking 
applications.  
2.3.1.2 Adenovirus 
Adenoviruses have been shown to be the second leading cause of viral outbreaks from exposure 
to contaminated environmental waters [1]. Several end-point PCR and qPCR assays for the 
detection of human adenovirus have been developed; however, these assays were not specifically 
developed for source tracking technologies and therefore do not report sensitivity or specificity 
estimates [20, 21, 97, 98]. One study developed adenovirus assays as part of a toolbox approach 
for source tracking applications. This study found the assays to exhibit 0-7% sensitivity in 
human fecal samples (n=15), but 36-100% sensitivity in sewage samples (n=11) [91]. The assays 
were also 100% specific (n=56) [91]. A multi-lab study evaluated adenovirus assays next to 
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other MST technologies and demonstrated assay sensitivities from 0-16.7%, while specificity 
was 100% [94]. In addition, adenovirus assays, along with human polyomavirus assays, have 
been demonstrated to be suitable indicators of norovirus presence in polluted waters while being 
present at higher concentrations and not exhibiting seasonal variability [95]. 
2.3.1.3 Enterovirus 
Enteroviruses, including echovirus and poliovirus, have also been shown to cause outbreaks in 
environmental waters [1]. Due to their health relevance and presence in environmental samples, 
several PCR assays for enterovirus have been developed [99-102]. Again, these assays were 
developed as diagnostic tools and not for specific source tracking applications, so knowledge of 
their occurrence and abundance in a range of human and animal fecal samples is limited. One 
multi-lab study included enterovirus assays in their comparison of MST technologies, finding the 
sensitivities of the assays ranged from 0-13.2% while the specificities ranged from 84.6-100% 
[94]. 
2.3.2 Non-Pathogenic Viral Targets 
Pathogenic viruses are often not present at high enough concentrations to be accurately detected 
as seen in the discussion of the above assays. In addition, it is not economical and feasible to 
screen for all pathogenic viruses that could potentially impact a body of water, due to the number 
of unique viruses of concern and the portion of the viral human gut microbiome that remains 
uncharacterized due to lack of similarity to currently described viruses [103]. In addition, the 
detection of these viruses can vary throughout the year based on the active human infection rate 
in a given population. Therefore, non-pathogenic viruses have been proposed as indicators for 
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viral pathogen presence. An appropriate viral indicator would co-occur with viral pathogens, be 
present at higher concentrations than viral pathogens for ease of detection, be consistently shed 
by human populations, and decay at a similar or slower rate to viral pathogens to serve as a 
conservative indicator.  
2.3.2.1 Human Polyomavirus 
Human Polyomavirus (HPyV) has been shown to cause lifelong asymptomatic infections in 
much of the human population, and is primarily shed in urine [104]. Although it is typically 
considered nonpathogenic, it is known to cause kidney nephritis in the immunocompromised 
[105]. Due to its wide presence in the human population, HPyV has been developed as a target 
for human source tracking applications. An end-point PCR assay was designed based on the T 
antigen gene and found to be 100% sensitive in human sewage (n=36) and 100% specific (n=25) 
[106]. The assay was adapted to a qPCR chemistry and found to be 100% sensitive towards 
sewage samples (n=39) and 23% sensitive towards individual urine samples (n=26) [23]. The 
assay did not cross-react with any non-target animal fecal (n=117) or urine (n=10) samples and 
was detected down to 10 copies per reaction [23]. A multi-lab study again found the assay to be 
100% specific, but sensitivities were much lower at 7.9-10.5% [94]. HPyV has been tested head-
to-head with the bacterial source tracking marker HF183 (detailed in section 2.2.1.1) and 
consistently exhibited a higher specificity at 100% compared to 81-96% for HF183 [23, 107-
109]. However, HPyV is less abundant in reference materials than HF183, showing 
concentrations 2 orders of magnitude lower [107, 108]. HPyV has been shown to not correlate 
with indicator bacteria [106], but has been shown to correlate with adenovirus in presence and 
decay studies [23, 110].  
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2.3.2.2 Pepper Mild Mottle Virus 
Pepper mild mottle virus (PMMoV) is a plant pathogen that is widespread and abundant in 
human fecal samples [111]. PMMoV is a member of the genus tobamovirus, capable of infecting 
a wide variety of pepper plants [112]. PMMoV has a single stranded RNA genome that was first 
sequenced in 1991 [113]. The virus is produced in copious amounts in the plants it affects and is 
assumed to be present in human sewage due to human consumption of pepper products such as 
hot sauce [112]. Since this marker is dietary in origin, it does not depend on active human 
infection rates. A qPCR assay was designed for its detection and demonstrated 67% sensitivity in 
human fecal samples (n=18), 100% sensitivity in sewage (n=12), and an LOD of 100 copies per 
reaction, but showed imperfect specificity cross-reacting with chicken and gull samples [24, 
111]. A recent study tested PMMoV head-to-head with HF183 in samples from Costa Rica and 
found the PMMoV assay to perform better, with 100% specificity compared to 94% for HF183 
[109]. Another qPCR assay designed on PMMoV was found to be 95% sensitive in human fecal 
samples (n=20) and 83% specific (n=53; cross-reacting with chicken, cow, and geese samples) 
[114]. This same study looked at survival of PMMoV, HPyV, and adenovirus spiked into river 
water. HPyV decayed the fastest, while PMMoV exhibited the highest stability [114]. In 
seawater exposed to wastewater treatment effluent, PMMoV co-occurred with several viral 
pathogens, including norovirus [24]. PMMoV has also been shown to exhibit increased 
persistence through wastewater treatment than pathogenic viruses, suggesting it could be a 
conservative indicator of enteric viruses [86]. 
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2.3.3 Challenges and Limitations 
Pathogenic human viruses are very specific towards human sources; however, they often are not 
present at high enough concentrations to be accurately detected. Because of this, their detection 
in impacted waters results in high confidence that human fecal pollution is present. Alternatively, 
their absence does not instill high confidence that human fecal pollution is absent. A multi-lab 
study found that enterovirus and adenovirus assays exhibited high false negative rates in test 
samples spiked with human fecal or sewage material (i.e. the assays were not detected although 
human fecal contamination was present). The false negative rates for human fecal samples were 
100% and 90% for enterovirus and adenovirus, respectively, and 60% and 40% in samples 
spiked with sewage [115]. Other viral targets have been suggested to act as indicators for viral 
pathogens. PMMoV is highly abundant and therefore easy to detect but shows some cross-
reaction with animals that may obtain the virus in their gut via their diet. Human Polyomavirus 
has yet to cross-react with any non-target animal sources and is detectable in environmental 
waters. Despite this, viral markers are often detected at concentrations 2-4 orders of magnitude 
lower than bacterial indicators [107, 108, 116, 117]. This could result in false negative results 
when monitoring sites that are subject to low levels of fecal contamination.  
Due to their lower abundance, water samples are often concentrated before screening 
with viral-based source tracking assays. However, concentration methods vary widely in their 
efficiencies and recovery rates. For example, enteroviruses were recoverable at 51% in 
freshwater and 23% in seawater using negatively charged cellulose acetate/nitrate filters [100]. 
Another study found 30-31% recovery of adenoviruses and 40-78% recovery of polyomaviruses 
when directly extracting from a negatively-charged filter after acidification [28]. The same study 
found only 2.4-5.3% recovery for adenoviruses and 5.9-12% recovery for polyomaviruses using 
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an absorption/elution procedure [28]. In addition, PCR inhibitors can be co-concentrated along 
with viruses, making it difficult to retain accurate results [28]. Many of the technologies 
available are also expensive, making them impractical for wide scale sampling of environmental 
waters [27]. To improve confidence in viral-based assays, more reliable, efficient, and cost-
effective concentration methods are needed. 
2.4 BACTERIOPHAGE MST ASSAYS 
Bacteriophages, viruses that infect bacteria, have long been investigated as surrogates for 
modeling pathogenic virus’ behavior in environmental fate, decay, and disinfection studies. 
Bacteriophages, or “phages”, have similar size and morphology to viruses and are suggested as 
surrogates due to ease of detection, cost, abundance in environmental waters, and safety 
compared with viral pathogens [30]. Bacteriophages have been shown to be more abundant than 
bacteria in most environments, which may ease dilution problems experienced with monitoring 
viruses [31]. Despite being more abundant than bacteria, they generally remain more difficult to 
detect as bacteria are easier to concentrate based on size exclusion filtering. Bacteriophages are 
safer to study than pathogenic human viruses, as phages do not infect humans. Likewise, 
facilities that study pathogenic viruses are costlier to set up and maintain compared to labs that 
research phages that can be studied in biosafety level 1 (BSL1) facilities. All of these reasons, 
along with their similarity to viruses in size and shape, make phages potentially ideal targets for 
human MST technology development. While this review focuses on molecular techniques of 
detection, many of the assays for detection of bacteriophages for source tracking remain culture 
based and will be discussed below. 
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2.4.1 F+ RNA Coliphage 
Much of the bacteriophage MST technology development has targeted coliphages. Coliphages 
are bacteriophages that specifically infect E. coli. There are distinct types of coliphage 
characterized by the means in which they infect E. coli. Somatic coliphages infect E. coli via 
their outer membrane and F+ coliphages infect E. coli via the pilus appendage found on the 
surface of E. coli cells [118]. Somatic coliphages are considered general indicators of fecal 
pollution since they are not specific to human fecal sources and are thus not discussed in this 
review. However, one method for source tracking of human pollution detects the frequencies of 
the four F-specific (F+) RNA coliphage genotypes to determine if the contamination has a human 
source. This method works on the basis that groups II and III are predominant in human sources 
and groups I and IV are predominant in animal sources; therefore, genotyping the phages allows 
the source to be discerned [119]. Oligonucleotide probes were first used to genotype the F+ RNA 
phages, and correctly identified the source for 100% of samples (derived from surface waters, 
sewage effluent, and animal fecal samples) [119]. Two different groups developed qPCR assays 
to simultaneously detect all four subgroups with an LOD of 10 copies per reaction, although 
sensitivity and specificity were not measured [120, 121]. A subsequent study that used F+ RNA 
phage genotyping as part of a toolbox approach showed that the assays were not specific to the 
expected source. Group II and III phages (expected to be of human origin) were not detected in 
human fecal samples (n=15) [91]. The only group detected in human fecal samples was group I, 
detected in 7% of the samples [91]. In addition, group II phages were found in 80% of pig 
samples, 100% of deer samples, 50% of cow samples, and 6% of duck samples [91]. However, 
groups II and III were detected more frequently in human sewage samples (n=11) at 91% and 
100%, respectively, compared to 55% for group I and 18% for group IV [91]. Another set of 
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qPCR assays was developed and were not tested for specificity; however, in human sewage 
(n=7) groups I and II were detected in 100% of samples, group III in 86%, and group IV in 0% 
[122]. A multi-lab comparison study included the assay for group II F+ RNA phages and found 
the assay was 18.4% sensitive and 84.6% specific, cross-reacting with gull and pigeon samples 
[94].     
2.4.2 Phages of Bacteroides 
Many assays for bacteriophage detection for source tracking remain culture based. A large 
portion of these methods focus on culturing phages that infect Bacteroides hosts. Just as 
Bacteroides species have long been pursued for human source tracking due to their abundance in 
the human gut, Bacteroides bacteriophages have also long been suggested [29, 123, 124]. 
Bacteroides phages generally have a narrow host range, do not replicate in the environment since 
their hosts are anaerobic, and do not exhibit seasonal variability [124]. These phages are also 
more persistent in the environment and more resistant to wastewater treatment than FIB, similar 
to pathogenic viruses and other bacteriophages [124]. A method for detecting phages of 
Bacteroides GB-124 was 100% sensitive in sewage samples (n=110) and 100% specific (n=30) 
[125]. A follow-up study confirmed the assay’s 100% sensitivity (nsewage=12) and 100% 
specificity (n=19) and showed the phages to co-occur with norovirus and adenovirus in sewage 
samples [126]. In contrast, another study found GB-124 bacteriophages had the highest 
sensitivity of four human-specific bacteriophage methods tested at 66.7%, but had the lowest 
specificity at 57.7%, cross-reacting with all animal samples except for deer and goose [94]. In 
addition, it may be necessary to isolate a new host for various geographic regions, and these 
bacteriophage methods rely on plaque assays cultured in anaerobic conditions, so results cannot 
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be obtained same-day [127]. Despite this, it has been speculated that sequence based 
technologies may identify more abundant phages of the non-culturable Bacteroidetes which 
appear to outnumber the culturable Bacteroidetes [124]. 
2.4.3 Challenges and Limitations 
Technologies targeting bacteriophages for source tracking of human fecal pollution have faced 
many challenges that have limited their application in water management. A major problem with 
existing bacteriophage assays is their lack of human-specificity. Since phages occupy the same 
habitats of their bacterial hosts, they will cross-react with other animal sources if their bacterial 
hosts are not specific towards humans. As was discussed in the above bacterial section, many of 
these assays have also demonstrated cross-reactivity with animal sources; therefore, it should not 
be surprising that phage assays cross-react as well. While phages can be more abundant than 
pathogenic viruses in environmental samples, their lack of specificity remains a significant 
hurdle. In addition, many of the methods developed still rely on culturing phages for 
enumeration, resulting in longer delays in data acquisition. It could be advantageous to further 
investigate the development of qPCR assays based on bacteriophages for source tracking 
applications.   
2.5 RESEARCH NEEDS 
The review of MST technologies above demonstrates the number of assays available and the 
varied performance exhibited by the assays. However, more research is necessary before these 
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technologies can replace FIB for regulation of environmental water quality management. The 
assays discussed above often exhibited a wide range of performance across studies that used 
different fecal libraries. Standards for evaluation of new assays are necessary to directly compare 
MST technologies to each other. Additional multi-lab studies should also be conducted 
evaluating multiple MST technologies to eliminate lab-to-lab variation. In addition, many studies 
have evaluated sensitivity and specificity for MST markers; however, there is a dearth of studies 
correlating markers to pathogens and health risk. In order to understand if we are properly 
capturing viral health risk with these technologies, additional studies are necessary. Assays that 
correlate with pathogen presence should next be evaluated in epidemiology studies to investigate 
if these assays can likewise be correlated with realized health risk. Ultimately, a tool-box 
approach may be necessary in which environmental waters are monitored with several markers 
(a combination of bacterial and viral) in order to capture a complete picture of total health risk.  
In addition, novel technologies should continue to be pursued as more of the human microbiome 
is explored through bioinformatics approaches.  
2.5.1 Ideal Marker Characteristics 
The above discussion shows the vast range of methods for testing and verifying MST assays. 
Assays based on bacteria, viruses, and bacteriophages all have advantages over the other types of 
assays. Likewise, all existing assays exhibit at least one shortcoming. Bacteria-based assays are 
abundant in reference materials and are easy to detect; however, these assays commonly cross-
react with fecal DNA from non-human animal sources and are not representative of viral 
pathogen health risk. Viral-based assays are highly specific towards humans and are a more 
direct measure of health risk; however, they are present at lower concentrations in reference 
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samples, lowering confidence in these tests when they fail to be detected. Bacteriophage-based 
assays are more representative of viruses in environmental systems; however, they also 
commonly cross-react with non-human animal samples and detection methods remain mostly 
culture based.  
 Novel MST methods continue to be developed in the hopes of designing a marker that 
can eliminate the obstacles experienced with the above assays. Examining existing technologies 
highlights several characteristics that an ideal marker would exhibit. First, an ideal marker of 
human fecal pollution would be present in all target reference materials, such as sewage (100% 
sensitive). Not only would an ideal marker be present, but it should be abundant in human 
reference materials to ease its detection. The marker would likewise be absent from all non-
target animal feces (100% specific). The assay should also have a known geographic 
characterization, as assays have been shown to perform differently on a regional or global scale. 
The assay should also correlate with pathogen presence and survival in the environment. Finally, 
the ideal marker detection method should be rapid (likely based on molecular methods) to 
facilitate water quality management decisions. A marker that exhibits all of these characteristics 
would greatly improve the way environmental waters are monitored and managed to protect 
public health.  
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3.0  METAGENOMIC EVALUATION OF THE HIGHLY ABUNDANT HUMAN GUT 
BACTERIOPHAGE CRASSPHAGE FOR SOURCE TRACKING OF HUMAN FECAL 
POLLUTION 
This work has been published as: 
Stachler, E. and Bibby, K. Metagenomic evaluation of the highly abundant human gut 
bacteriophage crAssphage for source tracking of human fecal pollution. Environ. Sci. Technol. 
Lett. 2014, 1 (10), 405-409. 
 
Recently, a highly abundant and widespread bacteriophage, named crAssphage, was identified in 
the human gut. Here, 86 publically available metagenomes were surveyed to determine the 
presence and abundance of crAssphage in various environments, and to identify its utility for 
source tracking of human fecal pollution. CrAssphage was found to be highly abundant in 
sewage and biosolids from the United States and Europe, and less abundant in sewage from Asia 
and Africa. CrAssphage was not definitively identified in other samples, including animal fecal 
material, with the exception of bat guano. Approximately half of mapped reads in the bat guano 
metagenome clustered to orf00045 in the phage genome, suggesting homology to a closely 
related phage. These results indicate the potential utility of a crAssphage based marker for source 
tracking of human fecal waste and highlight the utility of metagenomic approaches for initial 
identification and verification of microbial source tracking markers. 
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3.1 INTRODUCTION 
Markers of fecal pollution in the environment are used to protect public health and regulate 
recreational waters, drinking water resources, and food production [128]. Fecal indicator bacteria 
(FIB) are generally used to regulate and test for sewage contamination in natural waters, despite 
problems affecting their usefulness as indicators of fecal pollution, including challenges with 
indicating viral pathogen presence and source determination [9]. In response to the many 
problems surrounding FIB, significant effort has been expended to identify other potential 
markers for microbial source tracking (MST). A focus has been on culture free methods such as 
quantitative PCR (qPCR) to allow reliable same day contamination information [9, 64]. There is 
especially high value in identifying human specific markers since human waste poses a greater 
risk to human health than most other animal sources [18, 128]. Several markers have been 
developed and tested for various animals, including humans, enabling tracking of fecal 
contamination back to its source [10, 14]. Recently, considerable effort has been expended to 
identify the best-performing MST markers and methods [9, 55], including evaluation of viral and 
bacteriophage markers [94]. The ideal human waste marker would be both highly specific and 
sensitive, and have well-characterized geographic variability [9]. 
Viruses, including bacteriophages, have been proposed to be a better indicator of fecal 
pollution than FIB [24].  Bacteriophages of the bacterial genus Bacteroides have long been 
suggested for source tracking [29]. In contrast to other bacteriophage groups proposed for source 
tracking (e.g. coliphages), Bacteroides phages are not found in pristine waters and cannot 
replicate in the environment [29]. Bacteroides phage GB-124 was tested as a fecal indicator and 
found to be human specific when tested against many animal samples; however, it was found in 
lower concentrations than FIB, coliphages, and adenovirus, complicating detection when diluted 
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in natural waters [129]. Thus, alternative viral markers are an active topic of investigation. For 
example, pepper mild mottle virus (PMMoV), a plant pathogen found in food and in high 
numbers in sewage, has been suggested as an indicator since it is independent of active human 
infection rates [24]. PMMoV has also been found to be more abundant than other viruses in raw 
sewage, including adenovirus, Torque teno virus, norovirus, and polyomavirus [24]. In addition 
to the use of viruses or other pollution markers, the culture-independent sequencing of 
environmental samples, or ‘metagenomics’, has been proposed for the identification of both 
pathogens and indicators [90, 130, 131]. 
Recently, a novel bacteriophage was identified in the human gut [32]. The genome of the 
previously unrecognized “crAssphage” was produced through metagenomic data mining and 
verified by Sanger sequencing. CrAssphage was found to be more abundant than all other 
previously identified phages in the human gut combined, and to be conserved across individuals 
[32]. CrAssphage was suggested to be a Bacteroides phage using co-occurrence profiling [32]. 
Initial evaluation indicated that crAssphage was most common in fecal metagenome samples 
[32].  Based on the great abundance of crAssphage in the human gut, compounded with 
Bacteroides phages previously being suggested for source tracking [29], we hypothesize that 
crAssphage has significant potential as a highly sensitive and specific MST marker for human 
fecal contamination. 
In the current study, we seek to evaluate the utility of crAssphage as an MST marker by 
searching existing viral and microbial metagenomes from a wide variety of environments 
(sewage, biosolids, terrestrial animals, fish, reclaimed water, freshwater, hypersaline water, 
marine water, mosquito, coral, microbialites) to identify the presence and abundance of 
crAssphage in those environments.  In addition to exploring the utility of crAssphage as an MST 
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marker, this study serves to provide an example of how existing metagenomic data can be 
utilized for initial identification and evaluation of MST markers.  
3.2 MATERIALS AND METHODS 
3.2.1 Genome downloads 
The crAssphage genome was downloaded from Genbank (accession JQ995537) [32].  Other 
viral genomes downloaded from the NCBI nucleotide database include pepper mild mottle virus 
(accession NC_003630.1) [113], human adenovirus F (accession NC_001454) [132], human 
polyomavirus BK (accession NC_001538) [133], Torque teno virus (accession NC_002076) 
[134], and norovirus GII (accession HQ449728) [135]. 
3.2.2 Identification of metagenomes 
Google Scholar and NCBI Pubmed were used to search for existing viral and microbial 
metagenomes of various environments. Both viral metagenomes and whole microbial 
metagenomes were utilized. For the purposes of this study, viral metagenomes were considered 
to be metagenomes where virus-like particles were concentrated prior to sequencing, and all 
other metagenomes were considered to be whole microbial metagenomes. Targeted sequencing 
approaches were not considered. The metagenomes found in the literature search contained raw 
sewage and anaerobic digester samples from the United States (n=12) [103, 136, 137], a raw 
sewage sample from Europe (n=1) [136], raw sewage samples from Africa (n=2) [103, 136], raw 
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sewage samples from Asia (n=5) [103, 138], reclaimed water (n=6) [138, 139], viral (n=5) and 
whole microbial (n=8) metagenomes from various terrestrial animals (cow=4 [140], chicken=2 
[140], pig=1 [141], bat=2 [142, 143], sea lion=1 [144], rodent=3 [140, 145, 146]), freshwater 
(n=6) [140, 147], fish (n=2) [140], mosquito (n=3) [140], hypersaline water (n=12) [140], marine 
water (n=9) [140, 148, 149], coral (n=6) [140], and microbialites (n=3) [140, 150]. The accession 
numbers from these projects were used to download the metagenomic datasets from either the 
NCBI Sequence Read Archive (SRA) or MG-RAST [151], or obtained directly from the author. 
Since there was an extremely large number of reads per sample from the sewage sludge viral 
metagenomes [137], a random subset of reads was compared to the crAssphage genome. In 
addition, the NCBI SRA and MG-RAST were searched for additional relevant metagenomes not 
found through the literature search. Metagenomes found this way include raw sewage from 
Shanghai, China (n=1), bovine rumen (n=1), chicken cecum (n=2), and canine feces (n=2). 
Accession numbers for all metagenomes used in this study, along with additional sample details 
and alignment results, can be found in Table A1. 
3.2.3 Alignment to the reference genomes 
Metagenomic sequences were mapped onto viral genomes in the CLC Genomics Workbench 
7.0.3 (CLC Bio, Aarhus, Denmark) using default parameters (no masking, mismatch cost – 2, 
insertion cost – 3, deletion cost – 3, length fraction – 0.5, similarity fraction – 0.8, non-specific 
match handling – map randomly). Coverage data was computed for samples with at least 0.01% 
of reads mapping to the crAssphage genome.  
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3.3 RESULTS AND DISCUSSION 
Metagenomic sequences, termed ‘reads’, from various environments were mapped against the 
crAssphage genome to survey these environments for the presence and abundance of 
crAssphage. Figure 3.1 shows the percentage of reads mapped to the crAssphage genome for 
each environment, averaged over the total number of reads from each environment. Of the 86 
metagenomes surveyed, 51 metagenomes had at least one read that mapped to the crAssphage 
genome. However, only 17 metagenomes had at least 0.01% of the total reads map to the 
crAssphage genome. All metagenomes with less than 0.01% of total reads mapping had only 1-
16 reads map (0.00017-0.0048% of total reads), and were excluded from further analysis due to 
lack of genome coverage. The mosquito, coral, and microbialites environments (Table A1) did 
not include any samples with at least 0.01% of reads mapping and are not included in Figure 3.1. 
Samples that had at least 0.01% of reads mapped to the crAssphage genome include all sewage 
and biosolids samples (n= 13) from the United States and Europe (0.15% ± 0.09%), one out of 
two sewage samples from Africa (0.07% of reads), two out of six sewage samples from Asia 
(0.01% of reads from Shanghai and 0.05% of reads from Singapore), and one out of two bat 
guano samples (0.30% of reads). In addition, the reads from the United States and Europe 
sewage samples were mapped against other commonly investigated viral MST markers to 
compare the abundance of crAssphage to pepper mild mottle virus (PMMoV), human adenovirus 
F (HAdV), human polyomavirus BK (HPyV), Torque teno virus (TTV), and norovirus GII 
(NoV). Previous studies have investigated the utility of PMMoV [24, 114], HAdV [94, 95, 114], 
HPyV [94, 95, 114], TTV [114], and NoV [94, 95] as human MST markers, and PMMoV has 
been identified to be more abundant in sewage than other commonly used viral markers [24, 
114]. The average number of reads mapped from U.S. and Europe metagenomes to each viral 
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genome is shown in the inset of Figure 3.1 (Data in Table A2). While PMMoV was more 
abundant than HAdV, HPyV, TTV, and NoV, crAssphage was the most abundant virus tested. 
All samples had a low percentage of reads mapped to PMMoV compared to crAssphage, with 
only 0.01% ± 0.01% of reads mapping to the PMMoV genome for samples from the US. The 
European sample (Barcelona) had a higher percentage of sequences mapping to the PMMoV 
genome (0.23%) than the crAssphage genome (0.15%), potentially reflecting the diet of the 
region. Overall, the percentage of reads mapped to the PMMoV genome (0.02% ± 0.06%) was 
significantly less (p < 0.001) than the percentage mapped to the crAssphage genome (0.15% ± 
0.09%). This, together with metagenomic evidence for high crAssphage abundance in the gut, 
suggests that crAssphage may overcome detection limitations found with other viral markers.  
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Figure 3.1: Percent of sequence reads mapped to the crAssphage genome for metagenomes from 
different sources. Error bars indicate ± 1 standard deviation. Downward arrows indicate that no 
sample in that category had at least 0.01% of reads mapped to the crAssphage genome. Sample 
sizes are indicated as either viral (V) or whole microbial metagenome (M): sewage-US and 
Europe (Vn=13), sewage-Africa (Vn=2), sewage-Asia (Vn=6), terrestrial animal (Vn=4, Mn=12) 
(cow=5, chicken=4, rodents=3, canine=2, pig=1, sea lion=1), bat (Vn=2), fish (Vn=2), reclaimed 
water (Vn=6), hypersaline water (Vn=12), marine water (Vn=9), freshwater (Vn = 6). Inset: 
Number of reads mapped for all sewage and biosolids samples from the US and Europe to 
various viral genomes (crA-crAssphage, PMMoV-pepper mild mottle virus, HAdV-human 
adenovirus, HPyV-human polyomavirus, TTV-Torque teno virus, NoV-norovirus). 
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CrAssphage genome coverage was calculated for all samples with at least 0.01% read 
mapping (Figure 3.2). Excluding samples from Addis Ababa and Singapore, which had a low 
total number of mapped reads, all sewage and anaerobic digester samples showed a high 
coverage of the crAssphage genome (68% ± 14%). The Shanghai sewage sample had only 0.01% 
of reads mapping to the genome; however, this sample exhibited the second highest coverage of 
the crAssphage genome (87%), likely due to the large nature of the dataset (over 35 million 
sequence reads). The bat guano sample also showed a relatively high fraction of coverage of the 
crAssphage genome (39%); however, not as high as would be predicted based upon the large 
number of reads that mapped to the genome.  
 
 
 
Figure 3.2: The percent of sequences mapped for individual samples compared to the fraction of 
the crAssphage genome covered by the mapped reads. Fraction of reference covered was only 
computed and displayed here if the percent of sequences mapped was at least 0.01%. Error bars 
for the influent and effluent sludge from the U.S. indicate ± 1 standard deviation. 
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Figure 3.3 shows the coverage of the crAssphage genome from read mappings for three 
samples: sewage from Pittsburgh, USA; sewage from Shanghai, China; and bat guano from 
China.  For the bat guano sample, nearly half of the mapped reads (46%) mapped to orf00045 in 
the crAssphage genome. These reads mapped to one region of orf00045, representing only 36% 
coverage of orf00045. The median of the normalized percent of reads mapping to the crAssphage 
genome for bat guano, Pittsburgh sewage, and Shanghai sewage was 0.32, 0.84, and 0.85, 
respectively, indicating less even coverage of the crAssphage genome by the bat guano sample. 
This implies crAssphage may share some homology with a phage in the bat virome and care 
should be taken to eliminate this region in future assay development.  
 
 
 
Figure 3.3: Percent of mapped reads versus position on the crAssphage genome for a) raw 
sewage from Pittsburgh, PA, USA. b) raw sewage from Shanghai, China c) bat guano from 
China 
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Manual inspection of sewage and bat guano read mapping identified several regions 
exhibiting promise for development as an MST marker. These regions were entered into 
PrimerBlast [152] and searched against the NCBI nr database to investigate whether these 
regions contain crAssphage specific markers. Regions that warrant further investigation include 
(approximate values of crAssphage genome bp positions): 1770-1870, 78100-78270, 83860-
83970, 88370-88470, 90120-90280, and 93160-93340. Primers were found for all of these 
regions that were either specific only to crAssphage or to crAssphage and an uncultured 
organism clone from the human gut metagenome (accession GQ873945.1). 
Within sewage samples, crAssphage exhibits a strong geographic dependence, being 
more abundant in the US and Europe than Africa or Asia, consistent with previously recognized 
geographic dependence on the microbial ecology of the gut microbiome [153]. For example, a 
recent study noted an immediate shift in gut microbial ecology for an individual when traveling 
to the developing world, which was reversed when the individual returned to the US [154]. The 
factors driving this shift remain unresolved, but may play a strong role in the abundance of 
crAssphage in sewage. Although crAssphage was less abundant, its presence in samples from 
both Africa and Asia suggest that it is present worldwide. However, more research is warranted 
to investigate the full geographic prevalence of crAssphage to determine if it would be a suitable 
marker in these areas.  
The metagenomic approach applied here for identification of crAssphage for microbial 
source tracking has certain limitations. Samples for evaluation are constrained to metagenomes 
available in public databases. Additionally, the composition of samples is biased by the sampling 
and processing approaches used in each respective study while sample depth is limited to that 
obtained by the initial studies. Additional empirical data (e.g. qPCR) is necessary to confirm the 
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absolute abundance of crAssphage in human samples and absence in non-human samples. 
Despite these limitations, a metagenomic approach represents a considerable time and cost 
savings over laboratory methods for initial evaluation of MST markers. Further research is 
necessary before a crAssphage marker can be utilized in the field. Next steps include marker 
selection and testing in human and animal fecal samples as well as contaminated waters to assess 
the field sensitivity, specificity, limit of detection, geographic and seasonal variations, and co-
occurrence of crAssphage with human pathogens. However, this approach represents a valuable 
first step in verifying that these next steps should be pursued.  
This study sought to understand the utility of the newly discovered crAssphage as an 
MST marker for human fecal pollution by utilizing publicly available metagenomic data. 
Overall, this study has demonstrated that crAssphage is a strong candidate for a human MST 
marker based on its ubiquity in the human gut and human sewage and its absence in other 
environments, including other animals’ guts. In addition, crAssphage has been found to be even 
more abundant than other proposed viral markers and viral pathogens, decreasing challenges 
associated with the dilution of marker abundance in natural waters that has been observed for 
other viral markers. Further, this study has demonstrated the utility of publicly available 
metagenomic data for initial evaluation of a new MST marker, a powerful approach that allows 
rapid results with limited economic and time investment.  
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4.0  QUANTITATIVE CRASSPHAGE PCR ASSAYS FOR HUMAN FECAL 
POLLUTION MEASUREMENT 
This work has been published as: 
Stachler, E.; Kelty, C.; Sivaganesan, M.; Bibby, K.; Shanks, O. Quantitative CrAssphage pcr 
assays for human fecal pollution measurement. Environ. Sci. Technol. 2017, 51(16), 9146-9154. 
This work is also the subject of a patent application: 
Stachler, E.; Bibby, K.; and Shanks, O. Cross-Assembly Phage DNA Sequences, Primers and 
Probes for PCR-based Identification of Human Fecal Pollution Sources. Application Number: 
62/386,532 
 
Environmental waters are monitored for fecal pollution to protect public health and water 
resources. Traditionally, general fecal indicator bacteria are used; however, they cannot 
distinguish human fecal waste from other animal pollution sources. Recently, a novel 
bacteriophage, crAssphage, was discovered by metagenomic data mining and reported to be 
abundant in and closely associated with human fecal waste.  To confirm bioinformatic 
predictions, 384 primer sets were designed along the length of the crAssphage genome.  Based 
upon initial screening, two novel crAssphage qPCR assays (CPQ_056 and CPQ_064) were 
designed and evaluated in reference fecal samples and water matrices. The assays exhibited high 
specificities (98.6%) when tested against an animal fecal reference library and crAssphage 
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genetic markers were highly abundant in raw sewage and sewage impacted water samples. In 
addition, CPQ_056 and CPQ_064 performance was compared to HF183/BacR287 and HumM2 
assays in paired experiments.  Findings confirm viral crAssphage qPCR assays perform at a 
similar level to well established bacterial human-associated fecal source identification 
approaches.  These new viral based assays could become important water quality management 
and research tools. 
4.1 INTRODUCTION 
Many environmental waters are polluted with human fecal waste originating from numerous 
sources such as leaking sewer lines, faulty septic systems, improperly connected downspouts, 
and combined sewer overflows. Human fecal waste can harbor disease-causing pathogens that 
contribute to poor public health, reduced ecological outcomes, and economic burdens.  Many 
public health managers rely on general fecal indicator methods (e.g. E. coli and enterococci) to 
monitor fecal pollution levels, which do not discriminate between human and other potential 
animal sources of fecal pollution.  General indicators provide limited information which prevents 
focused remediation, because many areas are polluted by a combination of human, agricultural, 
and/or wildlife sources.  Information on human waste (i.e. sewage) is particularly important 
because it may pose a greater risk to public health compared to fecal pollution from other animal 
sources [18, 19, 52]. To compliment general indicator measurements and better characterize 
human fecal pollution, many researchers and water quality managers use fecal source 
identification technologies. 
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 Most currently available human fecal source identification technologies target fecal 
bacteria, mainly Bacteroides species [55]. These fecal bacteria are abundant in the human gut 
and sewage, facilitating their detection in diluted environmental water samples. Bacterial human 
fecal genetic markers, such as HF183/BacR287 and HumM2 are highly human-associated and 
reproducible in multiple laboratory validation studies [17, 55, 61].  Although bacterial methods 
exist for human fecal source characterization, technologies targeting viruses are also needed [8, 
87, 155]. 
Enteric viruses, such as norovirus, adenovirus, and enterovirus are reported to be the 
dominant etiological agents of waterborne and shellfish-borne disease [1, 2]. Several studies 
suggest enteric viruses react to environmental and waste treatment conditions in markedly 
different ways compared to bacterial fecal indicators [87, 156-159]. In addition, waterborne viral 
outbreaks have occurred when general bacterial fecal indicators are not detected or are below 
regulated levels [1]. Reliance solely on bacterial indicators limit the ability of water quality 
managers to link measures of human fecal pollution with public health risk; thus, viral human-
associated technologies offer an attractive alternative to bacterial fecal source identification 
methods. Researchers have previously recognized the potential value of viral human-associated 
methodologies, leading to the development of technologies targeting enterovirus [99-101, 160, 
161], adenovirus [20, 21], norovirus [22, 93], polyomavirus BK and JC [23], somatic coliphage 
[162, 163], Bacteroides phages [125-127], and pepper mild mottle virus [24], among others. 
However, a recent multiple laboratory study evaluated the performance of many of these virus 
methods and concluded that the technologies tested either lacked sensitivity or exhibited poor 
specificity, potentially limiting suitability for widespread water quality management applications 
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[94].  A recent comparison of human polyomavirus levels to predicted public health risk also 
illustrates that more sensitive viral methodologies are needed [107]. 
An ideal viral human-associated method for environmental water quality testing would 
target a virus that is both highly human-associated and consistently abundant in human waste 
sources.  Recently, a novel bacteriophage, “crAssphage”, was described via metagenome cross-
assembly and was predicted to be a Bacteroides phage by co-occurrence profiling [32]. The 
double-stranded DNA crAssphage putative genome was assembled from shotgun metagenomic 
libraries isolated from an individual human fecal sample [32]. Further bioinformatic testing 
predicted that the crAssphage genome is highly abundant and was identified in 73% of human 
fecal metagenomes surveyed [32]. A subsequent metagenome survey detected crAssphage in 
sewage from the United States and Europe, while crAssphage was absent in other environments, 
such as non-human fecal samples and water environments [164]. In addition, the crAssphage 
genome is estimated to be up to 10 times more abundant in sewage than other known human-
associated viruses, including norovirus and adenovirus [164].   
Near-ubiquity across human fecal metagenomes and the high abundance compared to 
other sewage-derived viruses, combined with potential human specificity, motivates the 
development of crAssphage as a fecal source identification technology [164]. However, several 
unknown issues remain that must be addressed for the successful development of a crAssphage 
fecal source identification tool. For instance, the crAssphage genome likely represents a viral 
quasi-species consensus sequence compiled from a collection of DNA regions with unknown 
sequence variability. Furthermore, most information about the crAssphage genome has been 
generated from computer predictions with minimal laboratory testing to verify findings. 
Extensive laboratory testing of fecal samples gathered from a wide variety of animal species and 
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sewage collected across a broad geographic range is necessary to evaluate the suitability of the 
crAssphage genome for human fecal source identification applications. 
The goals of the present study are to survey the crAssphage genome for human-
associated genetic regions, develop qPCR methods as potential future environmental water 
quality monitoring tools, and compare their performance to top performing bacterial human-
associated technologies. We employed a “biased genome shotgun strategy” where select genetic 
regions of the crAssphage genome were screened using end-point PCR for highly specific and 
abundant human-associated fecal pollution genetic regions. These genetic regions were 
subsequently utilized to develop two novel qPCR fecal source identification assays. Findings 
suggest that high throughput laboratory screening of novel virus genomes discovered through 
metagenomic DNA sequence mining is a successful strategy to develop host-associated qPCR 
methods that may be important for future research and water quality management activities. 
4.2 MATERIALS AND METHODS 
4.2.1 Sample Collection 
Individual fecal samples (n=222) were collected from various locations across the continental 
United States as previously described [61]. Animal fecal samples represent ten species including 
Anser spp. (Canada goose; n=18), Canis familiaris (dog, n=41), Bos taurus (cow, n=61), Larus 
spp. (gull, n=25), Equus caballus (horse, n=20), Cervus canadensis (elk, n=20), Gallus gallus 
(chicken, n=11), Sus scrofa. (pig, n=9), Castor canadensis (beaver, n=8), and Odocoileus 
virginianus (deer, n=9) (see Table B1 for sample details). Each fecal sample was collected from 
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a different individual as previously described [61] and stored at -80°C until time of DNA 
extraction (<18 months).  Primary influent sewage samples were collected at nine geographically 
distributed wastewater treatment plants within the United States (Table B2) as previously 
described [61]. Briefly, one liter of primary influent was collected and immediately packed in ice 
and shipped overnight to Cincinnati, OH USA for laboratory testing. DNA extraction of sewage 
samples was performed within 48 hrs of collection as described below. Finally, as a proof of 
concept pilot study, surface water samples were collected from the Heiserman Stream (East Fork 
Watershed, southwest OH USA) in close proximity to a treated sewage discharge area.  These 
samples were collected in a sterile 1-L container, immediately stored on ice and transported to 
the laboratory for DNA extraction and testing (<4 hrs). 
4.2.2 DNA Extraction and Quantification 
DNA was extracted from 10 mL of primary influent sewage with the QIAamp Blood Maxi Kit 
according to manufacturer’s instructions, except Buffer AVL was substituted for Buffer AL 
(Qiagen, Valencia, CA). DNA was extracted from individual animal fecal samples using the 
DNA-EZ Kit (GeneRite, North Brunswick, NJ USA) substituting Buffer AE (Qiagen, Valencia, 
CA USA) for the elution buffer in a modified protocol of the manufacturer’s instructions. 
Briefly, fecal slurries were made by adding molecular grade PBS and fecal matter to the bead 
mill tubes and were homogenized in a bead beater at 6 m/s for 30 s. After a prolonged 
centrifugation, 760 µL Binding Buffer was added to recovered supernatant and the 
manufacturer’s instructions were followed eluting with molecular grade water warmed to 60°C. 
For environmental water samples, a 200 mL sample was concentrated to a final volume of 
approximately 150 µL using an automated Concentrating Pipette with a single-use ultra-filtration 
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hollow fiber polyethersulfone tip following manufacturer’s instructions (InnovaPREP®, Drexel, 
MO USA). DNA extraction of concentrate was performed with the DNA-EZ Kit (GeneRite, 
North Brunswick, NJ USA) as described above for fecal sample processing. Water sample DNA 
extracts were stored at 4°C in GeneMate Slick low-adhesion microcentrifuge tubes (ISC 
BioExperess, Kaysville, UT USA) until time of amplification (< 24 h). Fecal and primary 
influent sewage DNA extract concentrations were determined with a NanoDrop ND-1000 UV 
spectrophotometer (NanoDrop Technologies, Wilmington, DE USA), diluted to 0.5 ng/µL to 
normalize sample test quantities for performance testing, and stored in low-adhesion 
microcentrifuge tubes at -20°C (<6 months).  For each batch of DNA extractions, three method 
extraction blanks with purified water substituted for fecal, sewage, or environmental water were 
performed to monitor for potential contamination. 
4.2.3 Selection of Candidate Genetic Regions for PCR-Based Assay Development 
To identify candidate genetic regions for the development of human-associated fecal source 
identification methods, select portions of the putative ~97 kbp crAssphage genome (accession: 
JQ995537) [32] were identified for end-point PCR laboratory testing. Due to the reported 
potential for rapid DNA mutation rates in the human gut virome, such as those described for 
Microviridae [165], efforts were focused on predicted coding regions to select for sequences 
with some evidence of genetic conservation. Metaviromic islands were also excluded due to 
increased genetic diversity leading to under-recruitment in metaviromes suggesting the potential 
for low abundance in environmental samples [32, 166]. In addition, regions bordering modular 
junctions were eliminated. Finally, since orf00045 has homology with bat guano virome 
sequences [164], it was not considered for human-associated crAssphage assay development.   
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4.2.4 Candidate Primer Set Design 
A total of 384 end-point PCR primer pairs were designed to amplify selected crAssphage 
genomic regions. Primer pairs were designed and tested in silico using Primer-BLAST [152] 
with default parameters, except PCR product length was constrained to 90-180 bps and primer 
pair specificity was evaluated using the nr database (May, 2015). Only primer pairs that 
generated BLAST hits (E-value < 30000) to crAssphage or clone DNA sequences from human 
gut metagenome projects were selected as candidate primer pairs. Genetic regions where no 
primer sets met design criteria were eliminated from further consideration. 
4.2.5 End-point PCR Amplifications 
Each 25 µL end-point PCR amplification consisted of TaKaRa Ex Taq Hot Start PCR reagents 
(Clontech Laboratories, USA), 100 nM each forward and reverse primer, 0.8 µg bovine serum 
albumin (BSA; Sigma-Aldrich, St. Louis, MO USA), 2 µL template DNA, and molecular grade 
water. End-point PCR tests were performed in duplicate or in triplicate on a Tetrad 2 
Thermocycler (Bio-Rad Laboratories) under the following conditions: 94°C for 5 mins followed 
by 40 cycles of 94°C for 40 s, 57°C for 1 minute, and 72°C for 30 s, followed by a final 
extension at 72°C for 10 minutes. To monitor for potential sources of extraneous DNA during 
end-point PCR amplification, a minimum of two no-template controls (reactions contained 
additional purified water instead of template DNA) were performed with each instrument run. 
PCR products were verified on a 2% agarose gel with 1% lithium borate and 1X GelStar (Lonza, 
Rockland, ME USA) and visualized on a Gel Logic 100 Imaging System (Eastman Kodak 
Company, Rochester, NY USA).  
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4.2.6 Candidate End-Point PCR Primer Set Evaluation 
In order to determine which candidate crAssphage genetic regions have human fecal source 
identification potential, all 384 primer sets were tested with end-point PCR in a three-round 
process. In the first round, candidate primer sets were challenged against two fecal DNA 
composites: sewage and non-human. A sewage DNA composite was created by combining 
primary influent sewage DNA from three geographic locales (1 ng total DNA/reaction, 0.33 ng 
DNA/reaction from each sample) and was used to identify the presence or absence of candidate 
genetic regions in a known human fecal pollution source. A non-human DNA composite was 
created from cow (n=9), dog (n=9), goose (n=9), and pig (n=9) fecal DNA (4 ng total 
DNA/reaction, 1 ng DNA/reaction from each animal group) and was used to determine the 
presence of candidate genetic regions in non-target fecal pollution sources. All primers were 
tested in duplicate against DNA composites. Candidate primer sets proceeded to a second round 
of testing if the following criteria were met: (1) a PCR product of expected size was present 
when primary influent sewage DNA composite was used as template, (2) PCR product of 
expected size was absent when the non-human DNA composite was used as a template, (3) low 
amplification efficiency was not observed in reactions with sewage DNA composite as the 
template as evaluated by manual inspection, and (3) absence of any spurious PCR products 
noticeably different in size from the expected PCR product, including primer dimers.  
In round two, remaining candidate primer sets were challenged against diluted 
preparations of the primary influent sewage DNA composite (0.1 ng/reaction, 1x10-2 ng/reaction, 
and 1x10-3 ng/reaction) and a higher concentration of individual animal group composites for 
cow (n=9), dog (n=9), goose (n=9), and pig (n=9) using 5 ng of total DNA per reaction. 
Candidate primer sets proceeded to a third round of testing under the following conditions: (1) 
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amplification of expected size in triplicate reactions when 1x10-2 ng total DNA per reaction from 
primary influent sewage composite was used as template, (2) absence of expected PCR product 
size in all reactions when a non-human DNA composite was used as template, and (3) absence of 
spurious PCR byproducts, including primer dimers. 
 Round three represented the most rigorous performance screening step for candidate end-
point PCR primer sets.  Testing began with specificity determination from an expanded fecal 
reference collection (n=70 individual samples), followed by geographic distribution 
characterization in primary influent sewage samples collected from nine different locations, and 
ending with limit of detection (LOD) assessment. Reference fecal samples for specificity 
screening included cow (n=9), goose (n=8), dog (n=9), pig (n=9), horse (n=9), elk (n=9), deer 
(n=9), and beaver (n=8). All candidate primer sets passing round two were challenged with 
individual DNA preparations at 1 ng of total DNA per reaction. Specificity was defined as the 
proportion of non-human samples testing negative for a crAssphage genetic region. Only 
candidate primer sets with an observed specificity of 100% proceeded to geographic distribution 
testing. Sewage distribution characterization entailed testing of 1 ng of total DNA per reaction 
isolated from nine primary influent sewage samples collected from different locations across the 
continental United States (Table B2). Candidate primer sets with ≥ 95% detection frequency 
were eligible for LOD assessment. LOD95 was measured based on repeated testing (40 replicates 
per primer set) of primary influent sewage composite serial dilutions (10, 1, 0.1, 1x10-2, and 
1x10-3 ng total DNA per reaction) consisting of equal DNA mass from samples collected from 
all nine geographic locales. LOD95 was defined as the lowest dilution concentration where a 
minimum of 95% (38 of 40) of reactions yielded an amplification product of the expected size. 
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4.2.7 DNA Sequence Verification of Top Performing End-Point PCR Primer Sets 
To verify that candidate primer sets passing round three screening were amplifying the intended 
crAssphage genetic region, amplification products from the round one primary influent sewage 
composite and an environmental water sample with known human sewage pollution impairment 
(Heiserman Stream, OH USA) were sequenced and evaluated. PCR was performed using primer 
sets passing round three, using the same amplification conditions as above. PCR products were 
cloned into plasmid vector pCR2.1-TOPO and transformed into TOP10 chemically competent 
cells using the TOPO TA Cloning Kit as described by the manufacturer (Invitrogen, Thermo 
Fischer Scientific, USA). Transformed E. coli colonies plated on LB plates with kanamycin and 
X-gal for blue/white screening were sent to GENEWIZ for sequencing (South Plainfield, NJ 
USA). Sanger sequencing was performed from transformed bacterial colonies for each primer-
template combination using the M13R primer for amplification. PCR products were aligned with 
the previously reported crAssphage sequence (accession: JQ995537) [32] using CLC Genomics 
Workbench 8.5.1 (Qiagen, Valencia, CA USA). 
4.2.8 CrAssphage qPCR Assay Development 
Candidate primer sets passing round three end-point PCR testing were adapted to TaqMan® 
qPCR chemistry. Primers and probes for putative human-associated crAssphage genetic regions 
were designed using default parameters of the Primer Express version 3.0.1 software (Thermo 
Fisher Scientific, USA). Fluorogenic minor binding groove (MGB) probes were 5’ labeled with 
6-carboxyfluorescein.  
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4.2.9 qPCR Amplifications 
Five qPCR assays were used in this study: two novel crAssphage assays (this study) and two 
previously reported human-associated bacterial fecal source identification methods 
(HF183/BacR287 and HumM2), as well as an environmental water sample processing control 
assay (Sketa22) [16, 17, 60]. Each 25 µL qPCR reaction was composed of 1X TaqMan® 
Environmental Master Mix 2.0 (Thermo Fisher Scientific, USA), 5 µg BSA, 1 µM of each 
primer, 80 nM 6-carboxyfluorescein (FAM)-labeled probe, 80 nM VIC-labeled probe 
(HF183/BacR287 and HumM2 only), 2 µL template DNA, and molecular grade water. All qPCR 
tests were performed in triplicate using the QuantStudio™ 6 Flex Real-Time PCR System 
(Thermo Fisher Scientific, USA).  The thermal cycling profile for all assays was 10 minutes at 
95°C followed by 40 cycles of 15 s at 95°C and one minute at 60°C. The threshold for qPCR 
assays was manually set to 0.03 (crAssphage, HF183/BacR287, and Sketa22) or 0.08 (HumM2) 
and quantification cycle (Cq) values were exported to Microsoft Excel. Six y-intercept control 
reactions (standard reference material at 100 copies/reaction) were performed with each 
instrument run to utilize a mixed calibration model approach [167]. To monitor for potential 
contamination, six no-template controls were performed with each instrument run. Amplification 
inhibition was monitored in all DNA extracts using the HF183/BacR287 and HumM2 IAC 
procedures as previously reported [168]. 
4.2.10 qPCR Standard DNA Material Preparation 
Standard DNA material consisted of a customized gBlock™ gene fragment containing target 
sequences for crAssphage, HF183/BacR287, and HumM2 standard curve generation and an 
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internal amplification control (IAC) plasmid construct for HF183/BacR287 and HumM2 
amplification inhibition screening (Integrated DNA Technologies, Coralville, IA USA) [168]. 
Standard DNA concentrations were determined with a NanoDrop ND-1000 UV 
spectrophotometer (NanoDrop Technologies, Wilmington, DE USA). For standard curve 
reference material, five dilutions were prepared to contain 10 to 1x105 copies/2 µL. IAC 
reference DNA material was prepared as previously described [168]. All reference DNA material 
preparations were stored in GeneMate Slick low-adhesion microcentrifuge tubes (ISC 
BioExpress, Kaysville, UT USA) at -20°C prior to use (<3 months). 
4.2.11 Performance Testing of crAssphage qPCR Assays 
To investigate the suitability of newly developed technologies for human fecal source 
identification application, the performance of crAssphage qPCR methods was evaluated in a 
series of head-to-head experiments with HF183/BacR287 and HumM2 bacterial human-
associated methods [16, 17]. Calibration model performance including amplification efficiency 
(E = 10(-1/slope)-1), lower limit of quantification (LLOQ), and precision (% coefficient of 
variation) at 10 copies per reaction were calculated from six standard curves generated from 
independent instrument runs. LLOQ (log10 copies/reaction) was defined as the upper bound of 
the 95% credible interval from repeated measures of the 10 copy per reaction standard curve 
dilutions. Next, the abundance of each genetic marker was measured in primary effluent sewage 
samples (n=9) at a test concentration of 1 ng of total DNA per reaction (Table B2). The 
prevalence of putative human-associated genetic markers in non-human pollution sources was 
evaluated with a reference fecal collection consisting of 222 individual samples from 10 different 
animals (Table B1; test quantity = 1 ng total DNA/reaction). Prevalence was expressed both 
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quantitatively (log10 copies/ng of total DNA) and qualitatively (specificity = TNC/(TNC+TPI), 
where TNC represents the total number of negative individual samples that tested negative 
correctly, and TPI is the total number of individual samples that tested positive incorrectly). 
Finally, as a proof-of-concept pilot demonstration, genetic marker concentrations were estimated 
from two environmental water samples known to be impacted by human sewage pollution 
(Heiserman Stream, OH). Average log10 copies per ng of total DNA (sewage) and log10 copies 
per reaction (water) with 95% credible intervals were determined (mean Cq for each sample 
group and assay combination transformed using respective mixed calibration model followed by 
a nested analysis of variance to estimate standard deviation values) and compared to identify 
similarities and differences between qPCR genetic marker concentrations. 
4.2.12 Data Analysis 
Mixed model calibration models, unknown DNA concentration estimates, and credible intervals 
were determined using a Monte Carlo Markov Chain (MCMC) approach [167]. MCMC 
calculations were performed using the publically available software WinBUGS, version 1.4.1 
(http://www.mrc-bsu.cam.ac.uk/bugs). 
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4.3 RESULTS 
4.3.1 Putative Human-Associated crAssphage Genetic Regions and Candidate Primer Set 
Design 
A total of 46,564 bp (48%) of the crAssphage genome were selected for end-point PCR 
screening to identify potential human-associated genetic regions. Select genetic regions were 
excluded due to: (1) non-coding regions (8%), (2) metaviromic island motifs (32%), (3) modular 
junction regions (3%), (4) evidence of similarity with non-human or non-crAssphage sequences 
(3%), and (5) regions not amenable for PCR testing based on primer design parameters (e.g., 
product size and melting temperature restrictions (6%)) (Figure 4.1). In total, 384 end-point PCR 
primer sets were designed with 90% coverage (41,794 bp) of select putative human-associated 
genetic regions (Figure 4.1, Table B3).  
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Figure 4.1: Map representation of the crAssphage genome. The outermost track represents the 
open reading frames (ORFs) on the forward and reverse strand of the crAssphage genome. The 
middle track represents the areas of the crAssphage genome that were eliminated from primer 
design, including non-coding regions, metaviromic islands, modular junction areas, non-target 
sequence homology, and regions unsuitable for primer design. The innermost track represents the 
location of the 384 end-point primer pairs designed in this study and their amplification products. 
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4.3.2 Identification of Human-Associated crAssphage Genetic Regions with End-Point 
PCR 
Candidate primer sets were subjected to three rounds of performance testing to identify human-
associated crAssphage genetic regions. The first round of testing comprised of testing the 
primers against a sewage DNA composite and non-human animal fecal DNA composite. Round 
one testing eliminated 327 (85.2%) candidate primer sets: 34.6% (n=133) failing to yield a 
clearly distinct PCR product of the expected size in the sewage composite, 44.0% (n=169) 
generating spurious PCR products (including primer dimerization byproducts), and 4.7% (n=18) 
yielding false-positive results in non-human composite tests. Forty-nine (12.8%) candidate 
primer sets failed more than one first-round criteria. A total of 57 candidate primer sets were 
deemed eligible for round two testing. 
In round two testing, primer sets were challenged against lower dilutions of sewage 
composite DNA and higher concentrations of non-target animal fecal composite DNA. A total of 
51 primer sets were eliminated due to: amplification product of expected size when non-human 
samples were used as DNA template (n=24), failure to consistently yield a PCR product of the 
expected size when 1x10-2 ng total sewage composite DNA per reaction was used as template 
(n=14), and/or evidence of spurious PCR byproducts, including primer dimerization (n=40). 
Twenty-seven primer sets failed more than one criteria. False positives observed with each non-
human animal group tested were: pig (n=15), cow (n=15), canine (n=6), and goose (n=1). Six 
primer sets passed round two testing, including crAss028, crAss056, crAss064, crAss301, 
crAss303, and crAss375.  
Round three testing included specificity determination with an expanded reference fecal 
collection, characterization of geographic distribution in sewage, and a limit of detection 
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(LOD95) assessment (Table B4). Primer sets crAss056 and crAss064 exhibited the best 
performance with 100% specificity and 100% detection in geographic sewage samples and were 
subject to LOD95 assessment. Both primer sets yielded an LOD95 of 1x10-2 ng total DNA per 
reaction. Primer sets crAss064 and crAss056 were detected in 52.5% and 45% of test replicates, 
respectively, at a DNA template concentration of 1x10-3 ng per reaction. 
4.3.3 DNA Sequencing Verification 
End-point PCR products from crAss056 and crAss064 primer sets were sequenced from a 
primary influent sewage composite and human fecal pollution impacted environmental water 
sample to confirm amplification of the expected crAssphage sequences. Sequencing efforts 
resulted in 91 sequences (Figure B1). Alignment of crAss056 sequences indicated that 84.1% (37 
of 44) of sequences exhibited 100% similarity to the corresponding reference crAssphage 
genome region (accession: JQ995537; 14735 to 14836 bp). Five additional variants designated 
B, C, D, E, and F were observed with 1 mismatch each (99% similarity to crAssphage genetic 
region). Primer set crAss064 alignments yielded 74.5% (35 of 47) of sequences with 100% 
similarity to reported crAssphage genomic region (16058 to 16152 bp). Variant D was observed 
in 12.8% (6 of 47) of the sequences with a one base pair substitution. The remaining six 
crAss064 sequences each exhibited sequence similarities ranging from 98% (2 mismatches) to 
99% (1 mismatch) designated variants B, C, E, F, G, and H. 
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4.3.4 Performance of crAssphage qPCR Assays 
Candidate primer sets crAss056 and crAss064 were adapted as CPQ_056 and CPQ_064 to 
TaqMan® qPCR chemistry, respectively (sequences in Table 4.1). A series of paired experiments 
were performed to characterize new crAssphage qPCR assays with established HF183/BacR287 
and HumM2 methods. Calibration model performance metrics are reported in Table B5 and 
include slope, y-intercept range, amplification efficiency (E), LLOQ range, and precision at 101 
copies per reaction. All assays had a range of quantification from 101-105 copies per reaction 
(full range of tested standard concentrations). CPQ_056 and CPQ_064 both exhibited a 
specificity of 98.6% cross-reacting with the same three individual samples from gull (n=2) and 
dog (n=1), while HF183/BacR287 (100%) and HumM2 (99.5%; elk=1) yielded slightly higher 
performance levels. CPQ_056 and CPQ_064 target log10 copies per ng of total DNA 
concentrations were ≤1.33±0.04 in the two cross-reacting gull samples and ≤ 2.60±0.01 in one 
dog sample. HumM2 was detected in a single elk sample (1.02±0.06 log10 copies per ng of total 
DNA). Genetic marker log10 copies per ng of total DNA concentrations in primary influent 
sewage samples collected from different geographic locations ranged from 1.49±0.05 to 
3.37±0.05 (CPQ_056), 1.83±0.04 to 3.47±0.05 (CPQ_064), 1.55±0.02 to 3.18±0.02 
(HF183/BacR287), and 1.13±0.02 to 2.09±0.02 (HumM2). Total log10 copies per reaction 
concentrations in polluted environmental water samples ranged from 2.12±0.04 to 2.50±0.04 
(CPQ_056), 2.33±0.03 to 2.55±0.03 (CPQ_064), 2.28±0.07 to 2.45±0.07 (HF183/BacR287), and 
1.06±0.06 to 1.49±0.06 (HumM2). Wastewater qPCR reactions contained 1 ng of template DNA 
extracted from 10 mL of wastewater while environmental water qPCR reactions contained 2 µL 
of DNA extracted from a total volume of 200 mL of impacted water. A comparison of mean 
estimates with 95% credible intervals both indicated that primary influent sewage (Figure 4.2, 
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Panel A) and environmental water samples (Figure 4.2, Panel B) show no significant difference 
between CPQ_056, CPQ_064, and HF183/BacR287 results, while HumM2 measurements were 
significantly lower (p<0.05).  
 
Table 4.1: CrAssphage qPCR assay oligonucleotides and targeted genomic regions 
 
qPCR 
Assay 
Primer/ 
Probe Sequence 5’  3’ 
Genomic 
Region 
CPQ_056 
056F1 CAGAAGTACAAACTCCTAAAAAACGTAGAG 14731-
14856 056R1 GATGACCAATAAACAAGCCATTAGC 
056P1 [FAM] AATAACGATTTACGTGATGTAAC [MGB] 
CPQ_064 
064F1 TGTATAGATGCTGCTGCAACTGTACTC 16030-
16177 064R1 CGTTGTTTTCATCTTTATCTTGTCCAT 
064P1 [FAM] CTGAAATTGTTCATAAGCAA [MGB] 
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Figure 4.2: Abundance of crAssphage and bacterial human-associated qPCR targets in primary 
influent sewage (Panel A) and environmental water samples (Panel B). Values are reported as 
mean log10 copies estimates per ng of total DNA (Panel A) or per reaction (Panel B) with 95% 
credible intervals. Sewage qPCR reactions contained 1 ng of template DNA extracted from 10 
mL of wastewater while environmental water qPCR reactions contained 2 µL of DNA extracted 
from a total volume of 200 mL of impacted water. 
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4.3.5 Experiment Controls 
No template control amplifications indicated the absence of contamination in 99.7% of control 
reactions (n=1884). All method extraction blanks were negative ensuring no contamination was 
introduced during sample DNA extraction procedures. All DNA preparations exhibited no 
evidence of amplification inhibition except three fecal sample preparations, which were 
discarded from the study (data not shown). All environmental water samples showed no evidence 
of matrix interference as determined using the Sketa22 approach (data not shown). 
4.4 DISCUSSION 
4.4.1 Identification of Human-Associated CrAssphage Genetic Regions 
Data mining of human fecal metagenomic DNA libraries recently identified a putative 
crAssphage genome [32]. Previously reported comparative sequence analyses suggest this 
genome is both highly abundant and broadly distributed in human fecal and sewage 
metagenomic DNA sequence libraries [32, 164]. To investigate the potential use of crAssphage 
for human fecal source identification qPCR method development, we interrogated 43% of the 
crAssphage genome via laboratory testing to identify candidate qPCR target genetic regions. 
Approximately 65% of end-point PCR candidate primer sets generated expected PCR products in 
primary influent sewage samples supporting bioinformatic predictions that the crAssphage 
genome is widespread in United States wastewaters [164]. In contrast, 35% of candidate primer 
sets targeting genetic regions selected by bioinformatic analysis were not detected in sewage. No 
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PCR product amplification from these primer sets may have been due to a lack of assay 
optimization (e.g., reaction mixture, thermal cycling conditions) or sequence variation at primer 
hybridization sites. Another plausible explanation could be low genetic conservation between 
individuals leading to reduced template availability in sewage DNA extracts.  The crAssphage 
genome is reported as a consensus sequence of a quasispecies population isolated from a single 
fecal sample [32], whereas sewage is typically a mixture of fecal material contributed typically 
from thousands of individuals. Diversity between individuals in the crAssphage genome is 
limited. A recent study identified that patients in China were missing one open reading frame 
(ORF) and had low identity to another ORF of the crAssphage genome in their samples; 
however, these ORFs were identified as metaviromic islands and were not interrogated for 
primer design within this study [32, 169]. Additional studies are warranted to characterize within 
and between individual sequence variation in these genetic regions. 
 Nearly 95% (n=366) of end-point PCR primer sets in round one testing did not yield 
amplification products of the expected size with non-human animal sources used as DNA 
template. These findings support bioinformatic predictions of a close association of the 
crAssphage genome with human fecal waste [32, 164]. The bioinformatic analysis limited the 
number of false-positives observed in laboratory testing; however, some false-positives were 
identified, suggesting that parts of the crAssphage genome share homology with gut microbiome 
associated microorganisms of animals tested. Fourteen of the 18 false-positive results in round 
one testing were located within ORFs with reported homology to known or hypothetical proteins 
[32]. In addition, 169 (44%) of the primer sets yielded spurious PCR products (e.g., incorrect 
size, primer dimerization) during round one end-point PCR screening of sewage and fecal DNA 
preparations. Primer dimerization products can occur when a short region of complimentary 
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bases is shared between oligonucleotides in the same reaction while byproducts of the incorrect 
size may result from the improper annealing of primers or the potential amplification of 
pseudogenes or conserved sequence motifs in DNA template preparations. Since the generation 
of spurious PCR products leads to competition for reagents between the DNA target of interest 
and amplification byproducts, these genetic regions were not considered for qPCR method 
development. However, since the current study did not employ any optimization of PCR reaction 
conditions, these genome regions may be human-associated and may yield adequate methods 
with additional optimization. 
After three rounds of screening, the crAss056 and crAss064 primer sets were selected for 
qPCR method development. These genetic regions represent the most human-associated and 
abundant candidate DNA targets based on end-point PCR amplification conditions and reference 
fecal and sewage collections utilized in this study. Both primer sets target the forward strand of 
the crAssphage genome (Figure 4.1). Primer set crAss056 (14712-14860 bp) amplifies a region 
within orf00024, which currently has no known protein homolog [32]. Primer set crAss064 
(16038-16177 bp) targets a region within orf00025, which was previously reported to have 
homology with a DNA primase/helicase protein from Veillonella sp. [32], a bacterial genera 
commonly found in the intestines and oral mucosa of mammals. DNA sequencing efforts 
verified that crAssphage amplification products from primer sets crAss056 and crAss064 are 
conserved in primary influent sewage and environmental samples tested in this study (Figure 
B1), implying a level of genetic stability for the crAss056 and crAss064 target regions. Limited 
information exists on DNA mutation rates of intestinal viruses; however, several studies report 
considerable variation in the human gut virome in samples taken from different individuals [165, 
170, 171]. In this study, we attempted to avoid genetic regions with high mutagenic or 
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recombination potential by focusing only on predicted protein coding regions without 
metaviromic islands or proximity to modular junction regions. The crAssphage assays may need 
to be monitored in the future to ensure DNA sequence stability of the targeted gene sequences.  
4.4.2 Performance of crAssphage qPCR Assays 
Systematic testing of 384 candidate primer sets identified two genetic regions (primer sets 
crAss056 and crAss064) that were selected for qPCR method development based on the study 
design. The performance of crAssphage CPQ_056 (based on primer set crAss056) and CPQ_064 
(based on primer set crAss064) qPCR assays was evaluated through a series of paired 
experiments with established HF183/BacR287 and HumM2 assays. The crAssphage-based 
assays exhibited high calibration model performance, comparable to the performance of 
HF183/BacR287 and HumM2 (Table B5). In addition, the crAssphage qPCR genetic markers 
were present at similar concentrations to HF183/BacR287 and were significantly more abundant 
(p > 0.05) compared to HumM2 in primary influent sewage and impacted environmental water 
samples tested in this study. In contrast, a recent multiple laboratory evaluation of fecal source 
identification technologies found sensitivities ranging from 0-60.5% for human-associated viral 
and bacteriophage genetic markers in challenge samples, in contrast to much higher levels 
reported for bacterial HF183SYBR (all labs reporting >87% sensitivity) [55, 94]. The high 
sensitivity exhibited by the crAssphage qPCR assays in this study (100%) is only matched by the 
pepper mild mottle virus assay [24] and could be another useful alternative to other currently 
available human-associated viral methods.   
In addition to exceptional sensitivity, the crAssphage qPCR assays designed in this study 
exhibited high specificity (98.6%) based on a fecal reference collection consisting of 222 
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individual samples from 10 different animal groups. All qPCR assays evaluated in this study 
exhibited high specificities ranging from 98.6-100%, well above the recommended 80% 
threshold for water quality management applications [55]. CrAssphage qPCR assays cross-
reacted with gull (n=2; 8%) and dog (n=1; 2.4%) samples, both common sources in recreational 
and residential areas.  However, the crAssphage marker concentration was often lower in non-
human sources compared to primary influent sewage.  In addition, false positives in dog and gull 
sources was rare, occurring in only 2.4% (1 of 41) dog samples and 8% (2 of 25) gull samples. 
Other human-associated methods cross-react with these same animal sources likely due to 
cohabitation with dogs and animal food scavenging [23, 24, 61].  HF183/BacR287 did not cross-
react with any samples in the quantifiable range; however, it has been shown to cross react with 
chicken and turkey at a much lower concentration than in sewage [17]. Despite the high 
specificity performance of the crAssphage qPCR assays, it is recommended that specificity is 
confirmed with reference samples from the local area of interest before implementation. 
4.4.3 Fecal Source Identification and the Human Fecal Viral Metagenome 
This study demonstrates that viral metagenomes are a valuable source of genetic information that 
can be mined for host-associated sequences to develop novel fecal source identification 
technologies; however, using metagenomic sequences for method development presents several 
challenges. First, compiled genomes are constructed from viral quasispecies, resulting in a 
genome sequence with unknown variability and stability. In addition, novel genomes discovered 
through metagenomic sequences may lack homology with known annotated genes, resulting in 
poor quality sequence annotation within compiled genomes. Hence, it is difficult to infer 
specificity of these sequences in silico without laboratory testing. To overcome these challenges, 
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we performed laboratory testing of select regions of the crAssphage genome to find the most 
abundant and broadly distributed human-associated genetic regions. This approach builds off of 
bioinformatic predictions, with extensive end-point PCR laboratory screening to narrow down 
regions for future genetic marker development. This strategy could also be used for other human-
associated viruses; for example, bacteriophages that infect Bacteroides strain GB-124 [125, 126]. 
Currently, no qPCR assays are available for these phages and they may require the isolation of 
new hosts based on geographic distribution [127]. This approach will continue to be of use as 
viral metagenome mining continues to improve with additional research efforts leading to more 
publicly available datasets.  
4.4.4 CrAssphage Fecal Source Identification Application 
Findings in this study highlight the benefits of crAssphage qPCR methods for human fecal 
source identification. First, the abundance of the crAssphage markers in sewage and polluted 
environmental waters implies it will be possible to monitor in smaller sample volumes (≤ 
200mL) compared to typical virus assays requiring ≥1 liter. The isolation strategy used in this 
study allows for simultaneous recovery of bacterial and viral genetic markers, as well as the 
same DNA purification technique because the crAssphage genome is dsDNA. In addition, there 
is some evidence of genetic stability for the crAssphage method genome regions based on Sanger 
sequencing in this study, further showing the potential utility of these assays. Findings also 
indicate that the crAssphage qPCR assays possess a strong human host association (>98%), 
performing on par with top bacterial human fecal source identification methods. Lastly, as a viral 
genetic marker, the crAssphage qPCR assays could be a convenient tool to compliment bacterial 
fecal pollution monitoring tools in future studies.   
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Despite the high performance observed with the crAssphage qPCR assays, necessary 
developments remain prior to application of these methods. In this study, environmental samples 
were processed with ultrafiltration, which is expensive and time consuming. The concentrating 
pipette procedure used worked well but was only tested with a small number of samples. More 
research should be conducted to determine the best concentration strategies for crAssphage, 
including how matrix composition influences recovery efficiencies. In addition, the crAssphage 
qPCR assays were found to be 98.6% human-associated. This requires specificity testing to be 
completed in each geographic region prior to implementation, especially in areas with high 
densities of dogs or gulls. Due to this cross-reaction, it may be necessary to pair these methods 
with other established human fecal identification technologies in a toolbox approach to improve 
confidence in results. In addition, future studies may be needed to verify the temporal genetic 
stability of the crAssphage DNA target sequences, even though the results of this study suggest 
some level of conservation. Additional studies are necessary to understand linkages of the 
crAssphage methods to currently recommended fecal indicators, other fecal source identification 
targets, and pathogens with public health relevance. Lastly, the bacterial host and genome 
sequence variability of crAssphage remains unconfirmed. While this information is not required 
to exploit crAssphage for fecal source identification, this information could prove valuable to 
further utilize this virus for other water quality management applications. The availability of 
reliable viral assays that are abundant in impacted waters could have broad implications for 
water quality monitoring and human fecal waste treatment.  
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5.0  EVALUATION OF CRASSPHAGE-BASED QPCR MARKERS IN AN 
IMPACTED URBAN WATERSHED 
Environmental waters are monitored for fecal pollution to protect the public during recreational 
activities as well as protecting waters used for drinking sources or food production. While many 
human-specific source tracking markers have been developed, many lack adequate sensitivity to 
be reliably detected in environmental waters or do not correlate well with viral pathogens. 
Recently, two novel human-associated source tracking qPCR markers based on the 
bacteriophage crAssphage, CPQ_056 and CPQ_064, were developed. These assays were highly 
human specific, abundant in sewage, and are viral-based, improving on many existing 
technologies. A 30-day sampling study was conducted in an urban stream impacted by combined 
sewer overflows to evaluate the crAssphage markers performance in an environmental system. 
The crAssphage assays were present at concentrations of 4.02-6.04 log10 copies/100mL 
throughout the study period, indicating their high abundance and ease of detection in polluted 
environmental waters. In addition, the crAssphage assays were correlated with rain events, 
molecular markers for human polyomavirus and HF183, as well as culturable E. coli, 
enterococci, and somatic coliphage. Stronger correlations were demonstrated for the crAss_064 
assay compared to the crAss_056 assay. This study is the first to demonstrate extended 
environmental application of crAssphage markers for monitoring of environmental waters. 
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5.1 INTRODUCTION 
The release of inadequately or untreated wastewater into the environment is a major source of 
microbial impairment of environmental waters. Release of viral pathogens occurs from WWTP 
effluent, where viruses are not eliminated as successfully as bacteria through treatment processes 
and can often pass through the system.[86, 87, 172] Another source of pollution comes from 
leaky septic tanks which have been shown to be the main source of fecal bacteria into the 
environment in some watersheds.[173] In addition, approximately 40 million people in the 
United States in 772 communities are serviced by combined sewer systems [174], which are 
engineered to overflow untreated sewage into natural water bodies during wet weather events, 
allowing viruses and bacteria from fecal material to pose a health risk to the public. 
 Fecal contamination in environmental waters is regulated through monitoring of fecal 
indicator bacteria (FIB). Well-known limitations of monitoring environmental waters with FIB 
include the lack of differentiation between sources of fecal contamination and inadequately 
capturing viral risk to human health. The field of microbial source tracking (MST) has emerged 
to address the former problem, aiming to develop host-specific assays for water monitoring 
applications. Assays have been developed for the detection of numerous animal species such as 
cattle [12], dog [11], and gull [10], as well as human-derived fecal matter.[15, 17, 21, 23, 24] 
Human-specific markers are particularly desirable since this pollution has been shown to pose 
greater health risks to humans than pollution from other animal sources.[18, 19, 52]  
 In addition to the inability to differentiate animal sources of fecal pollution, FIB have 
been shown to not correlate well with enteric viruses in environmental waters and through 
wastewater treatment processes.[1, 87, 172] Enteric viruses cause a significant amount of disease 
burden and cost society billions of dollars every year in health system costs. For example, total 
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norovirus infection costs society an estimated $4.2 billion in direct health systems costs and 
$60.3 billion in societal costs annually worldwide.[3] In addition to person-to-person contact, the 
public can be exposed to enteric viruses present in environmental waters through direct contact 
with impaired waters or through irrigating crops with contaminated water. It has been shown that 
approximately 16% of all norovirus gastroenteritis illness is caused by environmental sources, 
such as consuming contaminated water and shellfish.[7] In addition, the occurrence of outbreaks 
caused by enteric viruses is rising.[1, 3, 4] Though environmental waters are managed in order to 
reduce the public’s exposure to health risks, no human-specific viral-based marker is currently 
widely used due to low or variable concentrations in sewage, resulting in low detection rates and 
necessitating concentration of large volumes of water.[94, 107] Viral concentration methods 
often exhibit low recovery efficiencies and can co-concentrate inhibitors that interfere with 
downstream testing, such as PCR.[26-28] Many researchers have emphasized the need for a 
human-associated viral marker that is abundant and reliably detected.[8, 87, 155]  
 The bacteriophage crAssphage was discovered by metagenomic data mining and found to 
be highly human-associated and more abundant than other human gut phages and viruses.[32] 
CrAssphage was suggested for MST technology development and the crAssphage-based qPCR 
assays used in this manuscript, named CPQ_056 and CPQ_064, were recently published.[164, 
175] Other primers not evaluated in this manuscript have also been recently published.[176, 177] 
Results in the initial publication indicated that the CPQ_056 and CPQ_064 targets were as 
abundant as current bacterial-based assays in sewage and had high specificity to sewage.[175] 
The initial study also confirmed crAssphage presence in an environmentally-impacted 
sample.[175] A recent study evaluating CPQ_056 also confirmed high abundance in sewage and 
successful detection in a storm sewer outfall.[178] Despite prior successful short-term 
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demonstrations, environmental assay testing over an extended study period is necessary to 
evaluate assay performance and determine the environmental correlation of crAssphage markers 
with existing markers and pollution events.  
 The goals of the present study were to perform an environmental evaluation of 
crAssphage qPCR markers in an impacted urban stream and compare assay performance to other 
culturable and molecular markers. Nine Mile Run in Pittsburgh, PA was monitored daily for 30 
days for chemical and biological indicators of water quality. Ranges of concentrations for MST 
markers were measured and Spearman’s rank correlation was determined between all monitored 
parameters and assays to evaluate crAssphage performance. This is the first extended 
environmental validation study of the usefulness of crAssphage-based assays for source tracking 
of human fecal pollution, correlating the assays with culturable indicators, viral indicators, 
molecular indicators, and pollution events.  
5.2 MATERIALS AND METHODS 
5.2.1 Study Site 
Sampling for the present study was conducted at Nine Mile Run in Pittsburgh, PA daily from 
September 6, 2016 through October 5, 2016. The selected location has been previously used as a 
water quality study site.[179] Nine Mile Run is a small urban stream located in Pittsburgh’s 
Frick Park, with a watershed of approximately 19.4 square kilometers.[180] Nine Mile Run has 
been shown to be chronically polluted, including high levels of fecal indicator bacteria (E. coli 
and fecal coliforms), despite undergoing a restoration project in 2006.[180, 181] The small 
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stream can become overwhelmed during large rain events, and two combined sewer outfalls 
discharge directly into the stream. The specific sampling location (40.426385, -79.905262) used 
in this study is directly downstream of one combined sewer outfall in order to capture changes in 
concentration to the stream from this point source (Figure 5.1).  
 
 
 
 
Figure 5.1: Depiction of study sampling site within Frick Park. Google Map image (Map data © 
2017 Google) shows the sampling location downstream of where a CSO outfall joins with Nine 
Mile Run (NMR). 
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5.2.2 Sampling and Data Collection 
Samples were collected daily at 9:00 AM for 30 days. Each day, three liters of stream water were 
collected in sterile containers and transported on ice to the laboratory, where samples were 
processed within six hours. In addition, one additional sample was collected on the September 
30th during an active CSO event. The temperature of both the stream and the air were measured 
at the time of sampling. Rainfall data was collected in real-time from 3 Rivers Wet Weather 
(http://www.3riverswetweather.org/municipalities/calibrated-radar-rainfall-data), a nonprofit 
organization that operates and maintains rain gauges throughout the region. The data used for 
this project comes from rain gauge #11, which corresponds to Nine Mile Run.  Combined sewer 
overflow (CSO) events were monitored from the local wastewater treatment and conveyance 
authority’s (Alcosan) online Sewer Overflow Advisory Key status changes 
(http://www.alcosan.org/SewerOverflowAdvisories/SOAKStatusChanges2017/tabid/115/Default
.aspx). A CSO advisory is issued based on the wet well elevation at Alcosan’s Main Pump 
Station, which may or may not correspond to a CSO at Nine Mile Run. 
5.2.3 Chemical Parameter Characterization 
Chemical parameters were measured throughout the course of this study to monitor water 
quality. Sample pH was measured using a FiveEasy Plus pH meter (Mettler Toledo, Columbus, 
OH).  Turbidity was measured using Program 745 on a Hach DR900 meter (Loveland, 
Colorado). Total Organic Carbon (TOC) was measured by filtering 40 mL of sample through a 
0.45µm filter and analyzing on a TOC-L TOC Analyzer (Shimadzu, Kyoto, Japan). Total 
dissolved solids (TDS) were determined by filtering the sample through a 0.45µm filter and 
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drying in a lab oven at 180°C according to EPA Method 8163. All chemical parameters were 
tested in triplicate for each sample. 
5.2.4 Enumeration of Culturable Indicators 
Culturable bacteria and phage indicators were measured for each sample. E. coli were measured 
by filtration and culturing on HiChrome m-TEC agar (Sigma-Aldrich, St. Louis, MO) following 
the protocol of EPA Method 1603 [182]. Enterococci were measured by filtration following EPA 
Method 1600 and culturing on mEI plates [183], made with Difco mE agar (BD, Franklin Lakes, 
NJ) with the addition of indoxyl β-D-glucoside (Chem-Impex International, Wood Dale, IL). 
Somatic coliphages were enumerated via a single agar layer plaque assay procedure according to 
EPA Method 1602 [163].  
5.2.5 qPCR Assays 
Stream water was simultaneously concentrated for viruses and bacteria as previously 
described.[23, 28] Briefly, 500 mL of stream water was pH adjusted to pH=3.5 and filtered 
through a 47mm 0.45µm mixed cellulose HAWG filter (Millipore, Billerica, MA). Duplicate 
filters for each sample were then placed in tubes and frozen at -80°C for later bulk DNA 
extraction. For DNA extraction, filters and bead tubes were allowed to thaw to room temperature 
and DNA was extracted using a DNeasy PowerWater Kit (Qiagen, Valencia, CA), following 
manufacturer’s protocol. Extracted DNA was stored at -20°C. TaqMan qPCR assays targeting 
crAssphage (CPQ_056 and CPQ_064),[175] a Bacteroides species (HF183/BacR287),[17] and 
human polyomavirus[23] (HPyV) were performed as described previously. Each 25 µL qPCR 
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reaction for the crAssphage assays and HF183/BacR287 contained 1x TaqMan Environmental 
Master Mix 2.0 (Thermo Fisher Scientific), 5 µg Bovine Serum Albumin (BSA, Sigma-Aldrich, 
St. Louis, MO), 1 µM of each primer, 80 nM FAM-labeled probe, 80 nM VIC-labeled probe 
(HF183/BacR287 only), molecular grade water, and 2 µL of a 10x dilution of extracted DNA. 
Each 25 µL reaction for HPyV contained 1x TaqMan Environmental Master Mix 2.0, 5 µg 
Bovine Serum Albumin, 0.5 µM of each primer, 0.4 µM FAM-labeled probe, molecular grade 
water, and 2 µL of extracted DNA. All qPCR tests were performed in triplicate on a CFX 
Connect Real-Time System (BioRad, Hercules, CA). Each qPCR plate included a standard curve 
with 101-105 target copies per reaction that was prepared as previously described.[175] 
Thermocycler conditions for each assay were as previously reported.[23, 175] Fluorescence drift 
correction was applied and the threshold for quantification cycle (Cq) determination was auto 
calculated using a baseline determined from cycle numbers 10 to 20.  
5.2.6 Controls 
Three filter control DNA extractions were performed by placing a sterile filter in a bead mill 
tube, and three extraction blanks were performed and tested by qPCR for all assays. Controls for 
mTEC and mEI plates were performed by filtering sterile buffer rinse water through a filter and 
plating. Controls for the somatic coliphage procedure were performed by adding DI water to the 
test agar. Triplicate no template controls (NTCs) were included on each qPCR plate. All no 
template controls and process controls were negative throughout the course of the study. In 
addition, the HF183/BacR287 assay includes an internal amplification control (IAC) that allows 
for evaluation of PCR inhibition. Potential inhibition introduced through the water environment 
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or concentration procedures was determined as previously described.[175] No samples exhibited 
PCR inhibition as determined through the evaluation of the IAC control. 
5.2.7 Statistical Analysis 
Spearman’s rank correlation coefficients (r) were calculated on the means of log transformed 
data in GraphPad Prism 7 (La Jolla, CA) between culturable indicators, qPCR indicators, and 
chemical parameters, using two-tailed 95% confidence intervals. Coefficients are characterized 
by the following scale for comparison purposes: 0.2-0.39 (weak correlation), 0.4-0.59 (moderate 
correlation), 0.6-0.79 (strong correlation), and 0.8-1 (very strong correlation). One-way 
ANOVAs were performed in Minitab 17 (State College, PA) on log10 transformed data between 
dry weather days and wet weather days to determine if rain events significantly impacted water 
quality parameters.  Rainfall is reported as the total amount of precipitation recorded in the 24 
hours before sampling. A sampling day was considered to be a wet weather sampling event if it 
had rained within the past 24 hours.   
5.3 RESULTS AND DISCUSSION 
5.3.1 Site Background 
The goal of the current study was to demonstrate the use of crAssphage based qPCR assays to 
detect and quantify human fecal pollution in an impacted urban watershed. The study was 
conducted at Nine Mile Run in Pittsburgh, PA. Nine Mile Run is a small urban waterway 
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perpetually impacted by fecal contamination through combined sewer overflow events and storm 
water runoff.  This test site was chosen for this study due to known contamination events from 
CSO events and leaky sanitary sewers[179], facilitating detection and evaluation of fecal source 
tracking markers in a relevant environmental matrix. Samples were collected from a public 
access location point daily for a 30 day period in September 2016. An additional sample was also 
collected during an active CSO event. Samples were then transported to the laboratory at the 
University of Pittsburgh and immediately processed for water quality parameters and culturable 
indicators.  
5.3.2 Rainfall During the Study Period 
During the 30-day study period, it rained a total of 12 days, with 8 of those days reporting active 
CSOs. Total rainfall ranged from 0.02 to 1.01 inches of rain in a 24-hour period.   
5.3.3 Chemical Parameters During the Study Period 
Chemical parameters were measured throughout the length of the study to monitor water quality. 
Results for TOC, pH, turbidity, and TDS can be seen in Figure 5.2 along with a plot of the 
rainfall throughout the study. Throughout the study period, TOC ranged from 1.6-6.3 mg/L (1.6-
3.4 mg/L for dry weather days and 2.4-6.3 mg/L for wet weather days). The pH remained stable 
throughout sampling, ranging from 7.62 to 8.05. Turbidity ranged from non-detect (ND) to 40.7 
Formazin Attenuation Units (FAU) (ND-10 FAU for dry weather days and 2.7-40.7 FAU for wet 
weather days). TDS ranged from ND-947 mg/L (500-947 mg/L for dry weather days and ND-
692 mg/L for wet weather days). The chemical values measured during the active CSO event fell 
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within the range observed on study days for TOC and TDS but were observed outside of the wet 
weather range for pH (6.73) and turbidity (87.3 FAU). 
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Figure 5.2: Chemical parameters measured along with daily rainfall during the Nine Mile Run 
sampling period of 30 days. Rainfall is presented as the amount of rain that fell within the 24 
hour period before that day’s sampling. A red bar on the rainfall graph indicates rainfall that 
corresponded to a reported CSO event. The individual data points shown in red represent an 
additional sampling time point during day 25 during an active CSO event. 
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5.3.4 Correlation of Chemical Parameters with Rainfall Events 
One-way ANOVA analysis was performed between observed chemical values on dry weather 
days versus wet weather days. The analysis demonstrated a statistically significant difference (p 
< 0.05) for all chemical parameters between dry and wet weather days. TOC and turbidity were 
both positively correlated with rain events, i.e. their values increased significantly with rainfall. 
TDS and pH were both negatively correlated with rainfall, i.e. these parameters were 
characterized by significantly lower values on wet weather sampling days. No significant 
differences in values were observed between wet weather events that resulted in a reported CSO 
event versus no reported CSO event.  
5.3.5 Culturable and qPCR Indicators During Study Period 
Culturable and qPCR assays were evaluated in order to compare the crAssphage qPCR assays to 
fecal pollution indicators (Figure 5.3). Ranges observed for culturable indicators were: E. coli 
(2.38-4.49 log10 cfu/100mL), enterococci (2.06-4.31 log10 cfu/100mL), and somatic coliphage 
(2.02-3.74 log10 pfu/100mL). Ranges observed for qPCR indicators were: CPQ_056 (4.02-6.04 
log10 copies/100mL), CPQ_064 (4.33-5.94 log10 copies/100mL), HF183/BacR287 (2.80-5.64 
log10 copies/100mL), and HPyV (1.50-4.21 log10 copies/100mL). All indicators were detected 
each day of the study except for human polyomavirus (HPyV) on a single sampling day.  
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Figure 5.3: Culturable and qPCR indicators along with daily rainfall during the Nine Mile Run 
sampling period of 30 days. Rainfall is presented as the amount of rain that fell within the 24 
hour period before that day’s sampling. A red bar on the rainfall graph indicates rainfall that 
corresponded to a reported CSO event. The individual data points for the indicators represent an 
additional sampling time point during day 25 during an active CSO event. 
85 
5.3.6 Correlation of Human-associated Markers with Rainfall Events 
Similarly to the chemical parameters, one-way ANOVA analysis was performed on all biological 
indicators to understand if rain and/or CSO events significantly affected concentrations of the 
markers. The abundance of all markers was positively correlated with rain events, i.e. in all cases 
the indicator increased after a rainfall event. In addition, the abundance of all markers was found 
to be statistically significantly different (p < 0.05) between wet and dry weather conditions. No 
statistically significant difference was found between wet weather events that corresponded to a 
reported CSO event versus a rain event without a reported CSO event.  
5.3.7 Correlation of chemical and biological water quality parameters 
Spearman’s rank correlation coefficients were calculated between each pair of culturable 
indicators, molecular indicators, and chemical parameters (Figure 5.4, Table C1).  The reported 
correlation coefficients generally showed strong correlation between markers, with 91% of p-
values being statistically significant (<0.05) (Table C2). Although the two crAssphage assays 
strongly correlated with each other, their correlation with other indicators varied. The only 
chemical parameter that correlated strongly with crAssphage abundance was TOC with the 
CPQ_064 assay. pH did not correlate strongly with any other biological or chemical parameter. 
For culturable markers, the CPQ_064 assay strongly correlated with culturable E. coli and 
enterococci, while the CPQ_056 assay correlated strongly with somatic coliphage. For molecular 
markers, the CPQ_056 assay was only strongly correlated with CPQ_064. In contrast, the 
CPQ_064 assay was strongly correlated with the HF183 and HPyV assays, in addition to 
CPQ_056. 
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 In addition to the crAssphage correlations described above, there were several other 
correlations between other parameters measured in this study. The strongest correlations were 
observed between bacterial based indicators: E. coli vs. enterococci (0.93), E. coli vs. HF183 
(0.88), and enterococci vs. HF183 (0.86). The bacterial based indicators (E. coli, enterococci, 
and HF183) also had stronger correlations with chemical parameters than the viral indicators 
exhibited, with each being strongly correlated with TOC, turbidity, and TDS. 
 
 
 
Figure 5.4: Heat map of Spearman’s rank correlation coefficients matrix for culturable 
indicators, qPCR indicators, and chemical parameters. Coefficients are colored based on the 
following scale of the absolute value of the coefficients: red (0.2 to 0.39 - weak correlation), 
orange (0.4 to 0.59 - moderate correlation), green (0.6 to 0.79 - strong correlation), and dark 
green (0.8 to 1 - very strong correlation). Actual values of correlation coefficients are provided in 
Table C1. 
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5.3.8 Comparison of crAssphage qPCR Assays 
Overall, levels of both crAssphage markers were detected at similar concentrations to 
HF183/BacR287 and approximately two to three orders of magnitude greater than HPyV. 
Despite positive correlations between all biological indicators, the two crAssphage-based assays 
differed in the strength of their correlations with other indicators. The most notable difference is 
the strong correlation between the CPQ_064 assay and the HPyV assay, while the p-value 
between CPQ_056 and HPyV was one of the few in the study to not show statistical significance. 
Differences in assay performance highlighted in this study are notable and warrant further 
investigation, as it is likely that future investigations will choose a single crAssphage assay to 
apply, for example a recent study investigated only CPQ_056.[178] 
 This study demonstrates the high abundance of crAssphage-based indicators compared to 
other indicators of human fecal pollution in the environment and the ease at which they can be 
detected along with other DNA-based assays. Due to the high levels of fecal pollution at the 
selected study site, HPyV was detected in nearly all samples; however, HPyV had the lowest 
quantities detected of all the qPCR assays. Based on the results of this study, CPQ_064 
correlates well with HPyV yet is orders of magnitude more abundant, making crAssphage assays 
potentially useful in waters polluted at lower levels. 
 Recently, a separate crAssphage-based qPCR assay not evaluated in the current study 
was developed by targeting a short (78bp) genetically conserved genome fragment and 
evaluated.[176] In the initial evaluation of this assay, 61% of fecal samples derived from cows, 
pigs, and poultry were positive for this crAssphage sequence.[176] In comparison, the assays 
evaluated in this study have been shown to exhibit specificities of 98.6% (n=222), cross-reacting 
with a single dog fecal sample and two gull samples.[175] A recent study also showed CPQ_056 
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cross-reaction with poultry litter but still determined a specificity of 92.7%.[178] This further 
demonstrates the differing suitability of crAssphage genome regions for human-specific 
applications. Some genome regions of crAssphage may have homology to other phages within 
other animals’ intestinal tracts, as well as some regions may be human-specific. Hence, it is 
likely that crAssphage assays will perform differently based on the genomic region on which 
they are designed. 
5.3.9 Site Specific Considerations 
While the goal of this study was to demonstrate performance of crAssphage qPCR assays in an 
impacted urban stream whose results can be applied widely, the specific site chosen has some 
unique characteristics that should be considered. Nine Mile Run was selected as a test site due to 
its well-known contamination due to sewage inputs and the well-characterized nature of the 
system. The present study detected peaks in biological marker concentrations after rain events, 
which then decayed to a background level of pollution. Ideally, the peak in concentration would 
decay until the biological markers are no longer detectable to confirm that the marker signal is 
not present if fecal pollution is no longer present. However, NMR has been shown to be 
impacted by leaking sanitary sewers during baseflow conditions,[179, 184] resulting in a signal 
decay to this lower level of constant sewage input. Additional research should be conducted to 
quantify the decay of the crAssphage markers. In addition, it has been shown that during rain 
events, more pristine storm water dilutes the nitrate signal in the stream.[179, 184] This effect 
could also be present in this study, muting the peak concentrations of the biological markers.  
The current study evaluated a single system and results may vary between environmental 
systems. Previous studies have suggested the potential for geographic variation of crAssphage 
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abundance in sewage;[164] the crAssphage indicators should be studied in additional sites to 
verify findings. In addition, the study site demonstrated high levels of microbial water quality 
impairment. The concentrations of E. coli and enterococci were above the 2012 Recreational 
Water Quality Criteria recommendations throughout the duration of our study;[185] however, 
elevated levels of these indicator bacteria were readily observed on wet weather days allowing 
observations above background levels of pollution. Future studies should investigate both 
systems less chronically polluted and systems polluted by non-point sources to evaluate if 
crAssphage-based markers correlate better than indicator bacteria to pollution events in systems 
that are impacted from additional non-human pollution sources. Further, this study found no 
significant differences from CSO events and rain events not resulting in a reported CSO. This 
could be due to limitations in data resolution since the study system is located away from where 
the CSO levels are determined. Overflow events may have been occurring even when they were 
not officially reported. In addition, overflow events may have overwhelmed the study stream 
faster than the reporting system due to the small volume of the study stream. Finally, samples 
were necessarily concentrated for qPCR analysis. The concentration method used in this study 
conveniently allowed for simultaneous concentration of both viral and bacterial indicators. This 
method has previously been shown to perform well, with HPyV recovery efficiencies of 40 and 
78% in tap and river water, respectively;[28] however, the use of any concentration method 
likely underestimates the levels of both crAssphage and human polyomavirus.  
5.3.10 Environmental Implications 
This study demonstrated the first extended environmental application of crAssphage-based qPCR 
assays as indicators of human fecal pollution in an impacted urban stream. The crAssphage 
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assays were shown to correlate with other culturable and molecular indicators, as well as rain 
events. The assays were also shown to be present in contaminated waters at high abundance, 
orders of magnitude higher than the viral-based HPyV assay. This suggests their ease of 
detection and utility in less chronically impaired waters where other viruses may be too dilute to 
detect. While crAssphage-based assays remain a promising tool for water management 
applications, more research is necessary to fully understand marker performance. Additional 
study sites should be evaluated that are affected by non-point sources of pollution and that are 
less chronically polluted than Nine Mile Run. In addition, studies should be conducted to 
understand the persistence of crAssphage marker signals in different water matrices compared to 
other pathogenic viruses to understand if crAssphage behaves in a similar manner. Ultimately, 
these developments will improve our ability to more accurately assess viral presence and health 
risk in waters to ensure a more complete picture of water quality composition. 
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6.0  SUMMARY AND CONCLUSIONS 
6.1 MAJOR FINDINGS 
Environmental water quality monitoring is imperative to protect both environmental health and 
public health. A review of current microbial source tracking technologies showed that current 
techniques do not adequately capture viral health risk and are unable to distinguish the animal 
source of the pollution (Chapter 2). MST efforts have produced many new technologies for 
biological screening of environmental waters based on bacteria, viruses, and bacteriophages. 
Challenges remain with all assay types. Bacteria based MST assays cross-react with non-human 
animal fecal matter and do not correlate with viral presence in environmental waters. Viral 
assays are less abundant in environmental waters than bacteria and phages, making their 
detection unreliable and necessitating concentration methods that can be inefficient or increase 
inhibition in downstream testing. Bacteriophage assays largely remain culture based, which can 
necessitate additional bacterial host isolation and can cross-react with other animal species 
similarly to their bacterial hosts. The shortcomings of existing technologies were highlighted and 
ideal assay characteristics were identified. 
The bacteriophage “crAssphage” was identified as a candidate for a human-specific 
source tracking technology based on the criteria established in Chapter 2. A metagenomic 
evaluation of crAssphage for a source tracking specific application was performed (Chapter 3). 
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CrAssphage was abundant in human-derived sewage, although geographic variability in 
crAssphage abundance was observed. While crAssphage was observed in human sewage, it was 
not observed in other environments. This implies crAssphage is largely associated with the 
human gut. In addition, crAssphage was found to be more abundant than other viruses that have 
been proposed as viral water quality indicators. This metagenomic screening provided an 
economic and time efficient method of initial screening of a novel MST technology. The high 
abundance and human association demonstrated by crAssphage in this study warranted further 
investigation of crAssphage as an MST target. 
In Chapter 4, primer pairs were designed along the length of the crAssphage genome, 
tested by three rounds of end-point PCR, and then the best-performing primer pairs were adapted 
to qPCR assays. A total of 48% of the crAssphage genome was initially identified as ideal for 
primer development, eliminating regions suspected of being hyper-variable or non-selectively 
hitting to other species targets. Primer design resulted in 384 primer pairs spanning the 
crAssphage genome that were subjected to three rounds of PCR testing. After rigorous testing by 
PCR, two primer pairs were adapted to qPCR assays, CPQ_056 and CPQ_064. These assays 
were tested head-to-head with two bacterial-based assays and were found to be just as abundant 
or an order of magnitude more abundant than the bacterial-based assays. In addition, the assays 
were found to exhibit high human-specificity. This research detailed the development of novel 
viral-based qPCR technologies that are both highly human-associated and highly abundant in 
reference materials, improving on the lack of sensitivity experienced with existing viral 
technologies. 
An initial environmental evaluation of the developed crAssphage assays was performed 
(Chapter 5). Results showed that the crAssphage assays were significantly correlated with rain 
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events. In addition, the assays were positively correlated with culturable indicator bacteria and 
bacteriophages as well as with molecular bacterial and viral markers. However, this study 
demonstrated varied assay performance, suggesting the two developed crAssphage assays may 
perform differently based on the genomic area on which they are designed. This study further 
demonstrated the high abundance of crAssphage in environmental waters and provided evidence 
for assay correlation with existing technologies and pollution events.  
6.2 IMPLICATIONS 
The novel technologies developed from this research effort contribute to the tools available for 
monitoring environmental waters. Currently, environmental waters are monitored using general 
bacterial indicators of fecal pollution. These general indicators do not differentiate pollution 
based on its source and do not necessarily correlate with viral health risk in polluted waters. Two 
qPCR assays, CPQ_056 and CPQ_064, were developed herein. The developed assays improve 
upon existing technologies by: (1) exhibiting high human-specificity, (2) having high 
concentrations in reference materials, and (3) being of viral origin. CrAssphage-based assays 
have the potential to better represent viral risk to human health in environmental waters while 
remaining more reliable due to their ease of detection. 
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6.3 FUTURE RESEARCH 
Despite the contributions to the field from this dissertation research, future research is warranted 
in further evaluating crAssphage-based technologies for implementation in water management 
applications. The two assays designed should be verified with additional human and animal fecal 
reference samples to establish their specificity values over a wider geographic range, in addition 
to international surveillance. Further environmental surveillance should be conducted, including 
studies in less impacted sites and from non-point sources of pollution, such as agricultural runoff. 
Also, multi-lab studies should be conducted to ensure the quality of the crAssphage assays’ 
performance metrics, where they can be tested head-to-head with other MST technologies. 
Further research effort is required to correlate additional properties of the assays to those of 
human viral pathogens, including decay rates of crAssphage marker signal in environmental 
waters as well as through wastewater treatment. Lastly, the bacterial host of crAssphage remains 
unknown; therefore, there is no method available for culturing and isolating crAssphage in lab. 
While the research conducted in this dissertation provides an example of new MST technology 
develop based on bioinformatic data rather than culture-based, culturing methods would be 
desirable to study basic crAssphage biology, such as persistence in the environment and reaction 
to disinfectants. Established culturing methods will facilitate knowledge acquisition and 
implementation of crAssphage-based markers for water quality management. 
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APPENDIX A 
CHAPTER 3 – SUPPLEMENTAL INFORMATION 
Table A1: Metagenomes used in this study along with individual sample data and alignment results. References are provided 
where available. 
 
sample environment metagenome type 
number of 
sequences 
mapped 
% 
sequences 
mapped 
fraction of 
reference 
covered 
average 
coverage sequencing method accession reference 
 raw sewage 
- Barcelona 
human 
associated viral 1560 0.15 0.76 5.47 454 GS FLX Titanium SRA040148 [1] 
raw sewage - 
Pittsburgh 
human 
associated viral 2178 0.33 0.9 10.06 454 GS FLX Titanium SRA040148 [1] 
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Table A1 (continued) 
raw sewage - San Francisco human associated viral 454 0.08 0.42 1.44 454 GS FLX Titanium SRA054852 [2] 
A_influent - United States human associated viral 7948 0.34 0.64 2.27 Illumina HiSeq provided by author [3] 
A_effluent - United States human associated viral 4741 0.19 0.46 1 Illumina HiSeq provided by author [3] 
B_influent - United States human associated viral 8089 0.1 0.78 2.58 Illumina HiSeq provided by author [3] 
B_effluent - United States human associated viral 6721 0.08 0.58 1.5 Illumina HiSeq provided by author [3] 
C_influent - United States human associated viral 4731 0.06 0.61 1.94 Illumina HiSeq provided by author [3] 
C_effluent - United States human associated viral 6508 0.08 0.67 1.75 Illumina HiSeq provided by author [3] 
D_influent - United States human associated viral 12110 0.15 0.82 4.59 Illumina HiSeq provided by author [3] 
D_effluent - United States human associated viral 7585 0.09 0.61 1.79 Illumina HiSeq provided by author [3] 
E_influent - United States human associated viral 10639 0.13 0.72 4.05 Illumina HiSeq provided by author [3] 
E_effluent - United States human associated viral 8411 0.11 0.61 2.04 Illumina HiSeq provided by author [3] 
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Table A1 (continued) 
raw sewage - Addis Ababa human associated viral 446 0.07 0.06 1.78 454 GS FLX Titanium SRA040148 [1] 
raw sewage - Nigeria human associated viral 0 0 - - 454 GS FLX Titanium SRA054852 [2] 
raw sewage - Nepal human associated viral 16 0 0.02 0.04 454 GS FLX Titanium SRA054852 [2] 
raw sewage - Bangkok human associated viral 8 0 0.02 0.02 454 GS FLX Titanium SRA054852 [2] 
influent - Singapore human associated viral 88 0.05 0.3 0.37 454 GS FLX Titanium 4450219.3 [4] 
activated sludge - Singapore human associated viral 5 0 - - 454 GS FLX Titanium 4450221.3 [4] 
anaerobic digester - Singapore human associated viral 10 0 - - 454 GS FLX Titanium 4450224.3 [4] 
 raw sewage - China human associated viral 4537 0.01 0.87 4.79 Illumina HiSeq 2500 SRX450092  
fecal matter - California sea lion terrestrial animals viral 0 0 - - 454 GS FLX Titanium SRA044033 [5] 
fecal matter - wild rodent terrestrial animals viral 0 0 - - 454 GS FLX Titanium SRA030869 [6] 
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Table A1 (continued) 
bovine rumen terrestrial animals viral 4 0 - - 454 GS FLX Titanium SRX215440  
fecal matter - pig terrestrial animals viral 0 0 - - 454 GS FLX Titanium SRA030664 [7] 
bat guano terrestrial animals viral 0 0 - - 454 GS FLX Titanium SRA012669 [8] 
bat guano terrestrial animals viral 25991 0.3 0.39 5.41 Illumina Genome Analyzer DRA000500 [9] 
cow rumens pool plankton terrestrial animals microbial 1 0 - - 454 GS20 4440357.3 analyzed in [16] 
cow rumens 80F6 terrestrial animals microbial 0 0 - - 454 GS20 4440356.3 analyzed in [16] 
cow rumens 640F6 terrestrial animals microbial 7 0 - - 454 GS20 4440355.3 analyzed in [16] 
cow rumens 710 F terrestrial animals microbial 3 0 - - 454 GS20 4440387.3 analyzed in [16] 
lean mice terrestrial animals microbial 0 0 - - 454 GS20 4440463.3 [10], analyzed in [16] 
obese mice terrestrial animals microbial 0 0 - - 454 GS20 4440464.3 [10], analyzed in [16] 
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Table A1 (continued) 
chicken cecum NCTC terrestrial animals microbial 3 0 - - 454 GS20 4440367.3 analyzed in [16] 
chicken cecum uninfected terrestrial animals microbial 5 0 - - 454 GS20 4440368.3 analyzed in [16] 
chicken cecum A terrestrial animals microbial 5 0 - - 454 4440283.3  
chicken cecum B terrestrial animals microbial 3 0 - - 454 4440284.3  
canine beet pulp GI metagenome terrestrial animals microbial 0 0 - - 454 4444702.3  
canine control gastrointestinal metagenome terrestrial animals microbial 1 0 - - 454 4444703.3  
healthy fish slime fish viral 0 0 - - 454 GS20 4440065.3 analyzed in [16] 
morbid fish slime fish viral 1 0 - - 454 GS20 4440064.3 analyzed in [16] 
mosquito Oceanside Ca mosquito viral 0 0 - - 454 GS20 4440052.3 analyzed in [16] 
mosquito San Diego mosquito viral 5 0 - - 454 GS20 4440053.3 analyzed in [16] 
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mosquito Mission Valley Ca mosquito viral 5 0 - - 454 GS20 4440054.3 analyzed in [16] 
effluent - Singapore reclaimed water viral 2 0 - - 454 GS FLX Titanium 4450223.3 [4] 
park - RW reclaimed water viral 0 0 - - 454 GS FLX  SRA008294 [11] 
nursery - RW reclaimed water viral 0 0 - - 454 GS FLX SRA008294 [11] 
nursery - RW reclaimed water viral 0 0 - - 454 GS FLX SRA008294 [11] 
effluent - RW reclaimed water viral 0 0 - - 454 GS FLX SRA008294 [11] 
effluent - RW reclaimed water viral 1 0 - - 454 GS FLX SRA008294 [11] 
Solar Salterns medium salinity west California hypersaline viral 0 0 - - 454 GS20 4440427.3 analyzed in [16] 
Solar Salterns medium salinity west California hypersaline viral 0 0 - - 454 GS20 4440428.3 analyzed in [16] 
Solar Salterns high salinity West California hypersaline viral 0 0 - - 454 GS20 4440421.3 analyzed in [16] 
Solar Salterns low salinity San Diego hypersaline viral 0 0 - - 454 GS20 4440436.3 analyzed in [16] 
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Table A1 (continued) 
Solar Salterns low salinity San Diego hypersaline viral 3 0 - - 454 GS20 4440432.3 analyzed in [16] 
Solar Salterns medium salinity west California hypersaline viral 0 0 - - 454 GS20 4440431.3 analyzed in [16] 
Solar Salterns medium salinity west California hypersaline viral 0 0 - - 454 GS20 4440417.3 analyzed in [16] 
Solar Salterns high salinity West California hypersaline viral 0 0 - - 454 GS20 4440145.4 analyzed in [16] 
Solar Salterns high salinity West California hypersaline viral 0 0 - - 454 GS20 4440144.4 analyzed in [16] 
Solar Salterns low salinity west california hypersaline viral 3 0 - - 454 GS20 4440420.3 analyzed in [16] 
Salton Sea hypersaline viral 0 0 - - 454 GS20 4440327.3 analyzed in [16] 
Salton Sea hypersaline viral 0 0 - - 454 GS20 4440328.3 analyzed in [16] 
Marine GOM marine viral 6 0 - - 454 GS20 4440304.3 [12], analyzed in [16] 
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Table A1 (continued) 
Marine BBC marine viral 1 0 - - 454 GS20 4440305.3 [12], analyzed in [16] 
Marine SAR marine viral 6 0 - - 454 GS20 4440322.3 [12], analyzed in [16] 
Line Is Kingman marine viral 0 0 - - 454 GS20 4440036.3 [13], analyzed in [16] 
Line Is Christmas marine viral 1 0 - - 454 GS20 4440038.3 [13], analyzed in [16] 
Line Is Palmyra marine viral 8 0 - - 454 GS20 4440040.3 [13], analyzed in [16] 
Line Is Tabuaeran marine viral 6 0 - - 454 GS20 4440280.3 [13], analyzed in [16] 
Tampa Bay Mitomycin C induced marine viral 6 0 - - 454 GS20 4440102.3 analyzed in [16] 
Skan Bay marine viral 1 0 - - 454 GS20 4440330.3 analyzed in [16] 
freshwater lake freshwater viral 0 0 - - 454 GS FLX Titanium ERP000339 [14] 
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Table A1 (continued) 
freshwater lake freshwater viral 0 0 - - 454 GS FLX Titanium ERP000339 [14] 
tilapia pond 3 freshwater viral 1 0 - - 454 GS20 4440424.3 analyzed in [16] 
healthy fish pond freshwater viral 2 0 - - 454 GS20 4440412.3 analyzed in [16] 
healthy fish prebead freshwater viral 0 0 - - 454 GS20 4440414.3 analyzed in [16] 
tilapia pond  freshwater viral 2 0 - - 454 GS20 4440439.3 analyzed in [16] 
Porites compressa time zero coral viral 0 0 - - 454 GS20 4440376.3 analyzed in [16] 
Porites compressa control coral viral 0 0 - - 454 GS20 4440374.3 analyzed in [16] 
Porites compressa DOC coral viral 1 0 - - 454 GS20 4440370.3 analyzed in [16] 
Porites compressa pH coral viral 0 0 - - 454 GS20 4440371.3 analyzed in [16] 
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Table A1 (continued) 
Porites compressa nutrients coral viral 0 0 - - 454 GS20 4440377.3 analyzed in [16] 
Porites compressa Temperature coral viral 0 0 - - 454 GS20 4440375.3 analyzed in [16] 
Pozas Azule II microbialites viral 1 0 - - 454 GS20 4440320.3 [15], analyzed in [16] 
Rios Mesquites microbialites viral 0 0 - - 454 GS20 4440321.3 [15], analyzed in [16] 
Highborne Cay microbialites viral 4 0 - - 454 GS20 4440323.3 [15], analyzed in [16] 
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Table A2: Number of reads mapped for the U.S. and Europe metagenomes to the viral 
genomes 
 
  crAssphage PMMoV adenovirus polyomavirus TTV norovirus 
A_inf 7948 355 365 67 49 65 
A_eff 4741 138 374 121 75 103 
B_in 8089 583 858 152 118 167 
B_eff 6721 317 1007 195 122 169 
C_in 4731 62 240 145 36 67 
C_eff 6508 229 672 157 96 157 
D_in 12110 196 798 182 76 177 
D_eff 7585 228 662 197 111 156 
E_in 10639 184 1082 138 45 147 
E_eff 8411 127 553 226 98 98 
San Francisco 454 74 0 0 0 0 
Pittsburgh 2178 240 23 0 0 17 
Barcelona 1560 2404 2 0 0 0 
average 6283 395 510 122 64 102 
STD 3456 619 376 80 45 66 
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APPENDIX B 
CHAPTER 4 – SUPPLEMENTAL INFORMATION 
Table B1: Summary of reference fecal sample collection  
 
 
Host 
(Common Name) Locality Count 
Cow OR 52 WY 9 
Dog 
OR 11 
WI 11 
OH 10 
FL 9 
Gull 
OR 5 
WI 10 
OH 10 
Horse OR 11 WA 9 
Elk OR 11 WA 9 
Canada Goose OR 10 OH 8 
Chicken OR 11 
Pig OH 9 
Deer WA 9 
Beaver WA 8 
 
TOTAL 222 
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Table B2: Summary of primary influent sewage sample collection 
 
 
Sample Location 
1 Cincinnati, OH 
2 Davenport, IA 
3 Pittsburgh, PA 
4 Keokuk, IA 
5 Wichita, KS 
6 Miami, FL 
7 Corvallis, OR 
8 Costa Mesa, CA 
9 Milford, OH 
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Table B3: Candidate primer set sequence information. Information on whether each primer pair 
passed or failed round I, II, and III testing is given in addition to the reason why each primer pair 
failed selection criteria. 
 
Assay Primer Sequence 5’  3’ Genomic Region 
CrAssphag
e ORF 
Roun
d I 
Roun
d II 
Roun
d III Reason for Failure 
crAss
001 
crAss001
-For 
GGTGAAATTAGAGGTG
ACGAGAGG 1772 to 
1867 NA Pass Fail   Primer Dimer crAss001
-Rev 
CCACCATTTCATTCTCC
ACGAA 
crAss
002 
crAss002
-For 
GAAGATATTTACGAGC
CTTTCCAC 78103 to 
78274 77 Fail     
Low amplification, primer 
dimer crAss002
-Rev 
GGTCAGATTACTCCTGA
AATGCTT 
crAss
003 
crAss003
-For 
GACTTCCACAAACGTTC
TTCGT 83864 to 
83966 86 Fail     False Positive crAss003
-Rev 
TCCAAAATGATAATGGT
GGTACTTC 
crAss
004 
crAss004
-For 
ACGCATCATAAATAAG
AGGATAACG 93164 to 
93343 96 Fail     
Low amplification, primer 
dimer crAss004
-Rev 
AAGATGGCGTTAAAGG
GGCA 
crAss
005 
crAss005
-For 
CTGCTGCTCCTGAGAGT
GTTA 494 to 596 3 Pass Fail   False Positive, Spurious Band, Primer Dimer crAss005
-Rev 
TCCACTTGCGCAGAACT
TTG 
crAss
006 
crAss006
-For 
GCGCAAGTGGAAACCA
TTGA 586 to 703 3 Fail     False Positive crAss006
-Rev 
TGCCATTACGACCTGTA
CGTT 
crAss
007 
crAss007
-For 
ACGTACAGGTCGTAAT
GGCA 684 to 811 3 Fail     Primer Dimer crAss007
-Rev 
ATGGCATCTGAACAGC
ACCA 
crAss
008 
crAss008
-For 
GATGCCATTCAATCAGA
TACTGC 804 to 915 3 Fail     Primer Dimer crAss008
-Rev 
AGTCAGATACATACTA
GCAAAGCCA 
crAss
009 
crAss009
-For 
ATCTGACTGGTGTTGCT
GTC 908 to 
1057 3 Fail     Primer Dimer crAss009
-Rev 
CAGCAGGCTGTTCGATA
CCTAC 
crAss
010 
crAss010
-For 
CGAACAGCCTGCTGAC
CCTA 1044 to 
1189 3 Fail     Primer Dimer crAss010
-Rev 
CGTCATCACTCATTGCA
GTAGC 
crAss
011 
crAss011
-For 
GCCTAGAAAGAAAACT
ATGGCTGA 2733 to 
2844 9 Fail     Primer Dimer crAss011
-Rev 
AACAGTTTCACTACTAA
CAACAGCA 
crAss
012 
crAss012
-For 
GAGGGTAAACTTGTTGT
TCCTG 2779 to 
2906 9 Pass Fail   
False Positive, Spurious 
Band, Primer Dimer crAss012
-Rev 
GTTTGTTCTTCCTGTTTA
CGAACT 
crAss
013 
crAss013
-For 
GATGCTAAGACTGATA
AACGTGGT 2947 to 
3059 9 Fail     Primer Dimer crAss013
-Rev 
AGAGAAGTATGACGTC
TAAATGCAG 
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Table B3 (continued) 
crAss01
4 
crAss014-
For 
TGCATTTAGACGTCATACTTCTCT
T 3036 to 
3170 9 Fail     
Low amplification, primer 
dimer crAss014-
Rev CTACGAAGTCCACCATCAGCA 
crAss01
5 
crAss015-
For AGAGTTACTGCTGATGGTGGA 3142 to 
3251 9 Fail     
Low amplification, primer 
dimer crAss015-
Rev ACTCGCTGACTATCACTAGCA 
crAss01
6 
crAss016-
For 
TTCATGCAGAATGTCTAAGTCAA
GA 3556 to 
3648 9 
Pas
s Fail   False Positive, Primer dimer crAss016-
Rev AAACATCATTTTCAGGGTCAACA 
crAss01
7 
crAss017-
For CTCCAGACCAATATGTTAGAGGT 3829 to 
3963 
1
1 Fail     Primer Dimer crAss017-
Rev GCCAATCAAGTTCAAATCCATCT 
crAss01
8 
crAss018-
For TCAAACTAAGCTTGGTGTTTGTG 4754 to 
4899 
1
2 Fail     Low amplification crAss018-
Rev 
CACTAACACAACGACTAACACCT
TT 
crAss01
9 
crAss019-
For 
AACTCATACTAAAGGTGTTAGTC
GT 4865 to 
4974 
1
2 Fail     No Product crAss019-
Rev 
TCTGTTCATTATTCTTACCATCAC
G 
crAss02
0 
crAss020-
For 
GGCTATTGGAAAGATAAACTTGC
T 5247 to 
5410 
1
2 Fail     No Product crAss020-
Rev 
AAATCAATATAAGAACGAGCAGC
AG 
crAss02
1 
crAss021-
For 
TTGTAGGTAAATCCAAAGAGAAA
GG 6514 to 
6660 
1
5 Fail     
Low amplification, primer 
dimer crAss021-
Rev TTCTGTAACTTTCACCAGTAATGC 
crAss02
2 
crAss022-
For AAAGTTGTTTATGCTCGTCGATT 6672 to 
6799 
1
5 Fail     No Product crAss022-
Rev CCTTTAGCTATAAGTCCAGCAGC 
crAss02
3 
crAss023-
For 
TTTATATTCCTTTTGCTGCTGGAC
T 6763 to 
6872 
1
5 
Pas
s Fail   Sensitivity crAss023-
Rev 
TTCACTATCACCACGATTATAACA
C 
crAss02
4 
crAss024-
For 
ACTAAAGACCAAGAAATAGCTGT
GC 7013 to 
7122 
1
6 Fail     
Low amplification, primer 
dimer crAss024-
Rev GTCTTACCTGTTCCTCCAGCA 
crAss02
5 
crAss025-
For TCTTGCACAGCCTTGGGATA 7054 to 
7193 
1
6 Fail     
Low amplification, primer 
dimer crAss025-
Rev GTGTAGGAGCAGCACAACCTA 
crAss02
6 
crAss026-
For TATAGGTTGTGCTGCTCCTACAC 7171 to 
7332 
1
6 Fail     Primer Dimer crAss026-
Rev 
TCTTTTCCAACAGGATTAAAGGC
A 
crAss02
7 
crAss027-
For 
AGCTTCTATGCTTAATGCTAAACT
T 7369 to 
7479 
1
6 Fail     Primer Dimer crAss027-
Rev TCATTAACAGGTGGAAGCTGACT 
crAss02
8 
crAss028-
For TGACTCTAGTCAGCTTCCACC 7450 to 
7548 
1
6 
Pas
s 
Pas
s 
Fai
l Sensitivity crAss028-
Rev TCTCCTTGTCGTACAACTTCTTT 
crAss02
9 
crAss029-
For AAGAAGTTGTACGACAAGGAGAT 7527 to 
7625 
1
6 Fail     Primer Dimer crAss029-
Rev 
AATCAAGAAACTTCCATCCATTCT
T 
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Table B3 (continued) 
crAss03
0 
crAss030-
For 
GGATTTTATGTTTGTGGTCAAACT
G 7667 to 7798 16 Fail     Primer Dimer crAss030-
Rev ATTCCATTGTGCAACACGAC 
crAss03
1 
crAss031-
For TTCAAGCTATTCATGGTGGTGCT 7992 to 8135 16 Fail     
Low amplification, primer 
dimer crAss031-
Rev 
TACTTCCACGTTCAGAACTACTA
GC 
crAss03
2 
crAss032-
For AGCTAGTAGTTCTGAACGTGGA 8110 to 8243 16 
Pas
s 
Fai
l   Spurious band, sensitivity crAss032-
Rev 
TTGCAAAGCCATAATCTAAATCT
CT 
crAss03
3 
crAss033-
For TCTCATAGAGCACAAGGTTCTAC 8249 to 8428 16 Fail     Low amplification crAss033-
Rev TCGTCAACAGTTTTACTTGCC 
crAss03
4 
crAss034-
For TGGCAAGTAAAACTGTTGACG 8407 to 8539 17 Fail     No Product crAss034-
Rev 
TCACCTCTAGGAAATAGGAAAAC
A 
crAss03
5 
crAss035-
For TGGCTACTGGCGGTAAATATG 8803 to 8912 17 Fail     No Product crAss035-
Rev 
CCAATTAATATCATCAGCAAAAC
GC 
crAss03
6 
crAss036-
For 
GGAACTATCCATTGTGTTCAACCT
C 11349 to 
11490 
2
0 Fail     No Product crAss036-
Rev 
GACCATCAACAATTTCAGTTCTTC
T 
crAss03
7 
crAss037-
For 
AAAGATACTATTGATACTGCCAA
GC 11661 to 
11774 
2
0 Fail     Low amplification crAss037-
Rev CTCTACGGGGAGTAAAGCCC 
crAss03
8 
crAss038-
For 
CAGAGAGCCAATTTTGTTTGTTA
AT 11780 to 
11924 
2
0 Fail     Low amplification crAss038-
Rev AGCACTACGTCCATCTTGAGT 
crAss03
9 
crAss039-
For GTACTCAAGATGGACGTAGTGC 11902 to 
12040 
2
0 Fail     Primer Dimer crAss039-
Rev CGTTCAGCAAGAACAAGAGGAT 
crAss04
0 
crAss040-
For 
GTTCTTGCTGAACGAGTTAAGAC
T 12027 to 
12188 
2
0 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss040-
Rev AGTAGCAGCATATTCACCTCTCTT 
crAss04
1 
crAss041-
For 
CAAGTCTGGAAGCAAGAAAAGA
CA 12293 to 
12432 
2
0 Fail     No Product crAss041-
Rev CGCTTGTTTCTAGGCTGTCA 
crAss04
2 
crAss042-
For GAAACAAGCGTAGACGAATGGA 12423 to 
12566 
2
0 Fail     Low amplification crAss042-
Rev TGCTTCCTCAATAGTACCAGCTA 
crAss04
3 
crAss043-
For TGTTCAACATTCTGTTGCTCCA 12792 to 
12923 
2
0 Fail     No Product crAss043-
Rev GCAAGACCATCTTCAACAGACTT 
crAss04
4 
crAss044-
For AGTCTGTTGAAGATGGTCTTGCT 12902 to 
13051 
2
2 Fail     No Product crAss044-
Rev TCACGCTGCCTTTGACAAGT 
crAss04
5 
crAss045-
For CTTGTCAAAGGCAGCGTGAG 13033 to 
13172 
2
2 
Pas
s 
Fai
l   False Positive, Primer dimer crAss045-
Rev GTTTGTGCCTCTTTGGGAGT 
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Table B3 (continued) 
crAss04
6 
crAss046-
For 
TTACTCCCAAAGAGGCACAAAC
T 13151 to 
13323 
2
2 Fail     No Product crAss046-
Rev 
AGAAGCAATTTGTTTAGCTTCAG
CA 
crAss04
7 
crAss047-
For 
GCTTCTACTGGTAAAGTTCCTGT
T 13318 to 
13430 
2
2 Fail     Primer Dimer crAss047-
Rev 
TCACCAGTAGCAACCATATTAC
G 
crAss04
8 
crAss048-
For 
AGAACGTAATATGGTTGCTACT
GGT 13404 to 
13548 
2
2 Fail     No Product crAss048-
Rev ATTAGCAATTTCACGAGCACC 
crAss04
9 
crAss049-
For AAGATGCTATTGTTGCTGGATGT 13442 to 
13579 
2
2 Fail     Low amplification crAss049-
Rev CTTCTGTGCTTAAACAGCCCAT 
crAss05
0 
crAss050-
For 
AGAAAGGTTTGAGTTTTGGTAT
GGG 13740 to 
13854 
2
3 Fail     Low amplification crAss050-
Rev ACTTGGGCAGTCATACGGAA 
crAss05
1 
crAss051-
For GTTTCCGTATGACTGCCCAA 13833 to 
13962 
2
3 Fail     Primer Dimer crAss051-
Rev CAGAAAGCAACAACTTCGGGTA 
crAss05
2 
crAss052-
For CCCGAAGTTGTTGCTTTCTG 13943 to 
14091 
2
3 Fail     Primer Dimer crAss052-
Rev 
ACACGAGTAGTACAAGGATTAC
CA 
crAss05
3 
crAss053-
For 
ACTCGTGTTCGTATGACTAAGA
ATG 14084 to 
14206 
2
3 Fail     False Positive crAss053-
Rev ACCTTCACGACCAAGAGCAG 
crAss05
4 
crAss054-
For 
TAAAGCTGCTCTTGGTCGTGAA
G 14182 to 
14322 
2
3 Fail     Primer Dimer crAss054-
Rev 
GTTACACCAATACCAGACAAAG
CA 
crAss05
5 
crAss055-
For 
ATGTTTGGAAACAGTTGAAAGC
TGA 14343 to 
14452 
2
3 Fail     Primer Dimer crAss055-
Rev 
ACCGTTATTAACAACAGCTTCTT
GC 
crAss05
6 
crAss056-
For 
GCTGAACAAACTGCTAATGCAG
A 14712 to 
14860 
2
4 
Pas
s 
Pas
s 
Pas
s   crAss056-
Rev 
TCAAGATGACCAATAAACAAGC
CA 
crAss05
7 
crAss057-
For GCCTTCATTTGCTGGTATGAGT 14909 to 
15054 
2
4 Fail     Low amplification crAss057-
Rev AAGCACCTTTACCACCGGG 
crAss05
8 
crAss058-
For 
ATGTATTTGTTCTTAAAGGTCGT
GA 15097 to 
15212 
2
4 Fail     Low amplification crAss058-
Rev AACTTCCTCAGCTTCAACAGGT 
crAss05
9 
crAss059-
For 
AGCTGAGGAAGTTATAGCTGGT
T 15200 to 
15373 
2
4 Fail     
Low amplification, primer 
dimer crAss059-
Rev TTACTTCCAACAACAGCACGC 
crAss06
0 
crAss060-
For TGGTAAATGGCGTGCTGTTG 15344 to 
15469 
2
4 Fail     Primer Dimer crAss060-
Rev 
GGGTCAATATGCAAACTAGGAG
C 
crAss06
1 
crAss061-
For AGAACAATCTGCTCCTAGTTTGC 15437 to 
15574 
2
4 Fail     Primer Dimer crAss061-
Rev GGAGCAGCAGTTTGAACACC 
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crAss06
2 
crAss062-
For TTGCTATGCCTGGTGTTGGTG 15526 to 
15618 
2
4 Fail     No Product crAss062-
Rev GACTAAAATCTCCACCGCCATT 
crAss06
3 
crAss063-
For 
TACAACATTGCATAGATACAGG
AGA 15896 to 
16029 
2
5 Fail     Primer Dimer crAss063-
Rev ATCTCCCCACCAATATCCAGC 
crAss06
4 
crAss064-
For TGCTGCTGCAACTGTACTCT 16038 to 
16177 
2
5 
Pas
s 
Pas
s 
Pas
s   crAss064-
Rev 
CGTTGTTTTCATCTTTATCTTGTC
C 
crAss06
5 
crAss065-
For 
CAACGATTATAATATTGCTAGGG
CT 16173 to 
16290 
2
5 Fail     No Product crAss065-
Rev AACACCAAATTGTCCCCAATACT 
crAss06
6 
crAss066-
For GGGGACAATTTGGTGTTAATCTT 16274 to 
16423 
2
5 Fail     No Product crAss066-
Rev 
GCCCAAGAACGTAACCATAACA
T 
crAss06
7 
crAss067-
For AATCATTCCATCCTCTACGGGG 16615 to 
16742 
2
5 Fail     
Low amplification, primer 
dimer crAss067-
Rev 
TTCCGATTAAGTTTACTACGAAG
CC 
crAss06
8 
crAss068-
For 
TGGTGTTGTTAATATTCCACATG
AA 16662 to 
16798 
2
5 Fail     Primer Dimer crAss068-
Rev TCACAGCTTCCATAAGACCAGT 
crAss06
9 
crAss069-
For ACTTGGCGTTAAAGATTTTGCAG 16845 to 
16985 
2
5 Fail     No Product crAss069-
Rev TTACTTTCTTCCGTATCCCAAGT 
crAss07
0 
crAss070-
For TGCGTCCAATTACTGAAGAGGA 17031 to 
17205 
2
6 Fail     Primer Dimer crAss070-
Rev 
CCACCATTATCAGTATCAAGTAG
GC 
crAss07
1 
crAss071-
For 
CCTACTTGATACTGATAATGGTG
GA 17182 to 
17331 
2
6 Fail     False Positive crAss071-
Rev GCTGGCTTACCTATAAGACAATG 
crAss07
2 
crAss072-
For GTCTTATAGGTAAGCCAGCTCGT 17313 to 
17462 
2
6 Fail     Primer Dimer crAss072-
Rev TCAATTGCATCAGCCATTGTAGA 
crAss07
3 
crAss073-
For 
TGATAAATCTACAATGGCTGATG
C 17433 to 
17525 
2
7 Fail     Primer Dimer crAss073-
Rev GTTTGTCTAGGACGAGAACCA 
crAss07
4 
crAss074-
For ATCCTGATGGTTCTCGTCCT 17498 to 
17618 
2
7 Fail     No Product crAss074-
Rev 
TGAGCTTTTTCTGGATGATGTTC
T 
crAss07
5 
crAss075-
For 
CTAGAACATCATCCAGAAAAAG
CTC 17593 to 
17704 
2
7 Fail     Primer Dimer crAss075-
Rev 
CTGGGTTTCTTCTCTCGAAATCA
A 
crAss07
6 
crAss076-
For CGAGAGAAGAAACCCAGTACGA 17688 to 
17815 
2
7 Fail     No Product crAss076-
Rev TTGCAATACCGGTGCTAACG 
crAss07
7 
crAss077-
For AAGAACCAAGGAAACGCACT 17720 to 
17858 
2
7 Fail     Primer Dimer crAss077-
Rev GCTTTACGCTGAGCAATCGT 
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crAss07
8 
crAss078-
For ATTAACGTTAGCACCGGTATTGC 17791 to 
17900 
2
7 Fail     Primer Dimer crAss078-
Rev 
CCATTAAATGCAAAACTAACAGC
TT 
crAss07
9 
crAss079-
For 
GCTAGAGTTTGTATATGTTGTGGC
A 20535 to 
20649 
3
2 Fail     No Product crAss079-
Rev 
ATTCTTTACATACAATAGCCTCAG
C 
crAss08
0 
crAss080-
For ACTCCACTTGGAAATTCTGTTGA 20574 to 
20698 
3
2 Fail     Primer Dimer crAss080-
Rev 
TCCATGTCACAAGCTATAAAGCA
A 
crAss08
1 
crAss081-
For TTGCTTTATAGCTTGTGACATGGA 20675 to 
20795 
3
2 Fail     No Product crAss081-
Rev 
AATAGGCTGTATAGAATCAAGCT
CT 
crAss08
2 
crAss082-
For CCTGAACTTGAAGAACGCCTTG 22187 to 
22326 
3
5 Fail     Primer Dimer crAss082-
Rev 
TTACGAAGAACAGCTAATCGTTG
C 
crAss08
3 
crAss083-
For GAGCAACGATTAGCTGTTCTTC 22301 to 
22411 
3
5 
Pas
s 
Fai
l   False Positive, Primer Dimer crAss083-
Rev 
ATTACCAGACTTACCTAAATCTCC
A 
crAss08
4 
crAss084-
For 
TTTAGTAGAGATGTGCTTCTTGAA
C 22562 to 
22671 
3
5 Fail     
Low amplification, primer 
dimer crAss084-
Rev 
TCATCAAACGTAAAATAACCTCC
AG 
crAss08
5 
crAss085-
For 
TGGAGGTTATTTTACGTTTGATGA
T 22648 to 
22797 
3
5 Fail     Primer Dimer crAss085-
Rev ACACTGCTACTTCTAGTCATTTCA 
crAss08
6 
crAss086-
For GGGCTTATTCTGGTGCTATTGATG 23111 to 
23260 
3
7 Fail     No Product crAss086-
Rev TTCGGTCAAGTTCTTCATCAGTTC 
crAss08
7 
crAss087-
For 
GTGAACTAGTTGGTAAAATGCCT
AT 23201 to 
23330 
3
7 Fail     Primer Dimer crAss087-
Rev AAGGCGTTATCACACTTACGA 
crAss08
8 
crAss088-
For CGCCTTTGCTACCTATCGTACTG 23325 to 
23474 
3
7 Fail     
Low amplification, primer 
dimer crAss088-
Rev CCCCAAAATCCAGCAGTTTGCC 
crAss08
9 
crAss089-
For TGCTGGATTTTGGGGAAATGG 23460 to 
23595 
3
7 Fail     No Product crAss089-
Rev 
AATCTTAACTCCACCACTACCATC
A 
crAss09
0 
crAss090-
For CTCATGATGGTAGTGGTGGAGT 23567 to 
23692 
3
7 Fail     Primer Dimer crAss090-
Rev 
GAACACTAGTTGTATGTCGAAAA
CT 
crAss09
1 
crAss091-
For 
TTCAACGTTTAAAAGATACAGGA
CA 23846 to 
23994 
3
7 Fail     No Product crAss091-
Rev ATCTCTTTGACCGGGACCAT 
crAss09
2 
crAss092-
For TGATGGTCCCGGTCAAAGAG 23973 to 
24084 
3
7 Fail     Primer Dimer crAss092-
Rev 
ACTATCAAATCGCTTAGTACCTTC
A 
crAss09
3 
crAss093-
For TACAGCTTGGGGTGCAGTTA 24003 to 
24138 
3
7 Fail     Primer Dimer crAss093-
Rev TTCTGCAAGTGCAAAAGCAT 
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crAss09
4 
crAss094-For TGGTTCAACCCATTCTACCTAC 24243 to 
24392 
3
8 
Fai
l     Primer Dimer crAss094-
Rev GTTCACCATTAGCATCATTTCCAA 
crAss09
5 
crAss095-For TATTGGAAATGATGCTAATGGTGAA 24367 to 
24476 
3
8 
Fai
l     
Low amplification, primer 
dimer crAss095-
Rev TATAGTCTAAAGTACCAGGGGCA 
crAss09
6 
crAss096-For ATGGGCTATCGTGGAGAACT 25489 to 
25607 
4
0 
Fai
l     Primer Dimer crAss096-
Rev GGTAAATGCATATGTTCTCTCAACT 
crAss09
7 
crAss097-For AGTTGAGAGAACATATGCATTTACC 25583 to 
25709 
4
0 
Fai
l     No Product crAss097-
Rev CCATCACAATTATATGGCGGAGT 
crAss09
8 
crAss098-For AGTGCTGAACGTATTAGTTGGA 25741 to 
25850 
4
0 
Fai
l     No Product crAss098-
Rev TAAGCTTTAGCTCCTCCACCG 
crAss09
9 
crAss099-For AGGTGAATGGATTCCTGCTGT 25933 to 
26046 
4
1 
Fai
l     Spurious Bands crAss099-
Rev TCATTACCTTCAACTTTAGCATCAC 
crAss10
0 
crAss100-For AGTGATGCTAAAGTTGAAGGTAATG 26021 to 
26150 
4
1 
Fai
l     No Product crAss100-
Rev GCAAACTCAGGTAGAGCAAGAG 
crAss10
1 
crAss101-For AGGCTTCATAAAGCTCTTGCTCT 26116 to 
26234 
4
2 
Fai
l     No Product crAss101-
Rev GGAGCATCACTAATACCAGCACT 
crAss10
2 
crAss102-For TTGCTCTACCTGAGTTTGCC 26132 to 
26280 
4
2 
Fai
l     No Product crAss102-
Rev ATCGCTTTGCACACCACG 
crAss10
3 
crAss103-For TGGTAGACAAGAAGCGCGTA 26193 to 
26315 
4
2 
Fai
l     No Product crAss103-
Rev CCTAGCAGCTTGCGAAGATA 
crAss10
4 
crAss104-For AAGGCTGTTGCTGGTAAGAAT 26608 to 
26757 
4
4 
Fai
l     No Product crAss104-
Rev TTGTCTTGTAGGTTCATCTCCAG 
crAss10
5 
crAss105-For CTGGAGATGAACCTACAAGACAAA 26735 to 
26847 
4
4 
Fai
l     No Product crAss105-
Rev TTTCCACATCCAAGCAATAGCATC 
crAss10
6 
crAss106-For GCTTTAATAGCAGCAGCTTTACGTT 31336 to 
31425 
5
2 
Fai
l     No Product crAss106-
Rev TACTCAACAGTTGCCTACTATACCT 
crAss10
7 
crAss107-For AGGTATAGTAGGCAACTGTTGAG 31401 to 
31538 
5
2 
Fai
l     No Product crAss107-
Rev GGTTGGACAGCCAATGTTCC 
crAss10
8 
crAss108-For GTATTATTAGGAACATTGGCTGTCC 31510 to 
31620 
5
2 
Fai
l     No Product crAss108-
Rev TGATATGGGTTATCTTCCAGCTTT 
crAss10
9 
crAss109-For GCTGGAAGATAACCCATATCAACAT 31600 to 
31749 
5
2 
Fai
l     No Product crAss109-
Rev 
GTACAAAGTGGGAACAGGATATGA
T 
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crAss110 
crAss110-For TATCCTGTTCCCACTTTGTACTT 
31729 to 31851 52 Fail     No Product 
crAss110-Rev TGGTTCAGCTGTTGTTGGTAA 
crAss111 
crAss111-For GCAGCAGTTCTATCAATATCAGTC 
32050 to 32163 52 Fail     No Product 
crAss111-Rev TAGTGAACAAGTTGAAGAAAATGGA 
crAss112 
crAss112-For CACGTTTTGCTTTAGCTTTATCAGT 
32282 to 32371 52 Fail     No Product 
crAss112-Rev AAGATTTAGAACAACTCAAGACTGG 
crAss113 
crAss113-For CAAAACCAGTCTTGAGTTGTTCTAA 
32342 to 32472 52 Fail     No Product 
crAss113-Rev GAGCGAAGAAGAAATTAATGTAGGA 
crAss114 
crAss114-For CCTACATTAATTTCTTCTTCGCTCT 
32449 to 32574 52 Fail     No Product 
crAss114-Rev AGGCAATGGTATGCCTTATGTTG 
crAss115 
crAss115-For GAACGAATAATACCAACATAAGGCA 
32539 to 32652 52 Fail     No Product 
crAss115-Rev AGTTGATGGACGTAAAATACCTGA 
crAss116 
crAss116-For TGCACGTTCTTCAGGTATTTTACG 
32619 to 32752 52 Fail     No Product 
crAss116-Rev ATTTAAATTGGGCGTTTGAAGAAC 
crAss117 
crAss117-For CTTTAAGTTCTTCAAACGCCCA 
32723 to 32834 52 Fail     No Product 
crAss117-Rev ATGAAAGTTCCTGAATATCGTGAAG 
crAss118 
crAss118-For ATTACCATTAGCATCACGTTGACT 
32859 to 33008 52 Fail     No Product 
crAss118-Rev GCTGAAAGACTTCGTGCTTATCAA 
crAss119 
crAss119-For TTCAGCTACATTCAAATCATGACCA 
33003 to 33112 52 Fail     No Product 
crAss119-Rev AAAGTCAAGATGAAGAACTTGGACG 
crAss120 
crAss120-For CGTCCAAGTTCTTCATCTTGACT 
33088 to 33211 52 Fail     No Product 
crAss120-Rev AAGGAGATGATGGTATTCCTAAAGA 
crAss121 
crAss121-For TCTTTAGGAATACCATCATCTCCTT 
33187 to 33308 52 Fail     No Product 
crAss121-Rev AAACCTATCACAGTTCAAGATGAAG 
crAss122 
crAss122-For TCTTCATCTTTTCTTCCCAAACAGG 
33425 to 33534 52 Fail     No Product 
crAss122-Rev TAAATCCAGAGCTGCTAAAGATGGT 
crAss123 
crAss123-For ACCATCTTTAGCAGCTCTGGA 
33510 to 33653 52 Fail     No Product 
crAss123-Rev CGTGCTAATCGTAACTTTGTATTGC 
crAss124 
crAss124-For CGACCTTCTTCAACAGTACCCA 
33586 to 33698 52 Fail     No Product 
crAss124-Rev GCTTATGGAGATACTGGATTTATGG 
crAss125 
crAss125-For AGCATCAAATTCTTTCATAAGACCA 
33696 to 33788 52 Fail     No Product 
crAss125-Rev CATTCTGCTAGAAAAGATTGGTTTG 
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crAss126 
crAss126-For AAGCATTAAGAACATTCTGGGC 
34157 to 34266 52 Fail     No Product 
crAss126-Rev TAGTGTTGATGACCAAACTCCTAT 
crAss127 
crAss127-For GCTATTCCGCCCTCACTCAA 
35020 to 35168 52 Fail     No Product 
crAss127-Rev TGGAATCATCCCAATCCTCTTATT 
crAss128 
crAss128-For GGGATGATTCCAAGCTCTATCAAA 
35157 to 35271 52 Fail     No Product 
crAss128-Rev TAATGACGAAAGAAATAATCGTCGT 
crAss129 
crAss129-For ACATTACGACGATTATTTCTTTCGT 
35242 to 35361 52 Fail     No Product 
crAss129-Rev TGCTAGACTTACTCCTGCTCAA 
crAss130 
crAss130-For TTTGAGCAGGAGTAAGTCTAGCA 
35339 to 35467 52 Fail     No Product 
crAss130-Rev GAGCTTTAGAAGTTGGACGAGT 
crAss131 
crAss131-For ACTAATGTACCACTTACTCGTCCAA 
35431 to 35540 52 Fail     No Product 
crAss131-Rev TTACCTGTTACTGTTGTTAATGGTG 
crAss132 
crAss132-For TCACCATTAACAACAGTAACAGGT 
35515 to 35649 52 Fail     No Product 
crAss132-Rev AGCAGAATGGACTAAAGGTGGA 
crAss133 
crAss133-For TCCACCTTTAGTCCATTCTGCT 
35628 to 35758 52 Fail     No Product 
crAss133-Rev ATCCTAGTTTAGCTGCATTTTTACA 
crAss134 
crAss134-For TTGTAAAAATGCAGCTAAACTAGGA 
35733 to 35867 52 Fail     No Product 
crAss134-Rev TATGCTCCATCCTCTACGGG 
crAss135 
crAss135-For CCCCGTAGAGGATGGAGCAT 
35847 to 35961 52 Fail     Spurious Bands 
crAss135-Rev TCTTAGTGCTGATAAATATGGTGCT 
crAss136 
crAss136-For TTGTTTAGCACCATATTTATCAGCA 
35931 to 36075 52 Fail     No Product 
crAss136-Rev TCGTCTTAGAGGGGAAATGAATGG 
crAss137 
crAss137-For TAAAGCCTGCTGAACGCCA 
36036 to 36145 52 Fail     Spurious Bands 
crAss137-Rev TATTCAATTTAAGCGTTTCTGATGC 
crAss138 
crAss138-For TCAATTAGCTTTTTACGTCCAGCA 
36184 to 36295 52 Fail     No Product 
crAss138-Rev GTGTTCTTGCGGAAGGTACT 
crAss139 
crAss139-For ACCAAAACCAAGATTATGAGCAAC 
36222 to 36353 52 Fail     No Product 
crAss139-Rev GGATTTATGTGGCAACCTGCTA 
crAss140 
crAss140-For ATCAATAGCAGGTTGCCACA 
36327 to 36453 52 Fail     Spurious Bands 
crAss140-Rev CGATGTTATGAAAGAGGGGGCTA 
crAss141 
crAss141-For GCCCCCTCTTTCATAACATCG 
36433 to 36542 52 Fail     No Product 
crAss141-Rev CATAAGAATTTTGGTTGGTCTGGA 
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crAss142 
crAss142-For CTTATCATCTCCAGACCAACCA 
36510 to 36623 52 Fail     No Product 
crAss142-Rev GTGATTAGTGAGCAAGAAGCTG 
crAss143 
crAss143-For AGCTTCTTGCTCACTAATCACA 
36603 to 36751 52 Fail     No Product 
crAss143-Rev GGTTTGATGCTGCTACTTCCG 
crAss144 
crAss144-For AAGTAGCAGCATCAAACCAATCA 
36734 to 36882 52 Fail     No Product 
crAss144-Rev TGCTGCATTTGAAGAAAATACTACT 
crAss145 
crAss145-For GTAGTATTTTCTTCAAATGCAGCAG 
36859 to 36968 52 Fail     No Product 
crAss145-Rev TTAAAACTCCCCGTGGAGGATAC 
crAss146 
crAss146-For GACTACTTGTATCCTCCACGG 
36938 to 37049 52 Fail     No Product 
crAss146-Rev ACTCTTGAAGGTTATAATGGCAATC 
crAss147 
crAss147-For GCCATTATAACCTTCAAGAGTAGCA 
37029 to 37138 52 Fail     No Product 
crAss147-Rev AAGCTAGTCGTAAGATTCTTGGT 
crAss148 
crAss148-For AAGTCCTACCAAGAATCTTACGAC 
37109 to 37218 52 Fail     No Product 
crAss148-Rev TATTCCAACTGAAATTACTCACGCT 
crAss149 
crAss149-For TCTAGCGTGAGTAATTTCAGTTGG 
37191 to 37312 52 Fail     No Product 
crAss149-Rev TTGTTGTTCCTGATGAATGGGT 
crAss150 
crAss150-For CAGGAACAACAACAGTACTACCA 
37301 to 37432 52 Fail     No Product 
crAss150-Rev TTGAACAAGTTCCTGATAGCTTACG 
crAss151 
crAss151-For ACGTAAGCTATCAGGAACTTGT 
37407 to 37516 52 Fail     No Product 
crAss151-Rev AGATTGGAGAGGTTGATGGCA 
crAss152 
crAss152-For GGAGTGCCATCAACCTCTCC 
37492 to 37602 52 Fail     No Product 
crAss152-Rev TAGTGGATGGCATGCTGCTC 
crAss153 
crAss153-For GCAGCATGCCATCCACTAATA 
37585 to 37734 52 Fail     No Product 
crAss153-Rev AGCTCTTCTTGAGTTTTTCGATTTA 
crAss154 
crAss154-For TTTTCAACTCCTTGTTGTTGAGCAT 
37735 to 37873 52 Fail     No Product 
crAss154-Rev AAACTTGTGCTGAACTTGGTATT 
crAss155 
crAss155-For CCAATACCAAGTTCAGCACAAGT 
37849 to 37966 52 Fail     No Product 
crAss155-Rev TGCTTGATAATCTTCCTAATCGAAC 
crAss156 
crAss156-For TGTTGAGGAACTTCTTGCTGAC 
38014 to 38159 52 Fail     No Product 
crAss156-Rev GTTGCACAACATAATCGAATGACA 
crAss157 
crAss157-For AGTGTCATTCGATTATGTTGTGC 
38134 to 38274 52 Fail     No Product 
crAss157-Rev AAATGCTGAGTTTGTTCTTATTCCT 
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crAss158 
crAss158-For TGTCTAGAAACTTCAATACCAACAG 
38281 to 38425 52 Fail     No Product 
crAss158-Rev ATGCTGGACTTATTCAAAGTCTTAC 
crAss159 
crAss159-For CTGTAAGACTTTGAATAAGTCCAGC 
38399 to 38513 52 Fail     No Product 
crAss159-Rev GGCGGTGTTAATACTAATGATGCT 
crAss160 
crAss160-For TAACACCGCCTTTAAATGGTTC 
38504 to 38593 52 Fail     No Product 
crAss160-Rev TTATTGATAGACTCGATGACCAACT 
crAss161 
crAss161-For AAGTTGGTCATCGAGTCTATCAAT 
38568 to 38716 52 Fail     No Product 
crAss161-Rev AAGGTAATGCTGTTACTGTTCCT 
crAss162 
crAss162-For AACAGTATAAGGAACAGTAACAGCA 
38685 to 38801 52 Fail     Spurious Bands 
crAss162-Rev CAAGCTAGTGGTAATCCTTTTGGT 
crAss163 
crAss163-For GGATTACCACTAGCTTGTACTTCTT 
38785 to 38875 52 Fail     No Product 
crAss163-Rev TGTACGATATGTATGGTGGTGAC 
crAss164 
crAss164-For AGCAACACGTTGTTCTCCATTA 
39027 to 39117 52 Fail     No Product 
crAss164-Rev TAAGACTATTGACATCCTCTACGG 
crAss165 
crAss165-For GCTAAGTCCACGTGTAGACCC 
39072 to 39219 52 Fail     No Product 
crAss165-Rev TGGACACAAAGTTTTAGCTGGT 
crAss166 
crAss166-For CATTACATTAACAGCTTGAGCCA 
39357 to 39483 52 Fail     No Product 
crAss166-Rev TGCTGGATTGCGTAGTCAAC 
crAss167 
crAss167-For GACTACGCAATCCAGCAAGAC 
39467 to 39639 52 Fail     No Product 
crAss167-Rev ATATCGTAGTATGAGTGATGGTGAT 
crAss168 
crAss168-For TAATCACCATCACTCATACTACGAT 
39613 to 39742 52 Fail     No Product 
crAss168-Rev GAGTTGGAAATGGAACTCCTAAACT 
crAss169 
crAss169-For AGGAGTTCCATTTCCAACTCTTCT 
39723 to 39867 52 Fail     No Product 
crAss169-Rev GCAAAACGCTATGGTTGAAGC 
crAss170 
crAss170-For GCTTCAACCATAGCGTTTTGC 
39847 to 39975 52 Fail     No Product 
crAss170-Rev ACTTAATTCTCGTAATCCAGAAGGT 
crAss171 
crAss171-For TCAGGCATTTTAGTTCCTTTATCCT 
40057 to 40185 52 Fail     No Product 
crAss171-Rev TGCTAAGATTGGTCGTGTAGC 
crAss172 
crAss172-For CTACACGACCAATCTTAGCAATAG 
40166 to 40315 52 Fail     No Product 
crAss172-Rev TTCCTGCTGCTCGTGAAAAG 
crAss173 
crAss173-For ACTTTTCACGAGCAGCAGGA 
40295 to 40406 52 Fail     Spurious Bands 
crAss173-Rev GCTCGTGTAACTAATCCTAATACTG 
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crAss174 
crAss174-For ACATTACTAGTATCAGCACTAGCAT 
40600 to 40731 52 Fail     No Product 
crAss174-Rev ACTTACTGCTGCTTCTCAACTT 
crAss175 
crAss175-For GAGAAGCAGCAGTAAGTTTAGGTA 
40715 to 40894 52 Fail     Spurious Bands 
crAss175-Rev TAGGCGGTTATCTTGATGAAACT 
crAss176 
crAss176-For AGTTTCATCAAGATAACCGCCTA 
40872 to 41017 52 Fail     Spurious Bands 
crAss176-Rev ATTATGGTGCATTACTTCGTTCTTT 
crAss177 
crAss177-For GAAGAAATGCTCCAAGACCGT 
41045 to 41167 52 Fail     No Product 
crAss177-Rev ATGCTGGACTTAAACGCGCTA 
crAss178 
crAss178-For TAGCGCGTTTAAGTCCAGCA 
41147 to 41322 52 Fail     No Product 
crAss178-Rev AGAAGAACGTGGTTTGTTTAGTACA 
crAss179 
crAss179-For TCAGCAATAGAAGCTACATCATCCA 
41326 to 41466 52 Fail     No Product 
crAss179-Rev GGTTGAAGACCCAATCTTTAAGAAG 
crAss180 
crAss180-For CTACATACAGCTAAAACTGATGCGT 
41701 to 41790 53 Fail     No Product 
crAss180-Rev GCTGAATTAACTAGCCGTTTACCA 
crAss181 
crAss181-For AGTTAATTCAGCCATATTTGACACT 
41779 to 41920 53 Fail     No Product 
crAss181-Rev AACTGCTAGTACAGAACAAACTGAA 
crAss182 
crAss182-For TCTGTACTAGCAGTTTCTTCTTCA 
41906 to 42020 53 Fail     No Product 
crAss182-Rev GTTTATTAGCTGCTGCTAGAGATG 
crAss183 
crAss183-For CATCTCTAGCAGCAGCTAATAAAC 
41997 to 42144 53 Fail     No Product 
crAss183-Rev GCTCTTATGACTGCACTTAATGAAA 
crAss184 
crAss184-For TTCATTAAGTGCAGTCATAAGAGC 
42121 to 42257 53 Fail     No Product 
crAss184-Rev GGCTTGATATTCAAGATGATGCTAC 
crAss185 
crAss185-For ATCATCTTGAATATCAAGCCAAGC 
42238 to 42387 53 Fail     No Product 
crAss185-Rev GCTGGTCAAAGAGTTTATCGAGT 
crAss186 
crAss186-For CTGTATCACGATGATAAACAGCATT 
42417 to 42557 53 Fail     No Product 
crAss186-Rev ATTTTGCTAATGACCAAACTGCTA 
crAss187 
crAss187-For TCAATAGCAGTTTGGTCATTAGC 
42530 to 42679 53 Fail     No Product 
crAss187-Rev GGATGGAACAATACCTGAACAGC 
crAss188 
crAss188-For GATAGCTGTTCAGGTATTGTTCCA 
42653 to 42763 53 Fail     No Product 
crAss188-Rev TAATGAAACTGCTGGTAATTGGC 
crAss189 
crAss189-For AACAGGACGAAGAGCATTATCTA 
42976 to 43153 53 Fail     No Product 
crAss189-Rev AGGTGCACATTTTAATGGTAAAGA 
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crAss19
0 
crAss190-
For 
CTCCAAGATTTTGTTTAAGTTCAC
C 43245 to 
43355 
5
3 Fail     No Product crAss190-
Rev AAGGTGATGCTCGACGTATT 
crAss19
1 
crAss191-
For AATACGTCGAGCATCACCTT 43336 to 
43457 
5
3 Fail     Spurious Bands crAss191-
Rev 
ATCTTACTACTAATGGTATGCCTG
T 
crAss19
2 
crAss192-
For 
TACTTGACCTTGTACAACTACACC
A 43495 to 
43587 
5
3 Fail     No Product crAss192-
Rev 
GATGCTAATGGCAAATGGAATGA
TG 
crAss19
3 
crAss193-
For TCCATTTGCCATTAGCATCATCAA 43569 to 
43723 
5
3 Fail     No Product crAss193-
Rev 
TCATGAAGCTAGTATTAATCGTTG
G 
crAss19
4 
crAss194-
For GCCCAGCTAAATCAAAACTTGC 43773 to 
43894 
5
3 Fail     False Positive crAss194-
Rev 
TGCTGTTAAAGAAGAAGTTACAC
AA 
crAss19
5 
crAss195-
For AGTCTTTCAAGACGTTCTTTAGCA 44228 to 
44347 
5
3 Fail     Primer Dimer crAss195-
Rev CGCCAGCACTAATAATCAAGGT 
crAss19
6 
crAss196-
For AGTGCTGGCGTAAAGATAGTT 44338 to 
44513 
5
3 Fail     Primer Dimer crAss196-
Rev 
TGGATGATTTTGCTAATAGTGTTG
A 
crAss19
7 
crAss197-
For 
ACGTTCATTACCTGTAACAGTAG
CA 44530 to 
44639 
5
3 
Pas
s 
Fai
l   False Positive, Primer Dimer crAss197-
Rev 
ATATTATTGACGGTCTTACAGGA
GG 
crAss19
8 
crAss198-
For 
TTTGTTCAAATCCAGCTTGACTAA
G 44664 to 
44813 
5
3 Fail     Low amplification crAss198-
Rev ATTTCGAACGTGGTCAAATAGGT 
crAss19
9 
crAss199-
For AATCAGTACCTATTTGACCACGTT 44784 to 
44897 
5
3 Fail     
Low amplification, primer 
dimer crAss199-
Rev 
ATCAATCTCAAACTGAACAACCA
AT 
crAss20
0 
crAss200-
For AGTAGGCTCACTAGGAACCGC 44911 to 
45037 
5
3 Fail     Primer Dimer crAss200-
Rev AGAAGTTGCTCCTGTTAATCCTGA 
crAss20
1 
crAss201-
For CCCCGTGGAGGATGGAGATG 44953 to 
45083 
5
3 Fail     No Product crAss201-
Rev 
AGATTGCTGAGATTGAAAACGAT
GT 
crAss20
2 
crAss202-
For TTAACATCGTTTTCAATCTCAGCA 45056 to 
45165 
5
3 Fail     Primer Dimer crAss202-
Rev 
ATTATTCGAGATGCTTATGCTGCA
C 
crAss20
3 
crAss203-
For GCATTACGTAAATCGTCCATAGC 45245 to 
45403 
5
3 Fail     Primer Dimer crAss203-
Rev 
AGCAGAAGTTGTTAATGCTGAGA
T 
crAss20
4 
crAss204-
For ATCTCAGCATTAACAACTTCTGCT 45380 to 
45534 
5
3 Fail     Primer Dimer crAss204-
Rev 
CGTATTGCTCAATTAAATGAACG
TC 
crAss20
5 
crAss205-
For TTCAAATCCGCCACCAAGTC 45772 to 
45899 
5
3 Fail     
Low amplification, primer 
dimer crAss205-
Rev 
ATAAACTTGGATTACAACAGCAA
GA 
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crAss20
6 
crAss206-
For 
AAGTTCATTACTATCTTGCTGTTG
T 45862 to 
45972 
5
3 Fail     
Low amplification, primer 
dimer crAss206-
Rev 
TCTATGAACGCTGGTAATTTAGG
AC 
crAss20
7 
crAss207-
For ACGAAGTTCTTCTTCAGTACCAG 46015 to 
46149 
5
3 Fail     Primer Dimer crAss207-
Rev 
ACTGCTACTTTTCAAGCATATCAA
G 
crAss20
8 
crAss208-
For 
TATGCTTGAAAAGTAGCAGTACG
AC 46130 to 
46276 
5
3 Fail     Primer Dimer crAss208-
Rev TTGGGGTGCTCTTGGTGGT 
crAss20
9 
crAss209-
For CCCAAAATGCTTGCTCCCAT 46272 to 
46418 
5
3 Fail     Primer Dimer crAss209-
Rev GGACAGAAGGAGTTGAAGAAGC 
crAss21
0 
crAss210-
For TGTCCATTCAGCTCTAACACCA 46414 to 
46524 
5
3 Fail     Primer Dimer crAss210-
Rev GCTGCTGCAATTACTAACGCTT 
crAss21
1 
crAss211-
For AAGCGTTAGTAATTGCAGCAG 46503 to 
46648 
5
3 
Pas
s 
Fai
l   Primer Dimer crAss211-
Rev 
TGTTCTTTTTGACGTATGGCAAGT
T 
crAss21
2 
crAss212-
For GGAACTCCAATAGCAGTAGCTT 46859 to 
47007 
5
3 Fail     Primer Dimer crAss212-
Rev AGTACTGGTCTTGCTAAAGGTGT 
crAss21
3 
crAss213-
For AAAGAAACACCTTTAGCAAGACC 46979 to 
47095 
5
3 Fail     Primer Dimer crAss213-
Rev 
TCCTAATGCTGCTTTTGATATTGG
A 
crAss21
4 
crAss214-
For 
AAAAGCAGCATTAGGATTTTCTC
T 47080 to 
47229 
5
3 Fail     Primer Dimer crAss214-
Rev GGTTTTGCAGATTTAGCTGATGC 
crAss21
5 
crAss215-
For 
CTGCAAAACCAATAGCTGTACCA
AC 47220 to 
47355 
5
3 Fail     Primer Dimer crAss215-
Rev 
TATGTTAATCCTGTTGATGACCCA
G 
crAss21
6 
crAss216-
For 
TTAACAGCACGTTCTTTATCAAGT
T 47303 to 
47447 
5
3 Fail     Spurious Bands crAss216-
Rev ACCGGGGTCGTGGTCAT 
crAss21
7 
crAss217-
For CACGACCCCGGTCACTAATA 47436 to 
47550 
5
3 
Pas
s 
Fai
l   False Positive crAss217-
Rev 
GGTGGTAATAAAACACCTAATCC
TG 
crAss21
8 
crAss218-
For CTATGACCGCCACAGCGATA 52841 to 
52950 
5
6 
Pas
s 
Fai
l   False Positive crAss218-
Rev ACTGGTCTTGAACGTCCTGA 
crAss21
9 
crAss219-
For TCAGGACGTTCAAGACCAGTT 52931 to 
53073 
5
6 Fail     False Positive crAss219-
Rev AAAGCATGGATTGGTGCTGC 
crAss22
0 
crAss220-
For CTTTTCTACGTCCGCCACAT 53070 to 
53209 
5
6 Fail     Primer Dimer crAss220-
Rev TCAAGAAGCGGAACAGCGT 
crAss22
1 
crAss221-
For TGTTTACGCTGTTCCGCTTC 53186 to 
53335 
5
6 Fail     Primer Dimer crAss221-
Rev TGCTCTTCCCGGTTTAGGTAG 
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crAss22
2 
crAss222-
For ACCAGCTTTACGTCGAACTCT 53356 to 
53501 
5
6 Fail     Primer Dimer crAss222-
Rev CTGAAGCTCAAGCTGCACAAG 
crAss22
3 
crAss223-
For ATCTTTATGGTCTTGTGCAGCTTG 53470 to 
53579 
5
6 Fail     Spurious Bands crAss223-
Rev TTATTGGTGCAGCTGCTAGTATTG 
crAss22
4 
crAss224-
For AGAACTCATTCCAACCACTATCA 58165 to 
58300 
5
9 Fail     No Product crAss224-
Rev 
CATCCTGTGTTTAATCTTTCTGCT
A 
crAss22
5 
crAss225-
For 
TAGCAGAAAGATTAAACACAGGA
TG 58276 to 
58390 
5
9 Fail     
Low amplification, primer 
dimer crAss225-
Rev 
TGTGAGATTCCTGTTATACCTGCT
A 
crAss22
6 
crAss226-
For 
CCATTAGCAGGTATAACAGGAAT
CT 58362 to 
58524 
5
9 Fail     False Positive crAss226-
Rev 
CCCGTGGAGGATATGATAAGTCA
A 
crAss22
7 
crAss227-
For GGGGTCTGACAATGAGAATGAAC 58524 to 
58671 
5
9 Fail     Primer Dimer crAss227-
Rev TGCCCGATGATTGTTGTCCTAA 
crAss22
8 
crAss228-
For TTAGTAGCACGCTCCGGACT 58689 to 
58801 
5
9 Fail     No Product crAss228-
Rev GGTTGTGAAGTACCTAGAGCTGA 
crAss22
9 
crAss229-
For 
AGACCGTCATCAATAAGACAACA
TT 58821 to 
58942 
5
9 Fail     Primer Dimer crAss229-
Rev CCTGCTTGGTGTGTTGATGC 
crAss23
0 
crAss230-
For 
TTACCATTATTATGTGCTCCACGT
T 59062 to 
59151 
5
9 Fail     
Low amplification, primer 
dimer crAss230-
Rev 
TTATCTTGAACGAGAACCTAATGC
T 
crAss23
1 
crAss231-
For TACCATCATACTTAAGTCCACGAA 59363 to 
59477 
6
0 
Pas
s 
Fai
l   False Positive, Primer Dimer crAss231-
Rev GTTGATTGGAACGCTACTAGACT 
crAss23
2 
crAss232-
For TAAGTCTAGTAGCGTTCCAATCAA 59453 to 
59582 
6
0 Fail     Primer Dimer crAss232-
Rev GTTCATAAATGTGTTCTTGAAGGC 
crAss23
3 
crAss233-
For ATAAGCGTAGCCTTCAAGAACAC 59550 to 
59667 
6
0 Fail     Primer Dimer crAss233-
Rev TGTTGCTCTTAAACTCGCTACAA 
crAss23
4 
crAss234-
For TCAGAACGTTTTGTAGCGAGT 59635 to 
59750 
6
0 Fail     
Low amplification, primer 
dimer crAss234-
Rev 
AGTTATACAGTTGGAGAAAGACG
TA 
crAss23
5 
crAss235-
For 
TACGTCTTTCTCCAACTGTATAAC
T 59726 to 
59901 
6
0 Fail     Primer Dimer crAss235-
Rev GATGAAAGCTGATTGTCGTGCTT 
crAss23
6 
crAss236-
For GGAGTTTCATTTGTTTGACGAGGA 60031 to 
60162 
6
2 Fail     Primer Dimer crAss236-
Rev 
TGACCCTATTGATGATGAAGCTA
A 
crAss23
7 
crAss237-
For 
CAGTTTCGGTAGGAACAAGATAA
GG 60188 to 
60336 
6
2 Fail     
Low amplification, primer 
dimer crAss237-
Rev 
TCTTGCAGGTATGTGTAATCTTCC
T 
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crAss23
8 
crAss238-
For ACAGGAAGATTACACATACCTGC 60310 to 
60455 
6
2 
Pas
s 
Fai
l   Primer Dimer crAss238-
Rev GAAGTTCCAAAGCCAGTTAGATT 
crAss23
9 
crAss239-
For ACTGGCTTTGGAACTTCTTGT 60439 to 
60567 
6
2 
Pas
s 
Fai
l   Spurious Band, sensitivity crAss239-
Rev 
TGTTGATAAAGGTTTGCAACAAC
G 
crAss24
0 
crAss240-
For TCACCTATTGAAGTCTTACCATCA 66639 to 
66744 
7
2 Fail     Primer Dimer crAss240-
Rev 
TTGGTTTTATTGCAGGTAATTCTG
A 
crAss24
1 
crAss241-
For 
GTTGGCTTATCAAGAGTTAAAGG
AG 66855 to 
66964 
7
2 Fail     
Low amplification, primer 
dimer crAss241-
Rev 
ATTCATCGTGATGGTTATTGTTGG
T 
crAss24
2 
crAss242-
For AACCACCACCATGACGAATTA 66967 to 
67088 
7
2 Fail     Primer Dimer crAss242-
Rev 
TGGTGAAGTTATTAAAAGAGTTG
CT 
crAss24
3 
crAss243-
For TCTTTATAACCACCATGTCCATCA 67098 to 
67207 
7
2 Fail     Primer Dimer crAss243-
Rev 
GCTTGGCAATTAAAGAATCATGA
AA 
crAss24
4 
crAss244-
For 
TCATGATTCTTTAATTGCCAAGCA
T 67185 to 
67294 
7
2 Fail     Primer Dimer crAss244-
Rev 
AATCTTTGTGCTAATTGGTATGGA
A 
crAss24
5 
crAss245-
For ACATGACCTCTACTCAAACTTCCA 67251 to 
67372 
7
2 Fail     
Low amplification, primer 
dimer crAss245-
Rev TCAGGTGCTGAATGTGTTATGT 
crAss24
6 
crAss246-
For CACCTGAATTAGTATTATCGCCAC 67366 to 
67515 
7
2 Fail     
Low amplification, primer 
dimer crAss246-
Rev GGGGTAGTGATGATGGTCAAG 
crAss24
7 
crAss247-
For 
ACCCCAAATGTATCTAAGTTGGA
C 67511 to 
67660 
7
2 Fail     Primer Dimer crAss247-
Rev CGTCAAGGAGGAATTGCTCAAC 
crAss24
8 
crAss248-
For GTCATTCCAGCAACTGGGGTA 67700 to 
67825 
7
3 Fail     Primer Dimer crAss248-
Rev AGCTATTAATGACGGATGTGGAG 
crAss24
9 
crAss249-
For 
GAAGAAGTATCTCCCATTACTCTC
C 68015 to 
68159 
7
3 
Pas
s 
Fai
l   Primer Dimer crAss249-
Rev 
AACTTACAGGTATGGTTGGTGAA
G 
crAss25
0 
crAss250-
For CTGACCTTTAGCCCAATTACTACA 68086 to 
68235 
7
3 Fail     Primer Dimer crAss250-
Rev ACAATGCCTGTTGGTTGTGA 
crAss25
1 
crAss251-
For 
ACCATATCTTGAGTAAGAACAGC
TT 68297 to 
68440 
7
3 Fail     
Low amplification, primer 
dimer crAss251-
Rev TCTTTCTGATGAACGTCCAAGACT 
crAss25
2 
crAss252-
For TGGACGTTCATCAGAAAGACAAG 68422 to 
68541 
7
3 Fail     Primer Dimer crAss252-
Rev 
AGATGGACTATTGTAGAACCTAC
TG 
crAss25
3 
crAss253-
For TTCCATAAGCAGGAGTGTTGAC 68472 to 
68581 
7
3 
Pas
s 
Fai
l   False Positive, Spurious Band crAss253-
Rev 
GACTATTCATGATGGAGTTGGAT
TT 
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crAss25
4 
crAss254-
For 
TCAGTAGGTTCTACAATAGTCCAT
C 68516 to 
68651 
7
3 Fail     
Low amplification, primer 
dimer crAss254-
Rev 
GAACAGATTTAGGTAATACTGCT
GG 
crAss25
5 
crAss255-
For CCACGGGGAGTAAGACCTTG 68763 to 
68872 
7
3 Fail     Primer Dimer crAss255-
Rev 
TCCAGGTTGTTGTAATGTTAATCG
T 
crAss25
6 
crAss256-
For 
GATTAACATTACAACAACCTGGA
CT 68850 to 
68997 
7
3 
Pas
s 
Fai
l   Primer Dimer crAss256-
Rev 
CCAATTGCTGATGGAACCATTGA
T 
crAss25
7 
crAss257-
For 
CCAATTAGTAGAACGATTAATGC
CA 76436 to 
76561 
7
7 Fail     Low amplification crAss257-
Rev 
GTTATAGCACCTAGTAACTGGAG
A 
crAss25
8 
crAss258-
For 
ACTTGATGGTTATTATCACCGGAT
T 76560 to 
76678 
7
7 Fail     Low amplification crAss258-
Rev GCTGCTCCGGGTCGTAATG 
crAss25
9 
crAss259-
For TGAAGAGGTAAATCAGTACCACC 76614 to 
76728 
7
7 Fail     Low amplification crAss259-
Rev 
ATCTTGATTGGAAAACAGTTCTTG
A 
crAss26
0 
crAss260-
For CCCATAACAAAACGTCCTTGTGC 76776 to 
76887 
7
7 Fail     
Low amplification, primer 
dimer crAss260-
Rev AAGCTTGGATTGCTGCCGTT 
crAss26
1 
crAss261-
For TTCCCAACCATTAGGAGGAGTT 76811 to 
76936 
7
7 Fail     Primer Dimer crAss261-
Rev CAAGGTGGTGGAAGTGGACAA 
crAss26
2 
crAss262-
For CCACCTTGTCCAAATCCTTCTCT 76929 to 
77074 
7
7 Fail     Primer Dimer crAss262-
Rev 
CTTGGTGAAGCTAGAACAGGTAA
GT 
crAss26
3 
crAss263-
For GCAAGAAGCCAAGCATAGAACT 77622 to 
77745 
7
7 
Pas
s 
Fai
l   False Positive, Spurious Band crAss263-
Rev GGGATGGTGAAAAATGGGTAAG 
crAss26
4 
crAss264-
For TACTTACCCATTTTTCACCATCCC 77722 to 
77861 
7
7 Fail     
Low amplification, primer 
dimer crAss264-
Rev TGGAAATTGGGCTGTTGGT 
crAss26
5 
crAss265-
For ACAGCCCAATTTCCATCAAGAG 77847 to 
77977 
7
7 Fail     No Product crAss265-
Rev 
ATTATTCTTTGGAGAGGTGGTAG
AA 
crAss26
6 
crAss266-
For 
AGTTTGTCCAGCTAAACAATAAT
CA 77999 to 
78135 
7
7 Fail     Low amplification crAss266-
Rev 
ATGATTATAGTGGAAAGGCTCGT
AA 
crAss26
7 
crAss267-
For AGATATTTACGAGCCTTTCCACT 78105 to 
78237 
7
7 Fail     Low amplification crAss267-
Rev 
AACAAATGTTTACTGCTTCACAG
A 
crAss26
8 
crAss268-
For 
TTTACGAGCCTTTCCACTATAATC
A 78110 to 
78223 
7
7 Fail     Low amplification crAss268-
Rev GCTTCACAGATTACTAATGCAGC 
crAss26
9 
crAss269-
For 
TCAGGAGTAATCTGACCTTCAAG
TA 78258 to 
78399 
7
7 Fail     Primer Dimer crAss269-
Rev GTGCAGTTGCTGATGAATTTGG 
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crAss27
0 
crAss270-
For 
TACCAAATTCATCAGCAACTGCA
CG 78376 to 
78485 
7
7 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss270-
Rev 
GAAATGGCATCTTGAAGCTGATT
CT 
crAss27
1 
crAss271-
For 
TTCAGAATCAGCTTCAAGATGCC
A 78458 to 
78575 
7
7 Fail     No Product crAss271-
Rev 
GGAACAGATTGGAGTAGGTTGTG
A 
crAss27
2 
crAss272-
For AAGAGCATCTCTATCTTCCATTGT 78581 to 
78727 
7
7 Fail     Low amplification crAss272-
Rev TGGCAGCCTATTGCTAAACTTC 
crAss27
3 
crAss273-
For AGTTTAGCAATAGGCTGCCA 78708 to 
78845 
7
7 Fail     Primer Dimer crAss273-
Rev TGGTCAATGGAATGATAGACCTT 
crAss27
4 
crAss274-
For CCCAAAGTTTACCAGTTTCAGGG 79027 to 
79136 
7
8 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss274-
Rev TAGTGGTTCTATTACGCTTCCTGT 
crAss27
5 
crAss275-
For CCTTCTTCATCAACAGGAAGCG 79101 to 
79238 
7
8 Fail     Primer Dimer crAss275-
Rev GGCGGCATATCAACTTGGTC 
crAss27
6 
crAss276-
For TGCCGCCATAGCAGATTGAA 79232 to 
79343 
7
8 
Pas
s 
Fai
l   Spurious Band crAss276-
Rev 
TCTTATGGCACAATATGGACTTG
A 
crAss27
7 
crAss277-
For 
GCATATCAAGTCCATATTGTGCC
AT 79315 to 
79426 
7
8 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss277-
Rev 
ACTGAACAAGTTGAGATTGACCC
T 
crAss27
8 
crAss278-
For TCAACTTGTTCAGTTCCATCAGC 79413 to 
79561 
7
8 Fail     Primer Dimer crAss278-
Rev AGCACTAGAAGCCTTAGAATTGC 
crAss27
9 
crAss279-
For 
AGCAATTCTAAGGCTTCTAGTGC
TT 79538 to 
79669 
7
9 Fail     
Low amplification, primer 
dimer crAss279-
Rev ATTGCGTATTGCAAGCATGGC 
crAss28
0 
crAss280-
For 
AGATAATCTTCATCACCACGATA
CA 79898 to 
79996 
7
9 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss280-
Rev 
TCGTGACCAAATAGAATATAACG
CT 
crAss28
1 
crAss281-
For GCGTTATATTCTATTTGGTCACGA 79973 to 
80066 
7
9 
Pas
s 
Fai
l   False Positive, Primer Dimer crAss281-
Rev TGGTTAATGCAGCTTCGGAATG 
crAss28
2 
crAss282-
For TTCCGAAGCTGCATTAACCA 80047 to 
80160 
8
0 Fail     
Low amplification, primer 
dimer crAss282-
Rev 
CCTTTAGATGATATCGCCAAACTT
C 
crAss28
3 
crAss283-
For 
GAAGTTTGGCGATATCATCTAAA
GG 80136 to 
80250 
8
0 Fail     
Low amplification, primer 
dimer crAss283-
Rev CAAAATGCCTTTGAACAAGGTCT 
crAss28
4 
crAss284-
For 
AGCAGCTCCAGTAGGAAATGCTA
T 80430 to 
80554 
8
1 Fail     
Low amplification, primer 
dimer crAss284-
Rev 
AACCTGATAGTGCAGATGCTGGA
T 
crAss28
5 
crAss285-
For 
CAGGTTGTTTCAAAGGATTAAGC
GG 80549 to 
80698 
8
1 Fail     Primer Dimer crAss285-
Rev CAGCTACTGGTTTTCCTGCATA 
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crAss28
6 
crAss286-
For CTCCATATGCAGGAAAACCAGT 80672 to 
80796 
8
1 Fail     Primer Dimer crAss286-
Rev TGTTGCTGAGGCTAAAATCACTC 
crAss28
7 
crAss287-
For AGAGTGATTTTAGCCTCAGCA 80773 to 
80918 
8
1 Fail     No Product crAss287-
Rev AATGAACGTAATCGTTGGACTGC 
crAss28
8 
crAss288-
For GCAGTCCAACGATTACGTTC 80896 to 
81013 
8
1 Fail     Primer Dimer crAss288-
Rev 
AACCTGCTACTACTTTCTCTGCT
A 
crAss28
9 
crAss289-
For 
CATCTCCGATAGTAAGATTAGCA
GA 80972 to 
81087 
8
1 Fail     Primer Dimer crAss289-
Rev TGGTCGTGAAGCAAATGGTC 
crAss29
0 
crAss290-
For CTGGACCATTTGCTTCACGAC 81065 to 
81214 
8
1 Fail     
Low amplification, primer 
dimer crAss290-
Rev GCAAAGTCGCTTATGGAGCAG 
crAss29
1 
crAss291-
For GCTCCATTAGAAGTAGCACCA 81272 to 
81381 
8
2 Fail     Primer Dimer crAss291-
Rev 
AGAGAAGAAGATTGGGTTAATT
GTG 
crAss29
2 
crAss292-
For 
AACTTAACTTTAGCAGGTTCTTT
GA 81392 to 
81537 
8
2 Fail     Primer Dimer crAss292-
Rev AATCGTGCTGCGAAAGATGC 
crAss29
3 
crAss293-
For GAGCATCTTTCGCAGCACG 81516 to 
81655 
8
2 Fail     
Low amplification, primer 
dimer crAss293-
Rev TGATAGCGACGGAATAATGCT 
crAss29
4 
crAss294-
For 
GCCATTATAACTAACTTGAAAGC
CT 81604 to 
81720 
8
2 
Pas
s Fail   Spurious Band crAss294-
Rev GGTACTGTTAACGGCGGAGA 
crAss29
5 
crAss295-
For CGTTAACAGTACCCGCTGTG 81708 to 
81818 
8
2 Fail     Primer Dimer crAss295-
Rev TAGTAGAAAACGTCGGACCTG 
crAss29
6 
crAss296-
For AACAGGTCCGACGTTTTCTACT 81796 to 
81916 
8
2 Fail     Primer Dimer crAss296-
Rev GGCACAACAGATGGGTATGC 
crAss29
7 
crAss297-
For CCCATCTGTTGTGCCAGTTC 81902 to 
82049 
8
4 
Pas
s Fail   False Positive crAss297-
Rev 
GGTGCTAATGTTAAGGAAGCTGT
T 
crAss29
8 
crAss298-
For 
TCTTAAACCATGTAACAGCTTCC
TT 82013 to 
82131 
8
4 
Pas
s Fail   Sensitivity crAss298-
Rev 
AATTGAGGTTCTTATTTCTCGTG
G 
crAss29
9 
crAss299-
For 
TCTCCACGAGAAATAAGAACCT
CAA 82105 to 
82252 
8
4 
Pas
s Fail   
False Positive, Spurious 
Band crAss299-
Rev TTCCTAACGGTATGGCTATGGAT 
crAss30
0 
crAss300-
For CAGTATCCATAGCCATACCGTT 82226 to 
82375 
8
4 
Pas
s Fail   False Positive, Primer Dimer crAss300-
Rev AGCGTCTTGCTAAACATCGTC 
crAss30
1 
crAss301-
For AGCCGAATTAATTTCCTGACGA 82338 to 
82437 
8
4 
Pas
s 
Pas
s 
Fai
l False Positive crAss301-
Rev 
TGCTCTTATTAATTCTGACCCAT
CT 
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crAss30
2 
crAss302-
For 
AGCTTCTCTAAGTTCTTTAACTCC
T 82566 to 
82677 
8
4 
Pas
s Fail   Sensitivity crAss302-
Rev 
TTTCTTTTGGAATCGTAAACGAG
AT 
crAss30
3 
crAss303-
For 
TCTTCGGCTCTAAAACGAAGATA
A 82630 to 
82778 
8
4 
Pas
s 
Pas
s 
Fai
l Sensitivity crAss303-
Rev 
GGTCTTGCTCCTAATAATGAAAA
CT 
crAss30
4 
crAss304-
For 
AGTTTTCATTATTAGGAGCAAGA
CC 82754 to 
82863 
8
4 Fail     Primer Dimer crAss304-
Rev 
GGATAAGATTGGTAGTTGTGTTC
GT 
crAss30
5 
crAss305-
For AGAACTACGAACACAACTACCA 82833 to 
83012 
8
4 Fail     Primer Dimer crAss305-
Rev GGAGTAGATAAACAGCCTGCTA 
crAss30
6 
crAss306-
For 
TGTATTAGCAGGCTGTTTATCTA
CT 82986 to 
83097 
8
4 Fail     Primer Dimer crAss306-
Rev 
AAATGAAGCTAATAAAGCAGGA
GAA 
crAss30
7 
crAss307-
For CTACCTGCAAACCAATAGAGCCT 83181 to 
83290 
8
6 Fail     Primer Dimer crAss307-
Rev 
AGGTATGACTGATATTCCTGCTT
G 
crAss30
8 
crAss308-
For CAATCCCCAGCAAGCAGGAA 83257 to 
83402 
8
6 Fail     Primer Dimer crAss308-
Rev 
TGCCTATTACTTCTCATCAAGCT
G 
crAss30
9 
crAss309-
For GCAGCTTCAGCATCAGTACC 83438 to 
83550 
8
6 Fail     Primer Dimer crAss309-
Rev GGTGATGGTCTTTCTTATGGACG 
crAss31
0 
crAss310-
For 
AAAGTAACGTCCATAAGAAAGA
CCA 83521 to 
83668 
8
6 Fail     Primer Dimer crAss310-
Rev GAATGTAGCTCTTATGGGTGGC 
crAss31
1 
crAss311-
For TTGCCACCCATAAGAGCTACA 83645 to 
83790 
8
6 Fail     Primer Dimer crAss311-
Rev 
GCTGGTATGTTAGAAATTTGTCG
TG 
crAss31
2 
crAss312-
For ACAGTCAGAACTTCACCATAAGT 83729 to 
83873 
8
6 Fail     False Positive crAss312-
Rev TGTGGAAGTCTGAATATAACCGT 
crAss31
3 
crAss313-
For 
AACGGTTATATTCAGACTTCCAC
A 83850 to 
83965 
8
6 Fail     Primer Dimer crAss313-
Rev 
CCAAAATGATAATGGTGGTACTT
CT 
crAss31
4 
crAss314-
For GTTGAACTGTCGCATCTCTTCG 83905 to 
84054 
8
6 Fail     Primer Dimer crAss314-
Rev CCTGCTGGAATGACTTCTCAAC 
crAss31
5 
crAss315-
For GTCATTCCAGCAGGACCCAT 84041 to 
84152 
8
6 Fail     Primer Dimer crAss315-
Rev TTGACCCTCAATGGTTGGCT 
crAss31
6 
crAss316-
For 
TCATTGCCCAATACATACCTTTA
GC 84111 to 
84260 
8
6 Fail     False Positive crAss316-
Rev CTGCTCCTGATGGTGTTACTCA 
crAss31
7 
crAss317-
For TTGACCAGGTTTAGTAACAGCAG 84322 to 
84447 
8
6 Fail     
Low amplification, primer 
dimer crAss317-
Rev GAAGGTCAAGGTAGTCGTGGT 
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crAss3
18 
crAss318-
For 
AGGAAAACGGTCATCATCCAT
AC 84463 to 
84611 
8
6 
Pas
s 
Fai
l   
False Positive, Spurious Band, Primer 
Dimer crAss318-
Rev 
TGAAAACATTACGTGTTATTG
GACA 
crAss3
19 
crAss319-
For 
AGCTCCTTTTGTAGATTTACGT
TGA 84695 to 
84842 
8
8 
Fai
l     Primer Dimer crAss319-
Rev TGCTGAAAGACGCGATGAAG 
crAss3
20 
crAss320-
For ATCGCGTCTTTCAGCAGGAG 84827 to 
84975 
8
8 
Fai
l     Primer Dimer crAss320-
Rev 
TTCCCGAAACTGTTATTATTGA
ACG 
crAss3
21 
crAss321-
For 
TCGGGAATACGATAACCAGCA
AT 84969 to 
85095 
8
8 
Fai
l     Primer Dimer crAss321-
Rev 
TGCGTGAAGCTAATGCTAAAG
AAG 
crAss3
22 
crAss322-
For 
TAGCTTCACGCATTTCGTTATC
AG 85084 to 
85231 
8
8 
Fai
l     Low amplification, primer dimer crAss322-
Rev 
ATTGTTCGTGAGGCGTTTAAG
GA 
crAss3
23 
crAss323-
For 
ACTTATCAACATTACCACGAC
GAT 85180 to 
85300 
8
8 
Pas
s 
Fai
l   Spurious Band crAss323-
Rev GGCTTTGGTGAACTTCGAGA 
crAss3
24 
crAss324-
For ACCGCTTCTATCTCGAAGTTCA 85271 to 
85399 
8
8 
Fai
l     Primer Dimer crAss324-
Rev 
GACGAATTTGCTCAAGCTGGT
GT 
crAss3
25 
crAss325-
For 
CTTGAGCAAATTCGTCACGTTT
TA 85384 to 
85497 
8
8 
Pas
s 
Fai
l   False Positive, Spurious Band crAss325-
Rev 
GTGTTTCTGTTACTTCAGAAGA
TGG 
crAss3
26 
crAss326-
For 
AGTAACAGAAACACCTACAAG
TTCT 85484 to 
85632 
8
8 
Pas
s 
Fai
l   False Positive crAss326-
Rev 
ACGGTAATCTTATTGACGATA
AAGG 
crAss3
27 
crAss327-
For 
TTCTTTAAGATAAGCAGCAAC
TTCA 85562 to 
85709 
8
8 
Fai
l     Low amplification, primer dimer crAss327-
Rev TGACACTGATGCTGAACATGG 
crAss3
28 
crAss328-
For 
GTCATTCGCTTTGTCATTAGGC
TT 85706 to 
85854 
8
8 
Pas
s 
Fai
l   Primer Dimer crAss328-
Rev 
GTAAAACAGGGCAGTTAGATG
CTG 
crAss3
29 
crAss329-
For 
TCACTATTCCCATCTCCATTAC
CA 85776 to 
85897 
8
8 
Fai
l     Primer Dimer crAss329-
Rev 
GGTGATGGAAAACCTACTGAC
G 
crAss3
30 
crAss330-
For 
AAGTTGTGCTTCAACAGAAGT
C 86381 to 
86490 
9
1 
Pas
s 
Fai
l   False Positive, Spurious Band crAss330-
Rev 
GTGATGCTGAAAAGAATCAAG
CTG 
crAss3
31 
crAss331-
For 
AGTCTAGCATTTTCCATACGTT
CT 86442 to 
86554 
9
1 
Fai
l     False Positive crAss331-
Rev 
CTTGATGGTCAAATTGAAGCT
ATGA 
crAss3
32 
crAss332-
For 
TCTTTTCAGCATCACTAAGACC
A 86476 to 
86615 
9
1 
Fai
l     Low amplification, primer dimer crAss332-
Rev 
ACTTGCTAAGATTGATAGAAA
AGCA 
crAss3
33 
crAss333-
For 
CGTTTTTGCAATCTTGACTTTA
TCA 86318 to 
86450 
9
1 
Fai
l     Primer dimer crAss333-
Rev 
TGCTAGACTTAATCTTGAACG
TAGT 
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Table B3 (continued) 
crAss33
4 
crAss334-
For 
TTGACGAAGTTGTTCTGTTTGTTG
A 86624 to 
86738 
9
1 Fail     
Low amplification, primer 
dimer crAss334-
Rev TCGTGGAGATAATGTTGCTCA 
crAss33
5 
crAss335-
For 
GCAACATTATCTCCACGAATAGC
A 86721 to 
86830 
9
1 Fail     Primer dimer crAss335-
Rev 
TCTGTTAAAGAACGTGAGAAACT
TG 
crAss33
6 
crAss336-
For 
GTTCAAGTTTCTCACGTTCTTTAA
C 86803 to 
86951 
9
1 Fail     False Positive crAss336-
Rev TAAACTTGCTTGGATTGATGGTCT 
crAss33
7 
crAss337-
For AAGACCATCAATCCAAGCAAGTT 86927 to 
87049 
9
1 Fail     False Positive crAss337-
Rev GACGAAGCAGTTATTCGTGGA 
crAss33
8 
crAss338-
For AACTGCTTCGTCAGTAACTCC 87038 to 
87162 
9
1 
Pas
s 
Fai
l   Primer Dimer crAss338-
Rev 
TTACGGAACTTGGGCAACTTATT
C 
crAss33
9 
crAss339-
For GAATAAGTTGCCCAAGTTCCGT 87139 to 
87267 
9
1 Fail     Spurious Bands crAss339-
Rev ATCGTATGGCTGCTGATGGT 
crAss34
0 
crAss340-
For 
CCATACGATATATAGTTTCAGCA
GG 87259 to 
87437 
9
1 Fail     Primer dimer crAss340-
Rev AGAACTTTTGCCTGGTTTTGGA 
crAss34
1 
crAss341-
For TCTTCCAAAACCAGGCAAAAGT 87413 to 
87524 
9
1 
Pas
s 
Fai
l   False Positive crAss341-
Rev TGGCTCTCGTGCTACAAGTAT 
crAss34
2 
crAss342-
For ACGCCACACCCATTCAATACT 87551 to 
87690 
9
1 Fail     Primer dimer crAss342-
Rev GGCATACTGTTTGGAGAGGTGA 
crAss34
3 
crAss343-
For ACCATTATTAGCATCACGAGCC 87704 to 
87831 
9
1 Fail     Primer dimer crAss343-
Rev 
GCGATAGAGCACTTTTAAATTGG
G 
crAss34
4 
crAss344-
For 
CCCAATTTAAAAGTGCTCTATCG
C 87808 to 
87948 
9
1 Fail     Primer dimer crAss344-
Rev TTGCTGAACGTCGTATGTTGAC 
crAss34
5 
crAss345-
For TTGTTGTTTAGTCAACATACGACG 87917 to 
88008 
9
1 
Pas
s 
Fai
l   False Positive, Spurious Band crAss345-
Rev 
GTGTTAGAGATGCTTTTCCTGTTC
C 
crAss34
6 
crAss346-
For GCATCTCTAACACTAACAACACG 87996 to 
88133 
9
1 Fail     Primer dimer crAss346-
Rev 
TGTTATTGATGACCTTACTGATGC
T 
crAss34
7 
crAss347-
For CTTGTCCTTGTGCACTAATATCAT 88144 to 
88267 
9
1 Fail     Primer dimer crAss347-
Rev 
ATGCAGTTTGTTAATGAAGGCAA
TA 
crAss34
8 
crAss348-
For 
ATTATTGCCTTCATTAACAAACTG
C 88241 to 
88350 
9
1 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss348-
Rev 
TATTTGCTAGAGATGCTGAACTT
GG 
crAss34
9 
crAss349-
For 
AGCTCCAACAATAAAATCATGTG
G 88367 to 
88476 
9
1 Fail     Primer dimer crAss349-
Rev ATCTAACTCGTTTTCCAGCTACT 
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Table B3 (continued) 
crAss35
0 
crAss350-
For 
CATAGTAGCTGGAAAACGAGTTA
GA 88451 to 
88594 
9
1 Fail     False Positive crAss350-
Rev 
GCTGGTATTGCTTGTAAAGCTGAT
T 
crAss35
1 
crAss351-
For 
CAGCTTCTATAACGTAATCACAA
CA 88591 to 
88684 
9
1 Fail     False Positive crAss351-
Rev 
GGTAGACTTGATTTTCCTAATCAG
C 
crAss35
2 
crAss352-
For 
CTTCTGTAACTTTCTTACGACTAG
C 88756 to 
88866 
9
2 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss352-
Rev CCGAAGGTAACTTTGACCGTA 
crAss35
3 
crAss353-
For 
GTCAAAGTTACCTTCGGCATTAA
AC 88850 to 
88999 
9
2 Fail     False Positive crAss353-
Rev AAACTAGATGGTCTTCGACTTCT 
crAss35
4 
crAss354-
For 
GAACTCTTTAAGAAGTCGAAGAC
CA 88967 to 
89079 
9
2 Fail     
Low amplification, primer 
dimer crAss354-
Rev 
AACCTTTATATGTTTGGGATTCTG
C 
crAss35
5 
crAss355-
For 
TCTTTAACAGCAGAATCCCAAAC
A 89046 to 
89156 
9
2 
Pas
s 
Fai
l   Spurious Band, Primer Dimer crAss355-
Rev 
TGGACTTGTAGAAATAAATCGTG
GT 
crAss35
6 
crAss356-
For 
CACCACGATTTATTTCTACAAGTC
C 89131 to 
89243 
9
2 Fail     Primer Dimer crAss356-
Rev TGCTGCATATTATGGACGTACTGA 
crAss35
7 
crAss357-
For TGCAGCACACAACTTAGGTTTA 89237 to 
89381 
9
2 Fail     Primer Dimer crAss357-
Rev TCCCGGTACTTATGTTGCAGT 
crAss35
8 
crAss358-
For TGCAACATAAGTACCGGGAAGA 89363 to 
89479 
9
2 
Pas
s 
Fai
l   Primer Dimer crAss358-
Rev AGACGTGGTAACGAAGACCC 
crAss35
9 
crAss359-
For 
AGTTCCATCTTCAAATAGTTCACC
A 89564 to 
89711 
9
2 
Pas
s 
Fai
l   Sensitivity crAss359-
Rev TCAGCGTGCTTTATTTCCTGC 
crAss36
0 
crAss360-
For 
AGCACTACTAAAAGATTCAGCAG
GA 89672 to 
89784 
9
2 Fail     False Positive crAss360-
Rev AGCTTGCTGCACGAGAAAGA 
crAss36
1 
crAss361-
For TCAGCAGGAAATAAAGCACGC 89688 to 
89797 
9
2 Fail     Primer Dimer crAss361-
Rev CGAATAGGACTTAAGCTTGCTGC 
crAss36
2 
crAss362-
For TCGTGCAGCAAGCTTAAGTCC 89771 to 
89900 
9
2 Fail     No Product crAss362-
Rev 
TGCTCGTAATGAAGTTTGTGGATT
C 
crAss36
3 
crAss363-
For ATCCACAAACTTCATTACGAGCA 89878 to 
90005 
9
2 Fail     No Product crAss363-
Rev GGCTTGGGGAACTGCTACTG 
crAss36
4 
crAss364-
For AGCAGTTCCCCAAGCCATAA 89990 to 
90137 
9
2 Fail     False Positive crAss364-
Rev 
TGACTGTGCTATTGGTAAAGATG
C 
crAss36
5 
crAss365-
For 
TGCATTGTAGATAGCTCTTCAACT
T 90078 to 
90199 
9
2 Fail     
Low amplification, primer 
dimer crAss365-
Rev 
GGAGTTGAAGCTGATGATAGTTG
G 
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Table B3 (continued) 
crAss366 
crAss366-For GACCAACTATCATCAGCTTCAACTC 
90174 to 90284 92 Fail     Primer Dimer 
crAss366-Rev GTTCTTTGAAGAAAAGACTCCGTTT 
crAss367 
crAss367-For TCTTTTAAACGGAGTCTTTTCTTCA 
90254 to 90363 92 Fail     No Product 
crAss367-Rev TTGTTATTCATGTTGCGGCTG 
crAss368 
crAss368-For TCATTAGAACTATCAGCAGCCAT 
90387 to 90508 92 Fail     No Product 
crAss368-Rev GATGCTCAATTTTGGACTTGGC 
crAss369 
crAss369-For ACCTCCACGTCGAGTTTTATCA 
90422 to 90559 92 Fail     Primer Dimer 
crAss369-Rev ACTGAACATGGAGCTACTGC 
crAss370 
crAss370-For GCAGTAGCTCCATGTTCAGTAAC 
90540 to 90679 92 Pass Fail   False Positive 
crAss370-Rev TCTGCTCCTTGTTGGCAAAATC 
crAss371 
crAss371-For GGATTTTGCCAACAAGGAGCA 
90657 to 90788 92 Fail     Primer Dimer 
crAss371-Rev AGCTGCTAGAACATATCAAGCCA 
crAss372 
crAss372-For TGGCTTGATATGTTCTAGCAGCTT 
90766 to 90906 92 Fail     Primer Dimer 
crAss372-Rev AGAAAGCTAGTGATTGTGGATGGT 
crAss373 
crAss373-For GGGTCATACCATCCACAATCACT 
90876 to 90970 92 Pass Fail   False Positive 
crAss373-Rev ATGGCTGATGGTAAATATCCTTTTC 
crAss374 
crAss374-For AGTTGTATCAGTAGTGTTGACTCCC 
91265 to 91359 94 Fail     No Product 
crAss374-Rev CAGTGCTACTTGGGAGTTATTCAAG 
crAss375 
crAss375-For AAGCAAATCAAGATTCCATCTACC 
91642 to 91770 94 Pass Pass Fail False Positive 
crAss375-Rev TTTAATAGTCAGAGAGTTGCTGAAC 
crAss376 
crAss376-For TCATCAAGTTCAAATACATCCCAAT 
91772 to 91921 94 Fail     Primer Dimer 
crAss376-Rev GCAAGGTTGGACTATGATTGATTCT 
crAss377 
crAss377-For AATCAATCATAGTCCAACCTTGCC 
91899 to 91988 94 Fail     No Product 
crAss377-Rev TAAACGATAAAGATGATGCTGGTGG 
crAss378 
crAss378-For GTTTCCTTTTCCGGCAATATCA 
92296 to 92416 95 Fail     Primer Dimer 
crAss378-Rev TAGAACTCAAGATTCTCTTAACGCT 
crAss379 
crAss379-For TCAACAGCAAAAGCATACATACTAA 
92842 to 92973 96 Fail     False Positive 
crAss379-Rev AGTTAAACCTGCACAACAAACTAAT 
crAss380 
crAss380-For CAAACATTAGTTTGTTGTGCAGGT 
92944 to 93053 96 Fail     No Product 
crAss380-Rev AATTGTGCTGTTGTAGGCGAT 
crAss381 
crAss381-For TCCAATCGCCTACAACAGCA 
93029 to 93171 96 Fail     Primer Dimer 
crAss381-Rev TGATGCGTTTAAAATGTACACTGA 
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Table B3 (continued) 
crAss38
2 
crAss382-For AGTAACCATTACACCATCTTCTCG 93264 to 
93386 
9
6 
Pas
s 
Fai
l   Sensitivity, Primer Dimer crAss382-
Rev AAAGAAGCTTGTGAACGTGGAA 
crAss38
3 
crAss383-For GGTCAGCATCCAATCCAATTCC 94266 to 
94378 
9
8 
Pas
s 
Fai
l   Primer Dimer crAss383-
Rev TGCTGCTTATGCTAATCTTTGGC 
crAss38
4 
crAss384-For CGATACCAATTCTTTTGAATAGTGC 94577 to 
94669 
9
8 
Pas
s 
Fai
l   
False Positive, Spurious 
Band crAss384-
Rev 
TGAAAGTCTTGAAAAAGAAGCTA
GT 
 
 
 
 
 
 
 
Table B4: Summary of round three candidate end-point primer set testinga 
 
 
Primer 
Set 
Non-Human Host Distribution Sewage 
Distribution 
LOD95 
Specificity False Positives 0.01ng 0.001ng 
crAss028 100% None 92.6% --- --- 
crAss056 100% None 100% 100% 45% 
crAss064 100% None 100% 100% 52.5% 
crAss301 96% Pig (n=5); Goose (n=2); Dog (n=1) --- --- --- 
crAss303 100% None 92.6% --- --- 
crAss375 95% Pig (n=3); Horse (n=3); Goose (n=1); Deer (n=1); Dog (n=1); Cow (n=1) --- --- --- 
 
a Specificity, calculated as the percent of negative non-target animal samples; Sewage Distribution, calculated as the 
percent of positive sewage samples; LOD95, defined as the lowest dilution concentration where a minimum of 95% 
(38 of 40) of reactions yielded an amplification product of the expected size; a “---“ indicates that primer set was not 
evaluated. 
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Table B5: Summary of crAssphage and bacterial human-associated qPCR calibration model 
performance metricsa 
 
 
Assay Master Slope 
Y-Intercept 
Range E 
LLOQ 
Range CV 
CPQ_056 -3.47±0.03 37.7 to 39.3 0.94 0.82 to 0.94 1.88% 
CPQ_064 -3.39±0.03 39.4 to 40.7 0.97 0.86 to 0.97 0.81% 
HF183/BacR287 -3.48±0.03 35.9 to 36.9 0.94 0.86 to 0.95 1.62% 
HumM2 -3.36±0.05 37.1 to 38.2 0.99 0.85 to 0.96 1.79% 
 
aMaster Slope, average and standard deviation of six calibration curves ran for each assay; Y-Intercept Range, range 
of the six y-intercept measurements run on each individual plate; E, amplification efficiency, calculated as E=10(-
1/slope)-1; LLOQ Range, Lower Limit of Quantification Range, expressed in log10 copies/reaction, defined as the 
upper bound of the 95% credible interval from repeated measures of the 10 copy per reaction standard curve 
dilutions; CV, % coefficient of variation, calculated from standard data at 10 copies per reaction. 
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Figure B1: CrAssphage sequence verification alignment with sequences isolated from primary 
influent sewage and a human fecal pollution impact environmental water sample to the crAss056 
amplicon (A) and the crAss064 amplicon (B). The letters ‘A-H’ represent the variant designation 
and the number in parenthesis is the sequence count for respective sample source/variant 
combination. Differences are highlighted in black. 
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APPENDIX C 
CHAPTER 5 – SUPPLEMENTAL INFORMATION 
Table C1 Spearman’s rank correlation coefficients matrix for culturable indicators, qPCR indicators, and chemical parameters. 
 
 
 
 
E. coli Enterococci
Somatic 
coliphage CPQ_056 CPQ_064 HF183 HPyV TOC pH TDS Turbidity
E. coli 0.934 0.581 0.577 0.734 0.876 0.722 0.839 -0.481 -0.598 0.763
Enterococci 0.934 0.466 0.420 0.656 0.862 0.670 0.826 -0.443 -0.585 0.795
Somatic coliphage 0.581 0.466 0.669 0.541 0.539 0.378 0.469 -0.291 -0.570 0.506
CPQ_056 0.577 0.420 0.669 0.675 0.420 0.275 0.348 -0.395 -0.378 0.334
CPQ_064 0.734 0.656 0.541 0.675 0.784 0.716 0.675 -0.544 -0.524 0.430
HF183 0.876 0.862 0.539 0.420 0.784 0.774 0.777 -0.498 -0.666 0.732
HPyV 0.722 0.670 0.378 0.275 0.716 0.774 0.672 -0.256 -0.514 0.483
TOC 0.839 0.826 0.469 0.348 0.675 0.777 0.672 -0.397 -0.740 0.714
pH -0.481 -0.443 -0.291 -0.395 -0.544 -0.498 -0.256 -0.397 0.425 -0.369
TDS -0.598 -0.585 -0.570 -0.378 -0.524 -0.666 -0.514 -0.740 0.425 -0.708
Turbidity 0.762 0.795 0.506 0.334 0.430 0.732 0.483 0.714 -0.369 -0.708
136 
Table C2 P-values for Spearman’s rank correlation coefficients matrix for culturable indicators, qPCR indicators, and chemical 
parameters. 
 
 
 
E. coli Enterococci
Somatic 
coliphage CPQ_056 CPQ_064 HF183 HPyV TOC pH TDS Turbidity
E. coli 1.60 E -14 6.16 E -4 6.86 E - 4 2.63 E -6 1.11 E -10 6.57 E -06 3.83 E -09 6.11 E -3 3.77 E -4 6.18 E -07
Enterococci 1.60 E -14 8.22 E -3 0.0186 6.06 E -5 4.63 E -10 5.15 E -5 1.04 E -08 0.0126 5.41 E -4 9.17 E -08
Somatic coliphage 6.16 E -4 8.22 E -3 3.94 E -5 1.69 E -3 1.75 E -3 0.0397 7.73 E -3 0.113 8.26 E -4 3.72 E -3
CPQ_056 6.86 E - 4 0.0186 3.94 E -5 3.11 E - 5 0.0187 0.141 0.0554 0.0279 0.036 0.0667
CPQ_064 2.63 E -6 6.06 E -5 1.69 E -3 3.11 E - 5 1.83 E -07 8.59 E -06 3.16 E -7 1.58 E - 3 2.49 E -3 0.0158
HF183 1.11 E -10 4.63 E -10 1.75 E -3 0.0187 1.83 E -07 5.12 E -07 2.81 E -07 4.33 E -3 4.37 E -5 2.93 E -06
HPyV 6.57 E -06 5.15 E -5 0.0397 0.141 8.59 E -06 5.12 E -07 4.83 E -5 0.171 3.63 E -3 6.90 E -3
TOC 3.83 E -09 1.04 E -08 7.73 E -3 0.0554 3.16 E -7 2.81 E -07 4.83 E -5 0.0269 1.98 E -06 6.47 E -06
pH 6.11 E -3 0.0126 0.113 0.0279 1.58 E - 3 4.33 E -3 0.171 0.0269 0.017 0.0412
TDS 3.77 E -4 5.41 E -4 8.26 E -4 0.036 2.49 E -3 4.37 E -5 3.63 E -3 1.98 E -06 0.017 8.31 E -06
Turbidity 6.18 E -07 9.17 E -08 3.72 E -3 0.0667 0.0158 2.93 E -06 6.90 E -3 6.47 E -06 0.0412 8.31 E -06
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